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SUMMARY
Glucocorticoids cause the regression of certain lymphoid tumours,
though the precise mechanism by which this is achieved is still not
fully understood. Consequently, I studied the action of a glucocorti¬
coid, methylprednisolone (MPS), on human lymphoid cell lines as a
possible in vitro model for this effect.
MPS induced both a cytolethal and growth inhibitory response in
these cells, which I have defined on a kinetic and morphological basis.
The cytolethal response - measured by the ability of live cells
to exclude nigrosine after treatment over l|8hr - was dose-dependent,
occurring around 10 MPS. Maximal lethal effects occurred only on
continuous exposure of the cells to MPS. Morphological changes, as
observed by light and electron microscopy, were consistent with
apoptosis followed by autolysis, with increased nigrosine uptake
correlating closely with onset of autolysis. A low background level
of apoptosis and autolysis was also present in control cultures.
The growth inhibitory response - measured by an increase in
population doubling time after treatment over several days - was
_7
dose-dependent, occurring within the concentration range 10 M -
10 Si MPS. Again, continuous exposure to MPS was necessary for the
response to be maintained. Morphological changes resulting from sub¬
lethal damage were seen in mitochondria by electron microscopy; in
addition a small increase in the number of apoptotic and autolytic
cells was observed by light microscopy. Cell cycle kinetic analysis
revealed/...
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.revealed that growth inhibition was a stable effect caused by a
blockage of cells in G^ (or Gq); I was unable to determine whether
blocked cells were committed to death or maintained the ability to
return to cycle.
A correlation was made between my own results and biochemical
studies performed on human lymphoid cell lines by other workers in
our research group. The relationship between in vitro and in vivo
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The growth rate of tumours and of normal renewal tissue is
determined "by three kinetic factors: (a) the cell cycle time of
proliferating cells, (b) the proportion of cells proliferating
(i.e., the growth fraction) and (c) the rate of cell loss by death or
removal (Steel, 1967; Lamerton, 1976; Tubiana and Malaise, 1976)
(see fig. 1). Of these, cell death has been the least studied and
it is with this that the first part of my thesis is concerned.
There are at least two major modes of cell death apparent in
both normal and malignant tissues - coagulative necrosis and
apoptosis. Their morphological appearance and occurrence differ
markedly which suggests mediation by different mechanisms.
Coagulative necrosis results from the breakdown of normal
homeostatic control mechanisms (Trump and Ginn, 1969) which leads
to a change in permeability of the plasma membrane and loss of cell
volume control. This is measured by loss of normal membrane
potential (Saladino and Trump, 1968; Jennings, Ganote and Reimer,
1975) and change in ionic flux resulting in potassium loss and entry
of sodium and water into the cell (Laiho and Trump, 197U)•
Early morphological changes involve swelling of the cytoplasm
and organelles accompanied by patchy nuclear chromatin aggregation
and condensation (pyknosis) around the periphery of the nucleus;
later stages involve disorganisation and rupture of the plasma
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Fig. 1.
Schematic representation of the cell cycle in tumours
and normal renewal tissue
Proliferating cells pass through various phases of the
mitotic cycle (Howard and Pelc, 1953): G^, post-mitotic
phase of variable duration; S, DNA-synthetic phase; G^,
relatively short pre-mitotic phase; M, period of mitotic
division. A proportion of cells may be 'resting' in Gq
phase (i.e., growth fraction <100%) where they maintain
their capacity to be 'stimulated' back into the division
cycle (Lajtha, 19^3). Non-proliferating mature cells have
a limited life-span and are 'committed' to death.
This scheme excludes the possibility of 'G^-arrest' cells
known to occur in other tissues (Hill, 1976).
cell death
membrane and dissolution of intracellular structures, with fragmen¬
tation of chromatin clumps (karyorrhexis) followed by chromatin
dissolution (karyolysis) (Trump and Ericsson, 1965; Trump and Arstila,
1971)- Coagulative necrosis usually involves large numbers of
adjacent cells in tissues with no dissociation of junctional complexes
until cell death is well advanced (Trump and Ginn, 19^9)- There is
total disruption of structure of affected areas and there is usually
associated inflammation in surrounding viable tissues (Majno, 1961+).
Coagulative necrosis occurs: in states of anoxia e.g., in
ischaemic tissue injury (Jennings, Ganote and Reimer, 1975) or in
tumours due to vascular insufficiency (Thomlinson and Gray, 1955;
Tannock, 1968); due to inhibition of oxidative phosphorylation,
glycolysis or citric acid cycle (Saladino and Trump, 1968; Hawkins
et al, 1972; McDowell, 1972a, 1972b; Laiho and Trump, 197^+); on
exposure of plasma membranes to agents such as toxins (McLean, McLean
and Judah, 19^5) and complement (Hawkins e_t al, 1972); in in vitro
autolysis (Trump, Goldblatt and Stowell, 19^5; Trump and Ginn, 19&9)-
Apoptosis, a morphologically distinctive type of cell death
(Kerr, Wyllie and Currie, 1972) affects scattered single cells without
surrounding structural damage or inflammation. In some situations
it appears to play a role complementary to mitosis in the controlled
regulation of normal ('Wyllie ejt al, 1973) and tumour cell populations
(Kerr, Wyllie and Currie, 1972).
The essential features of apoptosis are shown diagrammatically
in fig. 2. Affected cells initially round up losing contact with
their/...
Fig. 2
Diagram to illustrate the morphological features of
apoptosis (from Kerr, 'Wyllie and Currie, 1972)
APOPTOSIS
their neighbours by junctional complex breakdown, show condensation
and peripheral aggregation of nuclear chromatin and condensation of
cytoplasm and organelles. This is followed by nuclear membrane
breakdown and nuclear fragmentation, accompanied by 'budding' or
'blebbing' of the cell to form morphologically distinctive membrane-
bounded apoptotic bodies which may or may not contain nuclear
remnants, and in which cytoplasmic organelles maintain their struc¬
tural integrity. Later stages involve phagocytosis of these bodies
by neighbouring unaffected parenchymal cells or histiocytes, where
they undergo destruction within phagosomes by fusion with cellular
lysosomes. This results in their progressive degradation, but
ultimately undigestible material may remain in the ingesting cell as
a lysosomal residual body. Release of lysosomal enzymes is not
considered as being involved in the genesis of apoptosis (Kerr, 1972).
Apoptosis appears to be a widespread phenomenon and a detailed
presentation of its incidence in vivo can be found in Kerr, Wyllie
and Currie (1972) and Wyllie (197i+) • The typical morphological
features of apoptosis have been reported in the following situations:
during embryonic morphogenesis in the involution of tissues e.g., in
the removal of interdigital webs in rodents (Ballard and Holt, 1968)
and reptiles (Fallon and Cameron, 1977); in teratogenesis (Crawford,
Kerr and Currie, 1972); during metamorphosis e.g., in epidermal and
skeletal muscle cell death in the regression of the anuran tadpole
tail (Kerr, Harmon and Searle, 197U); in hormone-induced atrophy e.g.,
in castration-induced involution of the prostate due to androgen
4
withdrawal (Kerr and Searle, 1973) or in the adult adrenal cortex
after withdrawal of adrenocorticotrophin (ACTH) secretion by prednisone
administration/...
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administration (Wyllie ^t al, 1973); on exposure of tissues to anoxia
or toxins where environmental conditions are not altered sufficiently
to -cause coagulative necrosis e.g., in ischaemia-induced atrophy of
the liver by ligation of the portal blood supply (Kerr, 1971);
after exposure of tissues to irradiation e.g., in irradiation of
intestinal epithelium and skin epidermis (Potten, Al-Barwari and
Searle, 1978).
Of more relevance to the work in this thesis, apoptosis is also
present: in normal healthy tissues in the normal physiological control
of cell populations (Wyllie, Kerr and Currie, 1973); in untreated
tumours e.g., in basal cell carcinoma of the skin (Kerr and Searle,
1972a, 1972b) and in squamous carcinoma of the uterine cervix (Searle
et al, 1973)- Apoptosis may be enhanced in therapeutically-induced
tumour regression e.g., in irradiation of human squamous cell carcinoma
(Kerr and Searle, 1972b) and in mouse ascites tumours after addition
of non-steroidal cancer chemotherapeutic agents (Searle ejb al, 1975)-
Apoptosis has also been seen in in vitro cell death e.g., in rodent
lymphoid cells after treatment with glucocorticoids (Wyllie, in
preparation) and after irradiation (Trowell, 1966).
The enhancement of apoptosis in tumour regression indicates the
obvious clinical importance of this mode of cell death. However,
whilst the occurrence and morphology of apoptosis are now well
established, little is known of the intracellular mechanisms by which
it is mediated and controlled.
We therefore set out to establish an experimental irt vitro
system/...
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system for the combined study of the sequence of morphological and
biochemical changes occurring in apoptosis. Although systems are
known for induction of apoptosis in vivo, an iai vitro system would
provide:
(a) results which can be analysed freely without the complex¬
ities of an in vivo environment
(b) predictable onset of apoptosis such that the earliest
morphological and biochemical alteration in cells may be studied.
The lethal effects of glucocorticoids on certain rodent lymphoid
cells have been known for many years (Dougherty and White, 19U5)>
and as a result they have been employed extensively in the treatment
of human lymphoid tumours (DeVita, 1973» Schein ejt al, 1975; Berard
et al, 1976). Initially glucocorticoids were used as a single agent
in the treatment of lymphoid tumours; however remission, when it
occurred, was only achieved for a limited period of several months
(Ezdinli jet al, 19^9; Henderson, 1969). During the last decade
glucocorticoids have been used more successfully as part of chemo-
therapeutic regimes involving combined drug therapy, especially in the
case of childhood acute lymphoblastic leukaemia (ALL) (Berard ejt al,
1976; Mauer, Simone and Pratt, 1977; Simone et al, 1978). However
most drug regimes are still designed on an empirical basis and the
mechanism by which glucocorticoids act is still not fully understood.
There are two lines of evidence which together suggest that
glucocorticoids exert a cytolethal effect on human leukaemic cells:
(a) the rapid occurrence of a marked lymphocytopaenia (Henderson, 19&9;
Lampkin, Nagao and Mauer, 19^9; Ernst and Kallmann, 1970), and (b) the
complication/...
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complication of hyperuricaemia in a small percentage of leukaemic
patients (the result of massive DNA degradation) (Sandberg, Cartwright
and Wintrobe, 19f>6; Wolff ert al, 1967) after glucocorticoid therapy.
However there is no direct morphological evidence as yet of the
mechanism of deletion involved. Nevertheless, as apoptosis is known
to play an important role in the regression of certain tumours, then
the treatment of neoplastic human lymphoid cells in vitro with
glucocorticoids might prove a suitable model for induction of
apoptosis.
It would be desirable to use freshly isolated human lymphoid
cells from patients with leukaemia and lymphoma for experimental
purposes, however several difficulties are attached to this approach:
(a) within each class of leukaemia or lymphoma there may be a
range of phenotypes (Leventhal and Konior, 1976; Habeshaw, Macaulay
and Stuart, 1977) and this difficulty in precise classification can
cause problems when data from different patients are correlated
(b) cells tend to be available most readily from patients
already exposed to chemotherapeutic agents
(c) there are ethical constraints on obtaining samples from
patients who may be extremely ill or undergoing debilitating chemo¬
therapy.
We therefore decided to use human lymphoid cell lines in
permanent culture to study the glucocorticoid-induced cytolethal
effect; this system is free from the above difficulties and provides




The human lymphoid cell lines we have used are derived from
patients with leukaemias and lymphomas, from lymphoid cells of
peripheral blood, lymph glands or lymphoid tumours. They have been
established as permanent cell lines in suspension culture either
spontaneously or by a process of co-cultivation with lethally
irradiated cells containing Epstein-Barr virus (EBV) (Pulvertaft,
19^5; Jensen et al, 19&7; Steel and Edmond, 1971; Steel, 1972).
All the cell lines studied contain the EBV genome and show certain
characteristics of B lymphocytes (Nilsson and Ponten, 1975)-
In addition to the cytolethal effect, evidence also suggests
that glucocorticoids affect the rate of proliferation of human
neoplastic lymphoid cells by exerting a 'cell cycle' or 'growth
inhibitory' (retardation) effect - this has been shown both in
freshly isolated leukaemic blast cells from bone marrow aspirates
(Lampkin, Nagao and Mauer, 19^9» 1971; Ernst and Killmann, 1970) and
in certain cultured lymphoid cell lines from patients with lymphoid
neoplasia (Hirshaut, Veiss and Perry, 19&9; Nilsson, 1971; Norman
and Thompson, 1977)* Thus the growth inhibitory effect may also be
an important component of the therapeutic activity of glucocorticoids.
However again, the intracellular mechanisms by which this affect may
be achieved are poorly understood, and hence we have also studied
this effect in human lymphoid cell lines, results of which are
presented in the second part of my thesis.
As well as their growth inhibitory effect on human neoplastic
lymphoid cells, glucocorticoids have also been shown to slow the
rate of proliferation in many other cell types both in vivo; in a
spontaneous/...
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spontaneous rodent mammary tumour (Braunschweiger, Stragand and
Schiffer, 1978); and in vitro: in HeLa cells (Kollmorgen, 19&9;
Adolphe and Lechat, 197U)> in inhibition of PHA-stimulation of normal
human lymphocytes (Mendelsohn, Multer and Bernheim, 1977)» in human
lung alveolar cells (Jones, Anderson and Addison, 1978), in connective
tissue fibroblasts (Nacht and Garzon, 197U)» in rat glioma cells
(Grasso et al, 1977)» in primary human skin and mouse fibroblasts
(Ponec et al, 1977) and in mouse lymphoma cells (Story and Melnykovych,
1973).
Prom some of these studies both in vivo and in vitro it has
been.reported that the growth inhibitory effect occurs due to an
accumulation of cells in the G^ or Gq phase of the cell cycle i.e.,
a blockage of the transition of G^ cells into the S-phase (Ernst and
Kallmann, 1970; Lampkin, McWilliams and Mauer, 1972; Mendelsohn,
Multer and Bernheim, 1977; Norman and Thompson, 1977; Braunschweiger,
Stragand and Schiffer, 1978). In vitro synchronised cell populations
have also been used to determine the point in the cell cycle at
which glucocorticoid effects are manifested and studies with HeLa
cells (Adolphe and Lechat, 1977+) have shown that the cells are least
sensitive to glucocorticoid during the S-phase and most sensitive in
Gr
At present, however, there is confusion over the fate of the
glucocorticoid-arrested cells as to whether they are then irrevocably
committed to die (Norman, Harmon and Thompson, 1978) or whether
they can be recruited back into cycle (Kollmorgen, 1969; Braunschweiger,
Stragand and Schiffer, 1978); hence this has formed part of our study
on/...
on' human lymphoid cell lines.
- The morphology of the glucocorticoid-induced growth inhibitory
response has also received scant attention and we have therefore
studied this in some detail. Sub-lethal injury - which could however
be involved in this response - has been described by Werthamer and
Amaral (1975) in the treatment of normal human lymphocytes with
Cortisol. Cytoplasmic organelles were affected, mitochondria in
particular, which showed deterioration in the foimation of myelin
figures denoting an autophagic activity. In addition the golgi
became very pronounced in structure, and occasionally there was
reorganisation of the endoplasmic reticulum resulting in a bizarre
array of parallel cisternae-like structures.
Much of the effort in elucidating the biochemical mechanism of
action of glucocorticoids has come from studies on rodent lymphoid
cells, in particular on rat thymocytes and steroid-sensitive mouse
lymphoma cell lines (see reviews by Claman, 1972; Thompson and Lippman,
1977+; Baulieu, 1975; Rosen and Milholland, 1975; Higgins and Gehring,
1978). Rodent lymphoid cells are veiy sensitive to the effects of
glucocorticoids and indeed the cytolethal response is well documented
(Dougherty and White, 19U5; Burton, Storr and Dunn, 19&7; Whitfield,
Perris and Youdale, 1968; Harris, 1970; Claman, 1972; Turnell, Clarke
and Burton, 1973; Leung and Munck, 1975)-
Although at present no proof exists that such a mechanism of
action is involved in the lethal response to glucocorticoids in
human lymphoid cells, the currently accepted model for steroid
hormone/...
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hormone action is illustrated in fig. 3. The steroid enters the cell
probably by passive diffusion in the case of glucocorticoids where
it hinds to high affinity specific protein receptor molecules present
in the cytoplasm. The hormone-receptor complex then undergoes a
temperature-dependent ( ^ 20°C) conformational change (activation)
and migrates to the nucleus, binding to nuclear acceptor sites on
the chromatin. This influences transcriptional activity of specific
parts of the genome and the altered gene products ultimately mediate
the steroid effects. The exact means by which the steroid-receptor
complex evokes these responses is as yet unknown, but an increased
accumulation of functional mENA for the specific induced protein
has been demonstrated (Schutz et al, 1975; Bell and Borthwick, 1976).
From the model, this induced cell response can then lead to
secondary inhibition effects; for example in rodent thymocytes,
glucocorticoids cause inhibition of glucose uptake and of RNA and
DNA synthesis (Makman, Nakagawa and White, 19^7)» and similar
inhibitory responses have been observed in mouse L cells (embryonic
fibroblast line) (Pratt and Aronow, 1966). All of these effects
are inhibited by actinomycin D and cycloheximide (Mosher, Young and
Munck, 1971> Baran, Lichtman and Peck, 1972) and are therefore
presumably dependent at some stage on macromolecular synthesis.
Compared to rodent lymphoid cells, human lymphoid cells appear
relatively insensitive to glucocorticoid (Claman, 1972), and hence
little work has been directed towards studying the biochemical
mechanism of action of glucocorticoids with human material. The role




Model of the mechanism of steroid hormone action
Abbreviations: H - hormone or steroid
R - receptor
R - activated receptor (conformational
change)
A - nuclear acceptor site (chromatin)
mRNA - processed messenger RNA
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leukaemia cells, however, is being investigated and some results
would suggest that the presence of specific glucocorticoid receptors
is necessaiy for the patient to show a therapeutic response (Gailani
et al, 1973> Lippman et al, 1973; Lippman, Perry and Thompson, 1975;
Yarbro ejfc al, 1977)* Thus the model of steroid hormone action could
be applied to glucocorticoid leukaemia therapy where the production
of altered gene products mediate effects which can induce either cell
death or growth inhibition in the leukaemic cell population, thus
causing the observed remission - what these gene products are and
how the effects are manifested are problems yet to be resolved. It
has also still to be resolved what role receptors play in acquired
resistance of leukaemic patients to glucocorticoid therapy and indeed
how useful the glucocorticoid receptor assay in vitro is for
determining the clinical response in vivo.
In summary, it is not clear (a) whether glucocorticoid induces
remission in human lymphoid tumours by causing cell death and/or
growth inhibition, (b) what morphological changes may be involved
in the response of human lymphoid tumour cells to glucocorticoid and
(c) what is the precise biochemical basis for glucocorticoid sensitivity
and resistance in human lymphoid cells.
I have therefore studied the kinetics and morphology of the
cytolethal and growth inhibitory responses induced by the glucocor¬
ticoid, methylprednisolone, on human lymphoid cell lines and attempted
to correlate the results with biochemical investigations performed by
other members of the group. Hopefully we may be able to enlarge our
basic understanding of how glucocorticoids act at the cellular level
in/...
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in this test system, and this may result in more rational therapeutic
regimes for the treatment of patients with lymphoid tumours.
- 16 -
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KINETICS OF THE CYTOLETHAL RESPONSE OF HUMAN
LYMPHOID CELLS TO GLUCOCORTICOID
Initially" it was necessary to establish an experimental system
to study the concentration of glucocorticoid necessary to produce a
cytolethal response in human lymphoid cells.
Growth characteristics of the cell lines were studied and
experiments were then performed on cultures in logarithmic growth
phase 'to ensure that 'non-specific' effects such as 'exhaustion' of
nutrients in the growth medium did not contribute to the cytolethal
effects of the glucocorticoid.
The cytolethal response was tested with glucocorticoid within
the concentration range 10 - 2 x 10 ^M. In all experiments, the
cytolethal response was assessed at i|8hr after treatment with the
glucocorticoid by the ability of live cells to exclude the vital dye
nigrosine.
The kinetics of the cytolethal response was studied over a
l+8hr incubation period with the glucocorticoid, and experiments
conducted to determine whether the continued presence of glucocorti¬
coid was necessary for a cytolethal response to occur.
As a comparison with our _in vitro model, the cytolethal response
of/...




(a) Lymphoid cell lines. These were obtained from the MRC Clinical
and Population Cytogenetics Unit, Western General Hospital, Edinburgh.
Their origins are shown in table 1.
TABLE 1 ORIGIN OF HUMAN LYMPHOID CELL LINES
Cell line Origin
BLA-| Acute lymphoblastic leukaemia (ALL)
RUS2 Acute myeloblastic leukaemia (AMI)




The cells were grown in suspension culture in conical glass
flasks or roller culture bottles in Eagle's minimum essential
medium (MEM, GLBCO-Biocult) containing sodium bicarbonate buffer
(20mM), glutamine (IpuM), streptomycin (80pg/ml) and penicillin
(80iu/ml), and supplemented with 20% heat-inactivated (56°C for 1hr)
foetal bovine serum (FBS, GIBCO-Biocult). (Heat-inactivation
destroys/...
destroys any glucocorticoid-binding capacity of globulins present in
the serum.) Cultures were incubated at 37°C and flasks were kept in
a humidified atmosphere of %% CO2 in air. Cells were maintained at
densities between 2-10 x 10^ cells/ml by feeding with fresh growth
medium every 3 - ^ days. Cultures were routinely tested for myco¬
plasma infection.
(b) Normal peripheral blood lymphocytes. lymphocytes were obtained
from buffycoat 'pig-tail* blood samples from the Blood Transfusion
Service, Royal Infirmary of Edinburgh.
Growth medium for lymphocytes was the same as for lymphoid cell
lines, but supplemented with 10% heat-inactivated calf serum (CS,
GIBCO-Biocult).
The blood was defibrinated by placing in a glass universal
container, containing glass beads and growth medium with 1% topical
thrombin, followed by agitation on a blood mixer for 10 min. The
defibrinated supernatant was removed and layered onto a 9% Ficoll/
33.9% Triosil mixture in a universal container. This was centri¬
fuge! at 1500 x g for 15 min. during which the red blood cells
pelleted at the bottom of the universal container and the lymphocytes
formed a layer at the interface between the Ficoll/Triosil and the
blood/medium supernatant. The lymphocyte layer was removed with a
pipette, washed once in growth medium, set up in test-tubes at
5 x 10^ cells/ml and incubated at 37°C in a humidified atmosphere of
5% CO2 in air.
Cell/.
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Cell counts and viability
The total cell concentration (TCC) was enumerated either using a
haemocytometer (improved Neubauer type) or a Coulter Counter
(Model ZF) for which samples were diluted 1 in £0 in Isoton (isoton
II, Coulter Electronics Ltd.).
The cell viability was assessed by the ability of live cells
to exclude the vital dye, nigrosine - the dead cells take up
nigrosine and are stained black. The cells were mixed with an equal
volume of 0.5% (w/v) nigrosine in phosphate-buffered saline and
counted in a haemocytometer. The viable fraction of the cells was
thus defined as the ratio of cells excluding nigrosine to the total
number of cells counted.
Prom these counts the viable cell concentration (VCC) could be
estimated: VCC = TCC x viable fraction.
Growth characteristics of cell lines
Stock cells were centrifuged at 1^00 x g for 5 min. and the cell
pellet resuspended in fresh growth medium. Flasks or test-tubes of
5
cells were then set up in duplicate at a concentration of 1-2 x 10
cells/ml. The viability and TCC were assessed every 2l(hr until the
plateau phase of growth was approached.
Glucocorticoid
Methylprednisolone sodium succinate (MPS, Solumedrone, Upjohn, Ltd.)






Stock cells were centrifuged at 1^00 x g for 5 min. and the cell
pellet resuspended in fresh growth medium. Nine flasks or test-tubes
5of cells were then set up in duplicate at a concentration of 2 x 10
cells/ml. After 2L|hr, to allow cells to settle into log growth
phase, the duplicate cultures were treated with 1% (v/v) of stock
MPS solution to give concentrations within the range 10 - 2 x 10
The viability and TCC were assessed at i|8hr after treatment.
Five test-tubes of normal peripheral blood lymphocytes were
set up in duplicate at a concentration of 5 x 10^ cells/ml (as
described on p. 19)• Duplicate cultures were treated with (v/v)
of stock MPS solution to give concentrations within the range
10~7M - 10~^M and the viability was assessed at i|8hr after treatment.
In all experiments, control flasks or test-tubes were set up
in duplicate and treated with 1% (v/v) of sterile distilled water
and assessed at L|.8hr after treatment as for test cultures.
Kinetics of cytolethal response in cell lines
Three flasks of cells resuspended in fresh growth medium were set
up in duplicate at a concentration of 2 x 10^ cells/ml. After
2l4hr, the duplicate cultures were treated with 1% (v/v) of stock MPS
-3 -3solution to give lethal concentrations of 0.75 x 10 , 1 x 10
and 2 x 10 % MPS. Duplicate control cultures were treated with
1% (v/v) of sterile distilled water. Samples were removed at




Duration of exposure to cytolethal concentration of MPS
Nine flasks of cells resuspended in fresh growth medium were set
up -in duplicate at 2 x 10^ cells/ml and treated with 1% (v/v) of
stock MPS solution to give a final concentration of 10 ^M MPS.
Duplicate cultures were washed three times (at 37°C) with fresh
growth medium after the desired period of exposure to MPS and the
cell pellet resuspended in the original volume of fresh growth
medium which contained no MPS. The viability was assessed before
washing and at intervals afterwards up to l|8hr.
Nine control flasks of cells were set up in duplicate and
treated with 1% (v/v) of sterile distilled water. Control cultures
were washed and assessed as for test cultures.
RESULTS
Growth characteristics of lymphoid cell lines
Growth characteristics were studied over a period of 120-1l4|hr in
culture during which time cultures were 'starved' of fresh growth
medium.
The log growth curves of the individual cell lines are shown
in figs. and 5. An initial short lag phase of growth is seen
in most cell lines due to handling of the cells in setting up
experiments. This is followed by a log phase of growth which is
maintained for about 72hr, until plateau phase or 'stationary'




Log growth curves of lymphoid cell lines
Cultures were assessed for total cell concentration (TCC)
'every 2ljhr after setting up. o 0> BLA-|; • •, EBj^;
▲ A, GS-|.
Each point represents the mean - 1S.E. of 2 or 3 separate
experiments each with duplicate observations (error bars
are omitted where overlapping occurs).
- 2k -
. Fig. $
Log growth curve3 of lymphoid cell lines
Cultures were assessed for total cell concentration (TCC)
"eveiy 2l|hr after setting up. □ □, RAJT; ■ ■, JIJOYE;
A A, RUS2.
Each point represents the mean - 1S.E. of 2 or 3 separate
experiments each with duplicate observations (error bars
are omitted where overlapping occurs).
Time (hr) in culture
- 25 -
'exhaustion8 of nutrients in the growth medium.
_ The effect of prolonged culture on cell viability of individual
cell lines is shown in table 2 (see p. 26). The viable cell
fraction remains constant throughout the experiment until plateau
phase of growth is approached (see figs. 1+ and 5) when it begins to
fall.
All the following cytolethal tests were therefore performed on
cell cultures which had been set up 2ljhr previously to ensure log
phase of growth and then assessed at I|.8hr after treatment (72hr
after setting up) when no viability change and minimal or no fall
in growth rate was observed.
- v' v , '4^'C ■' ' \
Glucocorticoid sensitivity of lymphoid cell lines
Cultures were treated with MPS concentrations within the range
10~7M - 2 x 10_3M. The log dose-response curves of individual cell
lines as assessed by viability change after lj8hr treatment with MPS
are shown in figs. 6-8. All show a typical S-shaped response curve
_-a
with lethal responses occurring within the range 0.5 x 10 -
2 x 10 % MPS. Calculations of values (the median lethal dose)
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Theviabilityofcelultureswasassessedev r21+hrfts ttingp. Eachvaluerepresentsthm a-1S.E.of2r3separa experimentsachwitdupli tebservatio s. ,novaluesrecord d.
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Fig- 6
Effect of methylprednisolone (MPS) on cell viability of
lymphoid cell lines (BLAi , EB)|)
~
Cultures were incubated with various concentrations of MPS
(10"7M - 2 x 10_3M) (test) or with water (control) and
assessed for viability after treatment for i|8hr.
O O, BLA-|; • 0, EB^; - - - LD^o values (median
lethal dose). LD^q values are presented in table 3 (see p. 30).
Each point represents the mean - 1S.E. of 3 separate
experiments each with duplicate observations. Error bars
are omitted where overlapping occurs.
Log^ MPS concentration (M)
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Fig- 7
Effect of methylprednisolone (MPS) on cell viability of
lymphoid cell lines (GSi, EAJI)
Cultures were incubated with various concentrations of MPS
(10_7M - 2 x 10_3M) (test) or with water (control) and
assessed for viability after treatment for l|8hr.
± A, GS-|; □ □, RAJT; - - - LDc£) values (median
lethal dose). LD^o values are presented in table 3 (see p.
Each point represents the mean - 1S.E. of 3 separate
experiments each with duplicate observations. Error bars
are omitted where overlapping occurs.
Log^ MPS concentration (M)
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Fig. 8
Effect of methylprednisolone (MPS) on cell viability of
lymphoid cell lines (JIJOYE, RUSp)
Cultures were incubated with various concentrations of MPS
(10"7M - 2 x 10_3M) (test) or with water (control) and
assessed for viability after treatment for L^hr.
■ ■» JIJOYE; A A, RUSpj - - - -> U>£o values (median
lethal dose). U>£o values are presented in table 3 (see p. 30).
Each point represents the mean - 1S.E. of 3 separate
experiments each with duplicate observations. Error bars
are omitted where overlapping occurs.
Logio MPS concentration (M)
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TABLE 3 LB^0 VALUES FOR LYMPHOID CELL LINES TREATED WITH
METHYLPREDNISOLONE (MPS) FOR 148m









the median lethal dose i.e.,the concentration of MPS at which the
viability of the treated cell population is £0% of the control
population viability at i^8hr after treatment. Values are obtained
from figs. 6-8 (pp.27 -29) as illustrated.
Assessment of TCC at l|8hr after treatment showed that the
growth rate of cell lines also decreased at the same concentrations
(0.5 x 10~% - 2 x 10"%) of MPS which caused a decrease in cell
viability (table I4, see p. 31 )• As this decrease in TCC after
treatment with MPS was consistently shown in all other cytolethal
experiments where measured, and as this change was not considered
to be a vital measure of the cytolethal response, then TCC results
are not presented further in Part I of this thesis.
Glucocorticoid sensitivity of normal human peripheral blood
lymphocytes
Cultures of normal human lymphocytes were treated with MPS concen¬
trations within/...
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within the range 10 - 10 \I. The dose-response curve as
assessed by viability change after i|8hr treatment with MPS is
shown in fig. 9«
A small lethal response was observed only with 10 MPS.
Kinetics of cytolethal glucocorticoid response
The kinetics of the cytolethal response of cells to MPS was
studied at concentrations within the range 0.75 x 10 - 2 x 10
known to produce a lethal effect by i;8hr after treatment.
. The effect on cell viability of BLA^ cells is shown in fig. 10.
This also represents the typical kinetic curves obtained for the
other cell lines studied-RAJI, JIJ0YE, GS^ and EB^. With the higher
concentrations (1 x 10 ^M and 2 x 10 \) a brief lag phase was
observed before progressive lethal effects ensued, whilst with the
lower concentration (0.75 x 10 ^M) there was a more protracted
latent interval.
Duration of glucocorticoid pulse and cytolethal response
The duration of the glucocorticoid pulse to which RUS^ cells were
exposed was varied by washing cultures free of a lethal dose of MPS
(10'-3M) at intervals up to ^hr.
Fig. 11 shows the effect of washing cultures free of MPS on
cell viability. It was found that continuous exposure of cells to




Effects of methylprednisolone (MPS) on viability of normal
human peripheral blood lymphocytes
'Cultures were incubated with various concentrations of MPS
(10 - 10 "^M) (test) or with water (control) and assessed
for viability after treatment for lj8hr.




Kinetics of methylprednisolone (MPS) lethal response in BLA-i
cells
~
Cultures were incubated with water (control) or with various
concentrations of MPS (test): O O, 0.75 x 10 "^M;
A A, 1 x 10~^M; O •, 2 x 10_3M. Samples were
removed at the times shown up to lj8hr after treatment, and
assessed for viability.
Each point represents the mean - 1S.E. of 3 separate
experiments each with duplicate observations. Error bars
are omitted where overlapping occurs.
Treatment time (hr) with MPS
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Fig. 11
Duration of methylprednisolone (MPS) (10 ^M) pulse and
cytolethal effect on RUSp cells
"
Cultures were incubated with MPS (test) or water (control)
for various periods of 'time up to l+8hr. Treatment was
removed by washing cells at the times (hr) shown (paren¬
thesis). Cell viability was assessed before washing (O O)
and at intervals afterwards ( • •) up to Lj.8hr.
Each point represents the mean of 2 or 3 separate experiments
each with duplicate observations.
Duration (hr) of MPS pulse
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COMMHHT
The cytolethal experiments on lymphoid cell lines were
carried out on cultures in logarithmic growth phase to ensure that
cells were in a 'healthy' metabolic state and that adverse culture
conditions were not responsible for any decrease in viability.
All cell lines are sensitive to lethal effects of MPS in the
region of 10 as shown by dose-response curves and LD^q values
which range from 0.79 - 1 -1 x 10 at IjShr after treatment. The
kinetic studies of the lethal glucocorticoid response are consistent
with.a dose-dependent relationship, with maximal lethal effects
occurring only where there is continuous exposure of cells to the
glucocorticoid.
However, the relationship between the concentration of
glucocorticoid required to induce this cytolethal effect in vitro
and that which induces remission induction in vivo is uncertain. It
seems that lethal effects in vitro can only be achieved with doses of
glucocorticoid which greatly exceed pharmacological levels _in vivo.
If it is assumed that equilibration of steroids within fluid
compartments is equal and non-concentrative, the highest pharma¬
cological doses of glucocorticoids employed in clinical practice
(100 - ^OOmg/m body surface) would achieve peak intracellular
concentrations around 1-5 x 10 ~^M. Maximum physiological plasma
^ n
steroid levels are generally considered to be about 10 - 10 M.
much of which is probably bound to plasma corticosteroid binding
globulin/...
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globulin (transcortin) (Burton and Westphal, 1972).
.. There is no observed difference in response to MPS between
cell lines derived from normally glucocorticoid sensitive diseases
such as ALL (Mauer, Simone and Pratt, 1977) or more glucocorticoid
resistant diseases such as Burkitt's lymphoma and AML (Brearley et al,
1977; Mauer, Simone and Pratt, 1977)> and indeed normal human
peripheral blood lymphocytes show the same resistance to pharma¬
cological dose levels. In another study in this laboratory, lymphoid
cells freshly derived from the peripheral blood of 6 patients with
ALL also showed similar resistance prior to treatment (Bird et al,
1975). despite the patients later undergoing an apparent remission
to chemotherapy which included prednisolone.
This observed insensitivity of cultured lymphoid cells cannot
be attributed to experimental design, as optimum conditions for the
cytolethal response were established by us (Bird jet al, 1977) and
were employed throughout my experiments - these include studies on
(a) glucocorticoid type, (b) glucocorticoid solvent, (c) density of
cell culture and (d) heat-inactivation of serum.
Human lymphoid cells in vitro thus appear to exhibit resis¬
tance to the lethal effect of glucocorticoid at concentrations which
are normally effective in in vivo therapy. In this, they differ
markedly from rodent lymphoid cells in vitro which are much more
sensitive to physiological doses of glucocorticoid (Claman, 1972).
The correlation between cytoplasmic glucocorticoid receptor
levels/...
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levels in human lymphoid cells in vitro and their cytolethal












MORPHOLOGY OF THE CYTOLETHAL RESPONSE OF
HUMAN LYMPHOID CELLS TO GLUCOCORTICOID
The morphological changes induced by lethal concentrations of
glucocorticoids on lymphoid cells in vitro have been studied mainly
using rodent tissues and conflicting observations have been
reported.
Burton, Storr and Dunn (19&7) and Whitfield, Perris and
Youdale (1968) working with glucocorticoid-induced cell death in
mouse and rat thymocytes and the steroid-sensitive mouse
lymphosarcoma P1798 sub-line, reported ultrastruetural changes which
focus on severe nuclear change - the nucleus loses its normal
chromatin pattern becoming swollen and homogeneous in structure to
give a 'pyknotic* or 'structureless* appearance. The nuclear and
cytoplasmic membranes then disrupt to give an overall classical
pattern of autolysis (Trump and Ginn, 1969)-
In contrast, Trowell (1966) working with rat thymocytes and
lymph node lymphocytes in organ culture, reported glucocorticoid-
induced morphological changes typical of what he termed 'radiomimetic
lesion'. The nuclear envelope disappears and the cytoplasm darkens
in appearance due to an increase in the number of ribosomes. The
cell membrane then disrupts and the nucleus shrinks and coarse and
dark/. . .
- 1+0 -
dark cytoplasmic debris remain. In lymph node lymphocytes there
is also a darkening in appearance of the nucleus at an early stage
accompanied by lobulation and shrinking. These changes closely
resemble apoptosis (Kerr, Wyllie and Currie, 1972 - see fig. 2,
p. 1+) and indeed apototic cells have also been observed more
recently by Wyllie (in preparation) after in vitro treatment of rat
thymocytes with a lethal concentration of glucocorticoid.
However, little work has involved the study of morphological
changes in glucocorticoid-induced cell death in human lymphoid cells
in vitro, although the morphological changes associated with sub¬
lethal injury have been described (Werthamer and Amaral, 1975)•
This section therefore deals with a study of morphological changes
seen by both light microscope and electron microscope studies in
BLA+ cells over a l+8hr incubation period with a lethal concentration
(1.1+ x 10' ^M) of MPS. I also carried out a similar light microscope
study on RAJI cells and the glucocorticoid-induced morphological
changes were essentially the same as for BLA^ cells.
MATERIALS AMD METHODS
Morphological studies
Cultures of BIAj cells resuspended in fresh growth medium were set
up at a concentration of 2 x 10^ cells/ml. After 2l+hr, to allow
cells to become established in logarithmic growth phase, the
cultures were treated with 1% (v/v) of stock MPS solution to give a
final concentration of 1.1+ x 10 ^M MPS. Control cultures were
treated/...
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treated with 1% (v/v) of sterile distilled water. Samples were
removed at Ohr, 30 min., 1hr, 2hr, 3hr, Ijhr, 6hr, 8hr, 12hr, 2l|hr
and l|8hr after treatment and prepared for light microscopy and
transmission electron microscopy. For scanning electron microscopy,
samples were removed at 30 min., 1hr, 2hr, 3frr, Ijhr, 6hr and 12hr
after treatment.
Cell smear preparation for light microscopy (hM)
q
2-5 x 10 cells were centrifuge! at I4.OO x g for 5 min. at room
temperature. The supernatant was discarded leaving a few drops in
which the cells were resuspended. The cells were then smeared onto
glass slides as shown in fig. 12. This method separates out the cells
for good staining with Giemsa hut keeps them at a fairly high density
for easier counting. Smears were dried rapidly in a cold air stream,
fixed in 95% methanol for 30 min., stained with I|% (v/v) Giemsa
(Gurr's Improved R66, Searle Diagnostic) for 10 min. and then
mounted in Harleco synthetic resin (Harleco).
Cell preparation for transmission electron microscopy (TEM)
50-100 x 10^ cells were centrifuge! at IjOO x g for 5 min. at room
temperature in a sterile plastic universal container (Sterilin),
and the resulting pellet resuspended in 1ml of reconstituted sterile
frozen-dried human plasma. All subsequent procedures, unless
otherwise mentioned, were carried out at JL|°C. Three % gluteraldehyde
(TAAB) in 0.2M sodium cacodylate buffer (BDH) at pH7 was added, the
suspension fixed for 1hr and then centrifuge! at 2,000 x g for 5 min.
to form a compact pellet in the cone of the universal container.




Preparation of cell smears
Cells are smeared onto a glass slide by applying a drop of
cells at one end of the slide, drawing this out along most
of the length of the slide with a second slide, then
allowing the suspension to drain back on the first slide by




to form a fairly cohesive cell pellet), the pellet was washed in
0.2M sodium cacodylate buffer for 2hr and then post-fixed for 1hr in
1%. osmium tetroxide (OsO^) (Johnson Matthey) in 0.2M sodium
cacodylate buffer. After 30 min. in OsO^, the pellet was scraped
gently from the cone of the universal container with a sharpened
wooden spatula, to allow full penetration of the sides of the pellet
with OsO^ for a further 30 min.; this resulted in fragmentation of
the pellet. The fragments were washed in 0.2M sodium cacodylate
buffer for 30 min. and then dehydrated through a graded alcohol
series allowing 20 min. for each change: 20%, ij.0%, 70%, 95% and three
times in absolute ethanol. Fragments were transferred to glass
phials and resuspended twice in epoxy-propane (BDH) at room
temperature and then impregnated and set in epon resin (TAAB). Thin
sections were cut on an LKB Ultrotome I with glass knives and
mounted on formvar (TAAB) coated grids (Athene-type old IjOO).
These were stained with saturated uranyl acetate (BDH) in 50%
ethanol for 15 min., followed by O.OI4M lead citrate (BDH) in 0.02M
sodium hydroxide for 5 min. Sections were viewed on an AEI Corinth
275 electron microscope.
Cell preparation for scanning electron microscope (SEM)
(This work was undertaken by Andrew Waddell.) The cells were
centrifuged gently (250 x g for 5 min.) and resuspended at 50 x 10^
cells/ml in the medium in which they were grown. One drop of this
suspension was placed at either end of a 6 x 35 111111 coverslip and
allowed to settle for 30 min. The cells were fixed by addition of
one drop of 1% 0s0^ in 0.2M cacodylate buffer, and after 30 min.
were gradually dehydrated by passing through increasing concentrations
of/...
- -
of acetone, and stored in 100% acetone. The samples were dried by-
critical point drying, which involved the substitution of acetone
with liquid CO^ and raising the temperature until it was above the
critical point at which there is instantaneous evaporation of the
CO^. After coating with gold, the samples were viewed in a
Cambridge Stereoscan 180 microscope.
RESULTS
LM and TEM observation on the lethal glucocorticoid response
Control cultures. BLA-] cells were round, oval or elongated with
occasional cytoplasmic protrusions and long slender surface processes;
cytoplasmic vacuoles were common (fig. 13)« TJltrastructurally,
the cytoplasm was rich in free polysomes and contained scanty
profiles of rough endoplasmic reticulum, mitochondria with plate¬
like cristae, golgi apparatus and lipid droplets (fig. 1l+). Cells
showed a high nuclear to cytoplasmic ratio and the nuclei, usually
one per cell, were of variable shape and size with chromatin
dispersed diffusely throughout the nucleoplasm and with one or more
nucleoli (figs. 13 and 11;). Scanty aggregates of heterochromatin
were seen round the periphery of the nucleus (fig. 11|)>
Small numbers of cells showing necrotic changes were also
observed (vide infra, see p. 59)-
Treated cultures. No significant differences were observed from





The cell surface shows cytoplasmic protrusions (p) with
numerous long slender surface processes (SP), and the
cytoplasm contains many clear vacuoles (V). The cells
have a high nuclear to cytoplasmic ratio, with the nuclei




Transmission electron micrograph (HEM) of control BLAi cell
The cytoplasm is rich in polysomes (p) with scanty profiles
of rough endoplasmic reticulum (EER), mitochondria with
plate-like cristae (m), golgi apparatus (G), and lipid
droplets (l). The nucleus (n) shows diffusely dispersed
chromatin with a prominent nucleolus (NTT). Some scanty
aggregates of heterochromatin are seen along the nuclear
membrane. Uranyl acetate and lead citrate (UALC). x 10,1^00.
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(-see table 5, p. 1+8) when two distinctive morphological changes
were seen.
The first type of change, whose incidence was markedly
increased from 1 to 6hr after treatment with a peak at 2hr (table 5>
p. U8), involved 'blebbing' of the cells. The cells showed loss of
long slender surface processes with contortion and blebbing of the
cytoplasm and indentation of the nucleus (figs. 15-17) which sometimes
showed pyknosis and fragmentation (figs. 15 and 17)* The 'blebbing'
cells then began to fragment into discrete membrane-bounded
cytoplasmic bodies of variable size (fig. 18), and were then seen as
a cluster of membrane-bounded fragments (fig. 19) > some of which still
contained a few structurally recognisable organelles and nuclear
fragments with or without nuclear membrane breakdown. In this
example (fig. 19) the nuclear membrane still appears to be intact
and there is no evidence of pyknosis.
By contrast, the second type of change, whose incidence was
increased from 1 to l+8hr after treatment with a peak at 1+hr (table 5»
p. 1+8) involved 'rounding up* of the cells. These cells showed loss
of protrusions and long slender surface processes and this was
accompanied by marked nuclear pyknosis, nuclear membrane breakdown
and sometimes nuclear fragmentation (figs. 20-21+). In smears, as
well as showing nuclear changes, the cytoplasm became intensely
stained and vacuoles appeared to congregate together within the
cytoplasm (figs. 20 and 21). This was confirmed by TEM (figs. 22
and 23) which demonstrated aggregation of cytoplasmic organelles;
several/...
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BLA-] cells 2hr after treatment with 1.1+ x 10 methylpred-
nisolone
The cell (arrowed) shows marked cytoplasmic and nuclear




TEW of BLAi cell 1hr after treatment with 1.1* x 10
methylprednisolone
The cell shows marked cytoplasmic blebbing and slight
blebbing of the nucleus. UALC. x 10,1*00.
_ 51 -
Fig. 17
TEM of BLA-| cell 2hr after treatment with 1.1| x 10
methylprednisolone
- The cell shows marked cytoplasmic blebbing, and nuclear
indentation and fragmentation. UALC. x 16,000.
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Fig. 18
TEM of BLAi cell 1hr after treatment with 1.U x 10
me thylprednisolone
The cell shows marked cytoplasmic blebbing with fragmentation
to form membrane-bounded fragments; cytoplasmic organelles
are still intact. UALC. x 6,2^0.
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Fig. 19
TEW of BLA-] cell 1hr after treatment with I.I4 x 10 ~^M
methylprednisolone
The cell is represented by a cluster of membrane-bounded
fragments, most of which contain structurally recognisable
organelles and one of which contains nuclear material
(arrowed). UALC. x 10,1^00.
- Sk -
Fig. 20
BLAi cells 1hr after treatment with 1.1; x 10 methylpred-
nisolone
The cell (arrowed) shows rounding up with loss of surface
protrusions and slender surface processes. The cytoplasm
contains aggregated vacuoles, and the nucleus shows the




BLA^ cells I(hr after treatment with 1.1; x 10 methylpred-
nisolone
The cells show rounding up with loss of surface protrusions
and slender surface processes. The cytoplasm contains




TEM of BLA-] cell 6hr after treatment with 1.U x 10
methylprednisolone
The cell shows rounding up with loss of surface protrusions
and slender surface processes, and cytoplasmic organelles
are aggregated together. The nucleus shows the initial
chromatin condensation pattern of pyknosis. UALC. x 10,14.OO.
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Fig. 23
TEM of BLA-j cell 6hr after treatment with 1.lt x 10
methylprednisolone
The cell shows rounding up with loss of surface protrusions
and slender surface processes, and cytoplasmic organelles
are aggregated together. The nucleus shows pyknosis with
nuclear membrane breakdown. UALC. x 10,1|00.
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Fig. 2k
TIM of BLA^ cell fjhr after treatment with 1.U x 10
methylprednisolone
The cell shows rounding up with loss of surface protrusions
and slender surface processes. The nucleus shows pyknosis,
fragmentation and nuclear membrane breakdown. (This
section is through the part of the cell which contains no
aggregated cytoplasmic organelles.) UALC. x 11,900.
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several mitochondria with cristae were occasionally visible.
Whilst these were the earliest morphological changes, from
2-3hr onwards after treatment an increasing percentage of cells
and fragments began to show more marked degenerative changes (table
5, p. i;8), and at L^8hr over 90% showed features of autolysis (Trump
and Ginn, 1969)- In smears, these cells were recognised by their
diminished intensity of nuclear and cytoplasmic staining. Ultra-
structural features typical of this late-stage process of cell death
included focal dissolution of the plasma membrane and breakdown of
cytoplasmic organelles, distended mitochondria with flocculent
matrix densities and loss of cristae and further dissolution of the
fragmented nucleus, the nucleoplasm becoming increasingly electron
lucent (fig. 2£).
About i$> of the cells appeared to have survived MPS treatment
and retained normal morphology i|8hr after treatment (table 5> P- U8).
Small numbers of dying cells were also seen in control culture
smears (table $, p. U8). Some of these cells contained aggregated
vacuoles and pyknotic nuclear fragments; some appeared as 'blebbing'
cells or cellular fragments with or without nuclear remnants; and
some showed changes typical of autolysis. These observations suggest
that death by both 'rounding up' and 'blebbing', followed by further
degenerative changes, were also occurring spontaneously in untreated
cultures. TJltrastructurally, changes typical of autolysis were also
observed at a low frequency, and an occasional cell also showed




TEM of ELA-j cell Ijhr after treatment with 1,lt x 10
methylprednisolone
The cell shows marked degenerative changes with focal
dissolution of the plasma membrane and loss of structure
of cytoplasmic organelles. The pyknotic and fragmented
nucleus is becoming electron lucent. UALC. x 16,000.
indentation of the nucleus and distension of the nuclear envelope
(fig. 26).
SEM observations on the lethal glucocorticoid response
Control BLA-] cells were basically round with a 'ruffled' surface,
and occasionally processes were seen adhering to the substrate
(fig. 27). After addition of 1.1; x 10 ^M MPS, there was an
increase in the number of cells showing 'blebbing' on an otherwise
smooth cell surface (fig. 28) and this reached a peak 2-3hr after
treatment. Cells were examined up to 12hr after treatment, over
which period there was a gradual increase in the number of small,
subcellular "particles in the samples, and of cells with an irregular
surface morphology (fig. 29) which presumably were 'rounding up'
cells. A gradual accumulation of enlarged cells and cell fragments
were also seen and these are undoubtedly autolytic.
COMMENT
The BLA-| cell line studied had morphological features typical
of human lymphoid B-cell lines (Nilsson and Ponten, 1975; Parker
et al, 1978).
In treated cultures, many of the morphological manifestations
of the lethal response to 1.1; x 10 ^M MPS were consistent with
apoptosis (Kerr, Wyllie and Currie, 1972). The features are also
I
similar to 'popcorn' and 'ballooning' processes of cell death




TEM of dying BLA-j cell in control culture
The cell shows dilatation of the endoplasmic reticulum and
golgi apparatus. The nucleus shows indentation and




Scanning electron micrograph (SIM) of control BLA-] cell
The cell shows a 'ruffled' surface with processes adhering
to the substrate, x 12,600.
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Fig. 28
SEM of BLA-| cell Ijhr after treatment with 1.lt x 10
methylprednisolone




SEM of BLA^ cell Ifhr after treatment with 1.U x 10 %
methylprednisolone
The cell shows an irregular surface, x 13,260.
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Eosenau and Lee, 1972).
The sequence of morphological changes occurring both in our
in vitro system and in apoptosis in vivo are summarised diagram-
matically in fig. 30. In BLA-^ cells, from 1hr onwards after
treatment with MPS, cells died by either 'blebbing' or 'rounding up'.
'Blebbing' cells showed contortion of the cytoplasm and nucleus
resulting in the formation of discrete membrane-bounded fragments
of variable size. These contained some apparently normal organelles,
and nuclear fragments which showed pyknosis and nuclear membrane
breakdown - in some cases nuclear pyknosis preceded cellular and
nuclear fragmentation. All these changes occur in apoptosis
in vivo (Kerr, Wyllie and Currie, 1972). The 'rounding up' cells
also showed morphological changes typical of apoptosis: loss of
cytoplasmic protrusions and long slender surface processes,
preservation of structure of cytoplasmic organelles, nuclear
pyknosis and fragmentation and nuclear membrane breakdown.
Both the 'blebbing' and 'rounding up' foims of cell death
appear to have certain features in common, but from these studies
it is not possible to say whether they are two distinct early
changes or whether one form precedes the other (fig. 30 and see
table £, p. i|8). We cannot claim that 'rounding up' precedes
'blebbing' which is the established sequence of events in apoptosis
in vivo. However, it seems likely that the response of cells in
suspension culture in vitro will differ in some respects from that




Diagrammatic summaiy of the sequence of morphological changes
occurring both in methylprednisolone (1.1| x 10 ^M) -induced
cell death in BLA^ cells in vitro and in apoptosis in_vlvo
SEQUENCE OF CHANGES IN
METHYLPREDNISOLONE-TREATED
BLA CELLS IN VITRO
NORMAL













r From 3hr onwards after treatment, increasing numbers of dying
cells and fragments showed further degradative changes typical of
coagulative necrosis in vivo (Trump and Ericsson, 19&5; Trump
Arstila, 1971) and of autolysis in vitro (Trump and Ginn, 19&9) or
post-mortem autolysis. Such degenerative changes are found in
apoptosis in vivo after apoptotic bodies are phagocytosed by
surrounding viable cells. However, it seems reasonable to suggest
that in an in vitro system, in the absence of phagocytes, 'autolysis'
would be expected to occur in apoptotic bodies. Ve suggest that the
morphological changes demonstrated in our system are consistent with
this sequence (fig. 30).
Certain in vivo studies also support such a possibility. In
mouse ascites tumour cells treated with various non-steroidal cancer
chemotherapeutic agents (Searle et al, 1975)j many tumour cells
which initially undergo apoptosis ultimately exhibit the features
of coagulative necrosis while lying free in ascitic fluid, where
apparently there are few active phagocytes. The same sequence of
changes has also been noted in apoptotic cells shed into the
glandular lumina of the involuting rat prostate in castration -
induced atrophy (Kerr and Searle, 1973)•
The morphology of spontaneous cell- death in control cultures
in vitro has received scant attention and it is of interest that
we found precisely the same sequence of changes - albeit affecting
only a small proportion of cells (table 5> P« U8 ) - as described




Since human lymphoid cells treated in vitro with glucocor¬
ticoids show a sequence of morphological changes closely similar
to-apoptosis in vivo then we believe that this provides a suitable
system for studying the early biochemical events and intracellular
control mechanisms involved in apoptosis. A correlation between
the observed morphological changes and biochemical investigations
is discussed later (see General Discussion,p. 157)-
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SECTION 3
RELIABILITY OF NIGROSINE UPTAKE AS A MARKER OF
GLUCOCORTICOID-INDUCED CELL DEATH IN HUMAN
LYMPHOID CELLS
Exclusion of high molecular weight vital dyes such as nigrosine
and trypan blue has been used classically as a light microscope
marker in determining metabolic cell death (Schrek, 193&; Phillips
and Terryberry, 19^75 Kaltenbach, Kaltenbach and Iyons, 1958;
Claesson, 1969)- The method is based on a measure of the integrity
of the plasma membrane, thus indicating cell membrane damage.
However there is controversy over the practical use of vital
dyes in measuring cell death in vitro. Apart from the fact that dye
uptake has been found to be extremely variable under different
staining conditions (Black and Berenbaum, I96I4), there is also well-
documented evidence indicating non-correlation of the method when
compared with other well-known markers of cell death. In experiments
involving X-irradiation of rat thymocytes, Myers and De Wolfe-Slade
(196I4) showed that under certain conditions, pyknotic cells and loss
of intracellular K+ always preceded cellular uptake of dye.
Medzihradsky and Marks (1975) on studies with rat lymphoid cells and
Ehrlich ascites tumour cells, showed that in response to adverse
experimental conditions such as exposure to heat, hypertonic
conditions and metabolic inhibition, txypan blue uptake was the least
responsive/...
responsive index of cell viability when compared with release of
cellular lactic dehydrogenase and decrease in the intracellular
ratio of K+/Na+. In proliferating populations of human lymphoid
cells after treatment with cytotoxic drugs, dye uptake was found to
be an insensitive marker for assessment of cell survival when
compared with "^H-thymidine uptake and colony formation inhibition,
the last marker being the most sensitive (Roper and Drewiriko, 1976)
- however this could be expected as both a decrease in ^H-thymidine
uptake and colony formation inhibition could indicate either reduced
proliferative capacity or metabolic cell death, whereas dye uptake
<1
only indicates metabolic cell death. In the same study, Cr
release which again indicates metabolic cell death - radioactive
chromate bound to protein is released as a function of cell damage
- was also found to be as insensitive a marker as dye uptake.
To determine the sensitivity of nigrosine as a marker for
glucocorticoid-induced cell death in our system, we have compared
the kinetics of nigrosine uptake with the kinetics of morphological
changes observed by light microscopy in BLA-| and RAJI cells after




Cultures of BLA-j and RAJT cells resuspended in fresh growth medium
were set up at a concentration of 2 x 10^ cells/ml. After 2l4hr, to
allow cells to become established in logarithmic growth phase,
cultures/...
- 72 -
cultures were treated with 1% (v/v) of stock MPS to give a final
concentration of 1.1+ x 10 ^M and 1 x 10 ^M MPS for BLA^ and RAJI
cultures respectively. (Although different steroid concentrations
were used to treat BLAi and RAJI cells these were both within the
observed cytolethal dose range - see figs. 6 and 7» PP- 27 and 28;
results are therefore comparable.) Control cultures were treated
with 1% (v/v) of sterile distilled water. Samples were removed
sequentially over a i|8hr treatment period (see figs. 31 and 32) and
(a) prepared for LM studies i.e., cell smear preparation (see
Materials and Methods, p. I|.1 ), (b) assessed for viability, by the
ability of live cells to exclude nigrosine (see Materials and
Methods, p. 20).
RESULTS
Kinetics of the lethal glucocorticoid response
The kinetics of the glucocorticoid-induced morphological changes
and the decrease in cell viability are shown in figs. 31 and 32 for
BLA-| and RAJT cells respectively.
(a) BI1A1 cells. The sequence of morphological changes was described
in the previous section and fig. 31 shows plots of values for the
morphological types presented in table 5 (p* U8). The cells described
as 'blebbing' and 'rounding up' in table 5 are grouped in fig. 31 as
'apoptotic',and 'degenerate' cells are classed as 'autolytic'.
The percentage of apoptotic cells increased within the first




Kinetics of the morphological changes associated with the
cytolethal response of BLA^ cells to 1.1| x 10 methyl-
~
prednisolone (MPS)
Cultures were incubated with 1.1; x 10 MPS (treated) or
water (control) for l;8hr and assessed over this period for:
morphological change, as observed from smear preparations
(1000 cells scored per smear); and viability, as measured
by the ability of live cells to exclude nigrosine (200
cells scored per observation). • •, apoptotic cells;
A A, autolytic cells; O- - - -O , nigrosine stained
cells.
Each point represents the mean of treated minus control
values for 5 separate experiments. Control percentages
were the means of counts at Ohr and l;8hr.
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Fig. 32
Kinetics of the morphological changes associated with the
cytolethal response of RA.JT cells to 1 x 10 methyl-
prednisolone (MPS)
Cultures were incubated with 1 x 10 MPS (treated) or
water (control) for I|.8hr and assessed over this period for:
morphological change, as observed from smear preparations
(1000 cells scored per smear); and viability, as measured
by the ability of live cells to exclude nigrosine (200
cells scored per observation). • •, apoptotic cells;
A A, autolytic cells; O- - - -O > nigrosine stained
cells.
Each point represents the mean of duplicate tests from one
experiment. Control percentages were the means of counts
at Ohr and 72hr.
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it declined to a plateau level of about 3% (fig. 31) ~ this reflects
the transient existence of apoptotic cells which become autolytic.
The percentage of autolytic cells increased exponentially after an
initial lag phase of about 2hr reaching a level of about 85% by l+8hr
after treatment.
The percentage of nigrosine-stained cells followed approxi¬
mately the same curve as for autolytic cells.
(b) RAJI cells. There was a delay of 6-8hr before onset of apoptosis
(fig. 32). The percentage of apoptotic cells then increased to reach
a peak of 5®% at about 28hr after treatment and then fell again to
its initial value. The percentage of autolytic cells increased
exponentially after a lag phase of about 2l+hr reaching a peak of
95% by 72hr after treatment.
Again, the percentage of nigrosine-stained cells followed a




The kinetic studies of the cytolethal response are essentially
similar for BLA-j and RAJI cells. However two differences are
observed: in contrast to BLA^ cells, RAJI cells showed a prolonged
delay before onset of morphological changes - this is possibly due
to the difference in MPS concentrations used (1 x 10 and
1.1+ x 10 ^M MPS for RAJI and BLA+ cells respectively) as the kinetics
of/...
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of the cytolethal response is dose-dependent (see fig. 10, p. 3U);
secondly, the percentage of apoptosis in RAJT cells reached a far
higher peak than for BLA^ cells which could reflect the existence of
different 'metabolic states' between the cell lines, or a difference
in the rate of transit from the apoptotic to autolytic stage.
The morphological appearance of apoptotic cells precedes a
decrease in viability as assessed by nigrosine dye uptake. This is
in agreement with studies by Wyllie (in preparation) on MPS-induced
cell death in rat thymocytes, where -apoptosis precedes uptake of
nigrosine by several hours. This suggests that apoptotic cells
initially have a still functioning plasma membrane and are there¬
fore capable of metabolic activity; indeed, morphological evidence
suggests that apoptotic cells (or fragments) have some functionally
intact organelles such as mitochondria (Kerr, Wyllie and Currie,
1972; and see previous section).
The increase in the percentage of autolytic cells (the result
of further degradative changes in apoptotic cells) follows the
increase in the percentage of nigrosine-stained cells. This reflects
the morphological nature of autolysis (Trump and Ginn, 19^9) where
the cell shows focal dissolution of the plasma membrane, indicating
a loss of membrane integrity and therefore leading to entiy of
nigrosine into the cell.
Thus as a marker of MPS-induced cell death in human lymphoid
cells in vitro, nigrosine uptake when compared with morphological





l^hr after treatment, which was the length of incubation time






SECTION 1 The lymphoid cell lines exhibit a marked cytolethal
response to MPS only around 10 ~^M, a concentration greatly in excess
of both physiological and therapeutically attainable glucocorticoid
levels in vivo: the response was assessed by the ability of live
cells to exclude the vital dye, nigrosine, over a l+8hr incubation
period with MPS. The kinetic studies of the cytolethal response
over a l|8hr incubation period are consistent with a dose-dependent
relationship and the continued presence of MPS is necessary for
progression of lethal effects to occur.
SECTION 2 An EM, TEM and SEM study of the morphological aspects
associated with the cytolethal response of BLA^ cells to 1.1| x 10 "^M
MPS over a lj.8hr incubation period, revealed two distinctive morph¬
ological changes occurring from 1hr onwards after treatment. One
showed contortion and 'blebbing' of the cytoplasm and nucleus
resulting in the formation of discrete membrane-bounded fragments of
variable size. These contained some apparently normal cytoplasmic
organelles, and nuclear fragments which showed pyknosis and nuclear
membrane breakdown - in some cases pyknosis preceded cellular and
nuclear fragmentation. The other showed 'rounding up' of the cell
with loss of cytoplasmic protrusions and long slender surface
processes, aggregation of well-preserved cytoplasmic organelles,
accompanied by nuclear pyknosis and fragmentation and nuclear membrane
breakdown. In both cases many of the features are typical of
apoptosis. The subsequent degeneration of cells and fragments not
unexpectedly/...
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unexpectedly resembled in vitro autolysis.
SECTION 3 Over a l|8hr incubation period of BLA^ cells with
I.I4. x 10 MPS, the morphological appearance of apoptosis was
found to precede a decrease in viability as assessed by nigrosine
dye uptake; however the decrease in viability was found to follow
the increase in the appearance of autolytic cells. This suggests
that nigrosine uptake is a satisfactory 'late' marker in the
assessment of the cytolethal response of lymphoid cells to
glucocorticoid.
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PART II GROWTH INHIBITORY GLUCOCORTICOID EFFECTS
ON HUMAN LYMPHOID CELLS
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SECTION 1
KINETICS OF THE GROWTH INHIBITORY RESPONSE OF HUMAN LYMPHOID CELLS
f TO GLUCOCORTICOID
Initially I established the presence of a growth inhibitory -
or growth retardation - response in our in vitro system. A series
of cell lines was tested with MPS within the concentration range
10 - 10 ^M, and the growth inhibitoxy response was assessed at
1l4jhr (6 days) after treatment with MPS by measurement of TCC and
viability.
An experimental system was then devised such that the kinetics
of the observed growth inhibitory response could be studied over a
more prolonged period of time - this involved feeding cultures every
2 days with fresh growth medium in order to keep them in logarithmic
growth phase for at least 2 weeks.
Experiments were also performed to determine whether the con¬
tinued presence of MPS was necessary for the growth inhibitory
response to be maintained.
MATERIALS AND METHODS
Growth inhibitory test - no feeding
Five tube or flask cultures of BLA^ , GS^ , RAJI and EB^ cells were set
up/...
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up in duplicate at a concentration of 0.5 - 1 x 10^ total cells/ml by-
diluting stock cultures with fresh growth medium. Duplicate cultures
were immediately treated with 1% (v/v) of stock MPS solution to give
concentrations within the range 10 "^M - 10 ^M MPS. Cultures were
assessed for viability (nigrosine exclusion) and TOO (Coulter Counter)
at 6 days- after treatment.
Control cultures were set up in duplicate and treated with 1%
(v/v) of sterile distilled water and assessed as for test cultures.
Growth inhibitory test - feeding every U8hr
Six flask cultures of BLA^ and EB^ cells were set up in duplicate at
a concentration of 2.5 x 10^ total cells/ml by diluting stock
cultures with fresh growth medium. Duplicate cultures were immediately
treated with 1% (v/v) of stock MPS solution to give concentrations
8 o
within the range 10 M - 0.5 x 10 il MPS. Cultures were assessed for
viability and TCC every l|8hr and fed with fresh growth medium at the
same time (as described below) until 16 days after treatment.
Control cultures were set up in duplicate and treated with 1%
(v/v) of sterile distilled water and assessed and fed as for test
cultures.
Counts and feeding
Eveiy l|8hr, 20% (by volume) of 'old' growth medium was removed from
each culture without either disturbing or removing any cells which
had settled as a layer on the bottom of the flask. The cells were
then resuspended by gentle swirling, and 0.5ml removed for assessment
of/...
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of viability and TCC. The appropriate volume of cell suspension was
then removed and discarded and the remaining cells fed with fresh
growth medium so that (a) the final volume in each flask was restored
to the original volume and (b) the final TCC was restored to 2.5 x
10^/ml.
This method of feeding ensured that:
(a) cells were maintained in logarithmic growth phase for the
duration of the experiment
(b) all cells, including the more slowly growing, received a
regular and substantial supplement of nutrients.
Measurement of doubling time
The doubling time is calculated from the assessment of TCC over one
l|8hr interval from the following equation:
Doubling time (t^,) = — where K = growth constant-L/JL &
- see Appendix I (a) (p. 181) for further details on calculation. The
mean t^ is calculated from successive !j.8hr assessments of t^ over
the duration of the experiment. In each experiment, the t^ over the
first l|8hr interval after treating cultures is not included in this
value, as the growth inhibitory response is not usually observed until
i; days (96hr) after treatment with MPS.
Cumulative total cell number
This represents the theoretical total cell number in each cell culture
after correcting results for all preceding dilutions due to feeding
every l|8hr, and is calculated from the following equation:




- see Appendix I (b) (p. 181) for further details on calculation.
Duration of exposure to growth inhibitory concentration of MPS
Five flask cultures of EB^ cells resuspended in fresh growth medium
were set up in duplicate at a concentration of 2.5 x 10^ total cells/ml
and immediately treated with 1% (v/v) of stock MPS solution to give
a final concentration of 10 ^M MPS. Duplicate cultures were washed
x 2 (at 37°C) with fresh growth medium after the desired period of
exposure to the glucocorticoid. The cells were resuspended in the
original volume of fresh growth medium containing no MPS and then
cultured for a further 12 days.
Throughout the duration of the experiment, flasks were fed and
assessed for TCC and viability every lj8hr as described above.
Five control cultures were set up in duplicate and treated with
1% (v/v) of sterile distilled water. Cells were washed, fed and
assessed for TCC and viability as for test cultures.
RESULTS
Glucocorticoid sensitivity of lymphoid cell lines
Treatment with MPS for 6 days (lljlihr) - no feeding of cultures. The
log dose-response curves of individual cell lines, as assessed by
measurement of TCC and viability at lijl^hr after treatment with MPS,




Effect of metbylprednisolone (MPS) on the growth rate of
lymphoid cell lines
Cells were treated with various concentrations of MPS
(10 ^ - 10 ^M) (test) or water (control) for ll^lpir when
they were assessed for total cell concentration (TCC).
A A, GS1; O O, BLA1; □ □, EAJI; • •, EB^.
Each point represents the mean of duplicate observations




Effect of methylprednisolone (MPS) on the viability of
lymphoid cell lines
Cells were treated with various concentrations of MPS
(10~7M - 10-3M) (test) or water (control) for iJjl^hr when
they were assessed for viability.
A A, GS.J; O O, BLA1; □ □, EAJI; • •, EB^
Each- point represents the mean of duplicate observations
from one (BLA.^), two (RAJI, EB^) or three (GS^) separate
experiments.
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With 10 -74 MPS all cell lines show the expected cytolethal
response (see Part I of this thesis), with a marked decrease in
growth rate (fig. 33) and viability (fig. 3h) over the 1 l+Ipax' treat¬
ment period.
EB^. and RAJT cells show growth inhibition over the concentration
range 10 - 10 Si MPS (fig. 33) with the TCC of MPS-treated cultures
falling to about 70% of control values with 10 Si MPS - this occurs
without any corresponding drop in cell viability (fig. 3h)•
_7
GS^ and BLA^ cells show growth inhibition over the range 10 M
- 10 ^M MPS (fig. 33) with TCC values of MPS-treated cultures again
falling to about 70% of control values with 10 Si MPS - however this
also occurs with a corresponding small decline in cell viability of
MPS-treated cultures over the concentration range, reaching about
81-86% of control values with 10 Si MPS (fig. 3b)-
Treatment with MPS for 16 days - cultures fed evexy U8hr. The growth
inhibitory response to MPS was studied further on EB^ and BLA^ cultures
over a treatment period of 16 days. To ensure that any growth
inhibition observed after MPS treatment was not due to cells reaching
plateau growth phase with a limited supply of nutrients, cultures were
maintained in logarithmic growth phase for the duration of the
experiment by feeding with fresh growth medium eveiy 2 days as described
in Materials and Methods (p. 82). Pig. 35 compares the growth rate
of fed and unfed (control) cultures, the fed cultures showing a steady
increase in the cumulative total cell number over 6 days, whereas the





Comparison of growth rate of fed and unfed (control)
cultures of (a) BLA^ and (b) EB^ cells
Cultures were assessed for total cell concentration eveiy
I|.8hr over a period of 6 days. The growth rate is expressed
in terms of cumulative total cell number (TCN) (see Appendix
l(b)» P» 181 for calculation).
• •, fed every IjShr; O O, unfed (control).
Each point represents the mean of duplicate observations
from one experiment.
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MPS-induced growth inhibition, as represented by an increase in
the mean t^ of cells over 16 days treatment with MPS, is observed to
be dose-dependent in both EB^ and BLA^ cells within the concentration
range 10_7M - 10~Si MPS (figs. 36 and 37). For EB^ cells (fig. 36)
this response reaches a maximum with around 10 MPS.
Dose-dependent growth inhibition can be similarly represented by
a slower rate of increase in the cumulative total cell number in MPS-
treated cultures within the concentration range 10 7M - 10 Si MPS.
Fig. 38 shows such a graph for EB^ cells (typical also for BLA^ cells)
and it reveals that the marked growth inhibitory response with 10 ^
- 10' Si MPS is not evident until after days of treatment; there¬
after the response remains stable.
With 0.5 x 10 Si MPS-treated EB^ cells (fig. 38) growth
inhibition is immediately evident after 2 days of treatment - there¬
after a state of no growth is observed, followed by cell loss indicated
by a decrease in cumulative cell number. This response is due to a
marked decrease in viability of the MPS-treated culture (table 6,
p. 93 - final column) which declines steadily from I4. to 6 days after
treatment reaching 1L$> of the control value by 16 days i.e.,a
cytolethal response is observed.
The viability of cultures treated with 10 Si - 10 "Si MPS is
also shown in table 6 (p. 93) as observed over the 16 day treatment
—8 —6
period. BLA^ cells treated with 10 M - 10 M MPS show no marked
viability change throughout the duration of the experiment; 10 -




Effect of methylprednisolone (MPS) on the doubling time
of EB, cells
~ Cultures were treated with various concentrations of MPS
(10 - 10 ^M) or with water (control) for 16 days.
Each point represents the mean - 1S.E. of doubling times
of cultures as assessed over successive I|.8hr feeding intervals
from-2-16 days after treatment, in one typical experiment
(for calculation see Appendix l(a), p. 181 and Materials and
Methods p. 83). The interval between 0 and 2 days was not
included as no growth inhibitory effect was yet apparent
(see fig. 38).
Log10 MPS concentration (M)
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Fig- 37
Effect of methylprednisolone (MPS) on the doubling time
of BLA^ cells
Cultures were treated with various concentrations of MPS
(10 ^M - 10 %l) or with water (control) for 16 days.
Each point represehts the mean - 1S.E. of doubling times
of cultures as assessed over successive l|8hr feeding
intervals from 2-16 days after treatment, in one typical
experiment (for calculation see Appendix l(a), p. 181 and
Materials and Methods p. 83). The interval between 0 and 2




Effect of methylprednisolone (MPS) on the growth rate of
EB. cells
— h
Cells were incubated with various concentrations of MPS
(10 8M - 0.5 x 10 ~^M) or with water (control) for 16 days.
Eveiy l4.8hr, cultures were assessed for total cell concen¬
tration and fed with fresh growth medium. The growth rate
is expressed in terms of cumulative total cell number (TCN)
(see Appendix l(b), p. 181 for calculation).
■ ■, control; □ □, 10~8M MPS; A A, 10_7M MPS;
A A, 10~6M MPS; © •, 10~^M MPS; O O, 10" MPS;
♦ ♦, 0.5 x 10_3M MPS.
Each point represents the mean of duplicate observations
from one typical experiment.
Treatment time (days) with MPS
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STABLE 6







Viable fraction , , using thecontrol ^
following concentrations of MPS (m):


















































- - - -
2 0.98 0.99 0.99 1.00 1.00 0.98
1+ 0.98 0.99 0.98 0.97 0.97 0.91+
6 0.99 0.99 0.99 0.97 0.97 0.89
E®),
8 1.00 0.97 0.98 0.92 0.93 0.68
4 10 0.98 1.01 0.97 0.86 0.93 0.60
12 1.01 1.01 0.92 0.87 0.89 0.28
11+ 0.99 0.99 0.99 0.89 0.91 0.19
16 0.98 0.98 0.93 0.88 0.86 0.11+
Cells were treated with various concentrations of MPS (10 M -
0.5 x 10 ^M) (test) or water (control) for 16 days. Every l+8hr,
cultures were assessed for viability and fed with fresh growth
medium. - - - no results available.
Each value represents the mean of duplicate observations from
one typical experiment.
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treatment - at most 1 $% below the control value. Similar but some¬
what more pronounced effects are noted in EB^ cells: there is a
downward trend in viability - at its maximum about 1 lf/o below control
values, in cells treated with 10 or 10 V MPS for 10-16 days.
Effect of removal of 10 MPS on growth inhibitory response after
various periods of treatment with MPS
The duration of the glucocorticoid pulse to which EB^ cells were
exposed was varied by washing cultures free of a growth inhibitory
concentration of MPS - 10 ^M - at 1;, 6, 10 and 11; days after treat¬
ment, time intervals known to show a growth inhibitory response from
previous experiments; cultures were then grown for a further 12 days
after washing. Throughout the duration of the experiments, cultures
were fed with fresh growth medium every 2 days (see Materials and
Methods, p. 82).
Table 7 (p. 95) shows the effect of washing on the
both MPS-treated and control cultures. For each period of incubation,
the "tjyp's of pre.-wash and post-wash control cultures remains within
approximately the same range (36.9-39-Ohr and 33-6-37•5hr respectively)
which suggests that the washing procedure and handling of cells has
no detrimental effect on the growth rate of EB^ cultures. During
MPS treatment, the characteristic long t^ is observed (ranging from
U7- 8-58.1hr), and for each period of treatment with MPS the t^
returns to control levels after washing free of MPS. The "t^'s for
control and MPS-treated cultures grown continuously for 26 days
without washing are within the range for control and MPS-treated




EFFECT OF REMOVAL OF 1Q~^M METHYLPREDNISOLOKE (MPS) ON DOUBLING




Doubling time (hr) - 1S.E. for cultures:
Control MPS-treated
























After various periods of treatment with MPS or water (control) (as
shown), cultures were washed free of treatment, resuspended in fresh
growth medium and cultured for a further 12 days. Cultures were
assessed for total cell concentration every lj.8hr before and after
washing and fed with fresh growth medium eveiy L|.8hr.
Doubling times (hr) - 1S.E. are assessed by meaning values over
successive l+8hr intervals from 2 separate experiments for periods
equivalent to those shown on fig. 39 (p. 97) - for calculation see
Appendix l(a), p. 181 . (The l+8hr interval after initial addition of
MPS is not included as no growth inhibitory effect was yet apparent.)
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method of feeding employed allows cells to remain in logarithmic
growth phase for a prolonged period of time.
Fig. 39 shows the effect of washing cultures free of 10 ~^M MPS
on the cumulative total cell number after 10 days treatment with
MPS - this graph typifies the effect seen also with 1]., 6, and 1l| days
treatment. As seen in previous experiments, the growth inhibitory
effect is not observed until I4. days after treatment with MPS. After
washing at 10 days, the growth rate of the MPS-treated culture then
returns to the faster growth rate observed in the control culture.
• The viabilities of MPS-treated cultures both before and after
—5L
washing free of 10 MPS are shown in table 8,/ Where a small decrease
in viability precedes washing (with 6, 10 and II4. days incubation), a
slow increase occurs again after washing free of MPS. The viability
of cultures treated continuously with MPS, which drops to ^JQP/o of
the control value after 10 days incubation, shows a small increase
again after 20 days.
CQMMFNT
Initial experiments on a range of lymphoid cell lines, when
assessing for TOO at 6 days after treatment, suggested the existence
n
of a growth inhibitory response to lower concentrations of MPS (10 M
- 10 Sfl) than that required to induce a cytolethal response (10 ^M).




Effect of removal of 10 methylpredjiisolone (MPS) on
growth rate and doubling time of EB^ cells
After 10 days treatment with 10 MPS or water (control),
cultures were washed free of treatment, resuspended in
fresh growth medium and cultured for a further 12 days.
Cultures were assessed for total cell concentration every
l|8hr before and after washing and fed with fresh growth
medium every l|8hr. The growth rate is expressed in terms
of cumulative total cell number (TON) (see Appendix l(b),
p. 181 for calculation). O O, control culture;
• •, 10~^M MPS-treated culture.
Each point represents the mean of duplicate observations
from 2 separate experiments. Doubling times (DT) (hr)
- 1S.E. are assessed by meaning values over successive
' l|8hr intervals for the periods shown on the graph (for
calculations see Appendix l(a), p. 181 ).




After various periods of treatment with MPS (test) or water
(control) (as shown), cultures were washed free of treatment,
resuspended in fresh growth medium and cultured for a further 12
days. Cultures were assessed for viability every lj.8hr before and
after washing and fed with fresh growth medium every i|8hr.
Underlining denotes the time at which cultures were washed;
no further assessments taken after 12 days post-wash.
Each value represents the mean - 1S.E. of duplicate observations
from 2 separate experiments.
























































































more detail on cultures kept in logarithmic growth phase for at
least 2 weeks by feeding every 2 days with fresh growth medium. EB^
and BLA.J cells both showed a dose-dependent growth inhibitory
response within the concentration range 10 ^M - 10 MPS as shown
by either an increase in the population t^ or a slower rate of
increase in the cumulative total cell number over 16 days treatment
with MPS. The continued presence of MPS was found to be necessary
for the growth inhibitory response to be maintained. For EB^ cells,
the maximum growth inhibitory response was reached with 10 ^M MPS;
0.5 x 10 ^M MPS elicited the expected cytolethal response with massive
cell death occurring. For BLA^ cells, the MPS concentration range
studied was not sufficient to give a maximum growth inhibitory
response.
A similar growth inhibitory effect has previously been shown
in vitro on cortisone-treated human lymphoid cells by Nilsson (1971)
and on hydrocortisone-treated HeLa cells by Kollmorgen (19&9) w^°
also found the glucocorticoid effect to be reversible.
A small decrease in viability occurred with EB^ and BLA^ cells
(though less markedly for the latter) within the concentration range
10 - 10""4y[ MPS, though the relationship with the observed growth
inhibitory response is not clear. Theoretically, growth inhibition
could be due to:
(a) an increase in cell deletion by death
00 a decrease in cell production with no loss of viability




However results here suggest that although cell death is involved to
a small extent it can only be an indirect consequence of (b) above
asi
(i) reduction in viability was first observed several days
after establishment of growth inhibition (table 6, p. 93)
(ii) after 20 days of continuous MPS treatment the viability
increased again (table 8, p. 99 )» although growth inhibition
remained stable (table 7> P- 95)-
This finding is in marked contrast to recent work by Norman and
Thompson (1977) who showed that glucocorticoid-induced growth
inhibition in an uncloned human lymphoid cell line (OEM) is due
directly to the death of a sub-population of cells with a sensitive
phenotype. Continuing proliferation of the sub-population of
resistant phenotype then restores the overall growth rate of the
population to that of the control.
In contrast to the glucocorticoid-induced cytolethal response
in human lymphoid cell lines, the growth inhibitoxy response occurs
with concentrations of glucocorticoid equivalent to the therapeutic
doses employed in clinical practice. It is possible then that the
growth inhibitory response plays an important role in the regression
of lymphoid tumours after glucocorticoid therapy.
The correlation between cytoplasmic glucocorticoid receptors in
lymphoid cell lines and the MPS-induced growth inhibitory effect is
discussed later (see General Discussion, p. 15>7)-
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SECTION 2
MORPHOLOGY OF THE GROWTH INHIBITORY RESPONSE OE HUMAN LYMPHOID CELLS
TO GLUCOCORTICOID
In the previous section, it was shown that cell death is
involved in the MPS-induced growth inhibitory response to a small
extent (as observed by nigrosine exclusion). To my knowledge, little
information exists as to the morphological changes involved in growth
inhibition in human lymphoid cells, although Werthamer and Amaral
(1975) have shown changes associated with sub-lethal injury after
treatment of normal human lymphocytes with Cortisol. This section
therefore studies the morphology of EB^ cells during growth inhibition
induced by 10 ^M MPS as observed by both LM and TEM.
Combined with this study, the kinetics of observed LM morph¬
ological changes are compared with the kinetics of nigrosine uptake
over the period of treatment of EB^ cells with 10 ~^M MPS.
MATERIALS AND METHODS
Kinetics and morphological studies
Duplicate flask cultures of EB^ cells were set up at a concentration
of 2.5 x 10^ total cells/ml by diluting stock cultures with fresh
growth medium and then were immediately treated with 1% (v/v) of
stock MPS solution to give a final concentration of 10 '%[ MPS.
Control/. . .
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•Control cultures were treated with 1% (v/v) of sterile distilled
water. Cultures were fed and assessed for viability and TCC every
1+Shr for the duration of the experiment (as described in Materials
and Methods, Part II, Section 1, p. 82). For morphological studies,
samples were removed at appropriate time intervals and prepared for
both EM (smears) and TEM (as described previously in Materials and




The typical morphology of EB^ cells, as observed both in smears and
ultrastrueturally, is illustrated in figs. 1+0 and 1+1 respectively.
Features are essentially the same as for BLA^ cells (cf. figs. 13
and 1l+, pp. 1+5 and 1+6), except that the surfaces of EB^ cells show




EM. The majority of the population of EB^ cells as seen on smears
appear morphologically normal even at 16 days after treatment with
10 ^M MPS (fig. 1+2). However from 1+ days onwards after treatment,
a very small percentage of cells show morphological changes typical
of apoptosis and autolysis (fig. 1+3) as previously described for
BLA^ cells after treatment with 1.1+ x 10 ^M MPS (see Part I, Section
2); coincidently there is an increase in the number of cells taking






The cell surface shows cytoplasmic protrusions (p) and the
cytoplasm contains many clear vacuoles. The cells have a
high nuclear to cytoplasmic ratio, with the nucleus some¬







TIM of control eb, cells
4
The cytoplasm is rich in polysomes (p) with scanty profiles
of rough endoplasmic reticulum (RER), mitochondria with
plate-like cristae (m), and golgi apparatus (g); although
often seen, no lipid droplets are present in this cell.
The nucleus (n) shows diffusely dispersed chromatin with
scanty aggregates of heterochromatin along the nuclear
membrane. TJALC. x 10,500.
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Fig. U2
EB^ cells 16 days after treatment with 10 methylprednisolone
The cells show the same morphological features as for
control cells. G. x 580.
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Kinetics of the morphological changes associated with the
growth inhibitory response of EB^ cells to 10 ~^M methyl-
prednisolone (MPS)
Cultures were incubated with 10 MPS (treated) or water
(control) for 12 days and assessed every l|8hr for:
morphological change, as observed from smear preparations
(1000 cells scored per smear); and viability, as measured
by the ability of live cells to exclude nigrosine (200 cells
scored per observation) • O, apoptotic cells,
A A, autolytic cells, O- - - -O , nigrosine-stained
cells.
Each point represents the mean - 1S.E. of treated minus
control values for duplicate observations from 2 separate




«TEM. At I4. days after treatment with 10 MPS, evidence of
ultrastruetural damage, other than apoptotic and autolytic changes,
is present in some cells - gross mitochondrial changes are seen
with varying degrees of disorganisation of mitochondrial cristae
and formation of myelin figures with lamellar configuration within
the mitochondria (fig. 1+lj.); not all mitochondria within one cell
show these figures.
COMMENT
Evidence of sub-lethal MPS damage was not observed in smears
even after 16 days treatment with 10 ^M MPS. However with TEM,
gross mitochondrial alterations were seen after days treatment
which included disorganisation of cristae and formation of myelin
figures. These changes are generally regarded as degenerative and
indicative of an ongoing autophagic process (Trump and Arstila,
1971) and are similar to the sub-lethal changes reported by
Werthamer and Amaral (1975) after treatment of normal human lymph¬
ocytes in vitro with Cortisol.
The presence in smears of a small increase in the number of
apoptotic and autolytic cells after I4. days treatment suggests the
presence of a small sub-population of EB^ cells which show a cyto-
lethal response to 10 MPS, a concentration 100-fold less than
that required to induce a cytolethal response within the entire
population (10 ^M). These could represent the subsequent death of
sub-lethally damaged cells or alternatively could represent death of
- 109 -
Fig- Mt
TEM of EB^ cell I4. days after treatment with 10 methyl-
prednisolone
The mitochondria show disorganisation of cristae and the
formation of myelin figures (MF). TJALC. x 39»000.
^p
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•a small population of cells sensitive to the lethal effect of 10
MPS. These alternatives could have been distinguished in TEM
studies by investigating the presence or absence of such mitochon¬
drial changes in apoptotic cells - unfortunately the percentage of
apoptotic cells in treated cultures was too small for this to be
possible.
A correlation between the observed morphological changes and




QUANTITATIVE AUTORADIOGRAPHIC ANALYSIS OF THE GROWTH INHIBITION
INDUCED IN HUMAN LYMPHOID CELLS BY
GLUCOCORTICOID
The increase in population observed in lymphoid cell lines
treated with a growth inhibitory concentration of MPS could be due
to the following effects on cell kinetic parameters:
(a) an increase in the cell cycle time
' 00 a decrease in the growth fraction
(c) an increase in the rate of cell death
(d) a combination of (a), (b) and (c).
In previous population kinetic studies on human lymphoid cells
and on other cells both in vitro and in vivo, it has been shown that
the glucocorticoid-induced growth inhibitory response occurs due to
a blockage of the transition of cells from G^ into S. However,
evidence is conflicting as to whether the blocked cells maintain the
capacity to return to cycle giving the appearance of a prolonged t^
(Kollmorgen, 19&9; Braunschweiger, Stragand and Schiffer, 1978) or
whether the cells are irreversibly committed to die (Norman, Harmon
and Thompson, 1978).
Prom morphological evidence in the previous section it would
appear that cell death plays a role in glucocorticoid-induced growth
inhibition/...
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inhibition in EB^ cells; this could possibly be due to death of cells
blocked in G^. As a better understanding of such mechanisms of
glucocorticoid action would be valuable in designing more effective
chemotherapeutic regimes in vivo which combine glucocorticoids with
other cell cycle active drugs, I have therefore studied the growth
inhibitory response of EB^ cells to 10 MPS by analysis of the
following kinetic parameters:
(a) number of cells in S-phase (tritiated-thymidine (^H-TdR)
pulse-labelling index)
(b) mitotic index
(c) length of the cell cycle time and duration of M, G^, G^ and
S phases of the cell cycle (percentage of labelled mitoses technique
- pulse-label with ^H-TdR; and ^H-TdR continuous-labelling technique)
(d) growth fraction (percentage of labelled mitoses technique
- pulse-label with ^H-TdR; and ^H-TdB continuous-labelling index).
"^H-TdR is widely used for autoradiographic studies in cell
population kinetics; it is a radioactive precursor entirely specific
to DNA (Quastler and Shexman, 1959) and the short range of ^B-ray
emission from "^H decay allows precise sub-cellular localisation of
incorporated nucleoside.
However it has been shown that if used at too high a concen¬
tration, the radioactive precursor can cause observable radiation
damage in cells which have incorporated it. Such damage includes
i
growth inhibition due mainly to a G^ + M block (Ehmann _et al, 1975)
and may also include mutations, chromosome aberrations and cell death
(Bedford _et al, 1975) a™! strand breaks in the DNA molecule (Cleaver,
Thomas/.. .
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•Thomas and Burki, 1972). The presence of excess thymidine itself can
cause a reversible inhibition of DNA synthesis and indeed as such is
used as a technique for synchronising cell cultures (Mitchison,
1971) - this inhibition arises due to overloading the complex
metabolic pool with exogenous thymidine.
Thus in this experimental system it was necessary to carry
out preliminary experiments to ensure that the concentration of
-TdR used for either pulse-labelling or continuous-labelling was
not itself sufficient to perturb the growth rate of the EB^ cells.
MATERIALS AND METHODS
^H-TdR
An aqueous solution of 6 - ^H-TdR, specific activity 21.9 Ci/mM,
was obtained from Radiochemicals, Amersham.
Pulse-labelling with ^H-TdR
For the preliminary experiment, five flasks of EB^ cells were set
up in duplicate at 1 - 2 x 10^ cells/ml and duplicate flasks were
treated with 1% (v/v) of stock "^H-TdR solutions to give concentrations
of 0.1, 0.5, 1.0, 2.0 and Jj.O^aCi/ml. The cells were incubated
with ^H-TdR for 30 min. at 37°C and then washed free of unbound
^H-TdR three times with ice-cold Hepes-buffered Hanks solution
(Hanks Balanced Salt Solution, Gibco-Biocult; 20mM Hepes buffer,
Gibco-Biocult). Cells were finally resuspended in fresh growth
medium at the original concentration and allowed to continue growth




•and viability every 2 days (for further details see Appendix II,
p. 182). Duplicate control cultures were treated with 1% (v/v) of
sterile distilled water for 30 min. at 37°C, then washed, resuspended
in fresh growth medium, fed and assessed as for ^H-TdR-treated
cultures.
Continuous-labelling with ^H-T&R
For the preliminary experiment, four flasks of both control (water)
and 10 ~^M MPS-treated EB^ cells were set up in duplicate at 2.5 x
10^ cells/ml and after 1+ days incubation duplicate cultures were
treated continuously for 10 days with 1% (v/v) of stock H-TcLR
solutions to give concentrations of 0.1, 0.05, 0.01 and 0.005yuCi/ml.
Flasks were assessed for viability and TOO and fed every 2 days
(see Materials and Methods Part II, Section 1, p. 82).
•%-TdR pulse-labelling index (Li) and mitotic index (Ml)
Flasks of both 10 ^M MPS-treated and control (water) EB^ cells were
set up in duplicate at 2.5 x 10^ cells/ml, and were fed and assessed
for TCC and viability every l+8hr over a period of 12 days (see
Materials and Methods Part II, Section 1, p. 82). At selected time
intervals, samples were removed from all flasks and (a) smeared and
stained with Giemsa (see Materials and Methods Part I, Section 2,
p. l+l) for measurement of MI, or (b) pulse-labelled with 1.0 ^iCi/ml
^H-TdR for 30 min. at 37°C and smears of cells then prepared for
autoradiography for measurement of %-TdR LI.
Percentage labelled mitoses technique (PLM)-pulse-label with ^H-TdR




/up in duplicate at 2.5 x 10 cells/ml, and were fed and assessed for
TCC and viability eveiy lj8hr (see Materials and Methods Part II,
Section 1, p. 82). After 6 days incubation, control and 10 ~^M MPS-
treated cultures were pulse-labelled with 0.1 ^Ci/ml ^H-TdR for 30 min.
at 37°C and washed and resuspended in fresh growth medium as described
above under 'Pulse-labelling with ^H-TdR' (treatment with water and
10 ^M MPS was maintained). After pulse-labelling, samples were then
removed from treated and control cultures at I[hr intervals up to J6hv,
and smears of cells prepared for autoradiography.
TdR continuous-LI and PLM curve
Flasks of 10 ^M MPS-treated and control (water) EB^ cells were set
5
up in duplicate at 2.5 x 10 cells/ml and fed and assessed for TCC
and viability every ij.8hr (see Materials and Methods Part II, Section
1, p. 82). After 6 days incubation, all cultures were continuously
exposed to 0.01 yuCi/ml ^H-TdR. Samples were removed at selected
time intervals after addition of "^H-TdR and smears of cells prepared
for autoradiography.'
Autoradiography
Smears of cells were prepared on glass slides, air-dried and fixed
in 3% methanol for 15 min. Slides were dipped in liquid emulsion
(ilford K5, diluted 2:1 with 1% glycerol) at lj.30C in the dark for
various periods of time: 5 days for 1 ^uCi/ml ^H-TdR; 5 weeks for
0.1 yuCi/ml "^H-TdR; 6J- weeks for 0.01 jiCi/wl ^H-TdR. The emulsion
was then developed in Kodak D19 developer for 3i min., rinsed and
fixed in Kodak metafix for 10 min. Slides were then stained with
Giemsa. A 'cold' standard, i.e., a smear of EB^ cells not exposed
to/...
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•to -II-TdR, was included as a control in all experiments.
Background grain counting for autoradiographs
This was estimated by scoring the frequency of the number of grains
overlying each nucleus in a population of 500 live cells ( as assessed
C
morphologically in smears) on duplicate slides i.e., 1,000 cells/test.
Measurement of LI, MI and PIM
For each time point (unless indicated otherwise in 'Results' section),
the pulse- and continuous-LI was assessed by scoring 2,000 live cells
as labelled or unlabelled; 500 cells were counted on duplicate slides
for each test i.e.,1,000 cells/test, and each test was performed in
duplicate.
For each time point, the MI was assessed by scoring the number
of mitoses in a population of 5>000 live cells; 1,250 cells were
counted on duplicate slides for each test i.e.,2,500 cells/test, and
each test was performed in duplicate.
For each time point, the PIM was assessed by scoring 200 mitoses
as labelled or unlabelled; 50 mitoses were counted on duplicate slides
for each test i.e.,100 mitoses/test, and each test was performed in
duplicate.
Slides were scored 'blind' for each experiment and several





Effect of a 30 min. pulse of ^H-TcLR on the growth rate of EB^ cells
The effect of pulse-labelling on the growth rate of EB^ cells using
3various concentrations of H-TcLR is shown in fig. 1|5» This prelim¬
inary experiment was necessary so that the PEM experiment, which
involves pulse-labelling with ^EI-TcLR, could be performed with a
3suitable concentration of H-TdR such that the growth rate was not
affected over a period of 9^hr. These results show a "^H-TdR dose-
dependent effect on the growth rate; by l|8hr after pulse-labelling
cells treated with 5*0 ^iCi/ml show a rapid and marked decline in
growth rate, this being less marked with 2.0 and 1.0yuCi/ml and non¬
existent with 0.5 and 0.1 yiCi/ml; by 9&hr after pulse-labelling, all
concentrations of ^H-TdR show some effect on the growth rate, though
0.5 and 0.1 ^iCi/ml show a reduction in growth rate of <10% of the
control value; by lljlpir, all concentrations show a further decline in
the growth rate. From these results, 0.1 ^iCi/ml was chosen as the
optimum concentration of ^H-TdR suitable for the PIM experiment (for
further details on this preliminary experiment see Appendix II, p. 182).
Effect of continuous-labelling with ^H-TdR on the growth rate and
viability of both control and 10 MPS-treated EB. cells
^
The effect of continuous-labelling on the viability and growth rate
of EB^ cells using various concentrations of "^H-TdB is shown in
figs. I46 and 1+7 respectively; both control and 10 MPS-
treated EB^ cells were tested after 9^hr in culture, i.e.,once
growth inhibition with the MPS was observed. After 10 days incubation
with 0.1 and 0.05 yrCi/ml ^H-TdR a marked decrease in viability was
noted/...
Fig- US
Effect of ^H-TdR pulse-labelling on the growth rate of EB^ cells
EB^ cells were labelled for J>0 min. at 37°C with various
concentrations of "^H-TcLR (0.1 - 5>-0 ^uCi/ml) (treated) or
pulsed with water (control), washed three times in ice-
cold Hepes-buffered Hanks solution and resuspended in fresh
growth medium for a further 1 liljhr. ^H-TdR concentrations:
V v> 0.1 yiCi/ml; □ □, 0.5^Ci/ml; O <>» 1.0^iCi/ml
O O, 2.0yuCi/ml; A A, 0^Ci/ml.
Each point represents the mean of duplicate observations
from one experiment.
TIME (HR) AFTER PULSE
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Fig. U6
Effect of ^H-TdR continuous-labelling on the viability of
10 ~^M MPS-treated and control EB^ cells
After 96hr in culture (arrow), 10 ^M"MPS-treated and control
(water) cultures of EB^ cells were labelled continuously
with various concentrations of ^H-TdR (a) 0.1 ^iCi/ml,
(b) 0.09/iCi/ml, (c) 0.01 ;uCi/ml, (d) 0.009/iCi/ml.
Cultures were assessed for viability and fed with fresh
growth medium every l|8hr. • •, control EB^;
■ ■, 10 ^M EPS-treated EB^; O- - - -O , control EB^ +
"^H-TdR; □ □ , 10~^M MPS-treated EB^ + ^H-TdR.
Each point represents the mean of duplicate observations
from one experiment.
Time (days) in culture
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Fig- hi
Effect of ^H-T&R continuous-labelling on the growth rate of
10~^M MPS-treated and control EB^ cells
After SGhr in culture (arrow), 10 ~^M MPS-treated and control
(water) cultures of EB^ cells were labelled continuously
with various concentrations of ^H-TcLR (a) 0.1yiCi/ml,
(b) 0.05> ^pCi/ml, (c) 0.01 ^iCi/ml, (d) 0.005 yuCi/ml.
Cultures were assessed for total cell concentration and
fed with fresh growth medium every [|.8hr. • #, control
EB^; ■ ■, 10 MPS-treated EB^; O- - - -O , control
EB^ + ^H-TcLR; □ □ , 10~^M MPS-treated EB^ + %-TdR.




noted with both treated and control EB, cells - this was not
4
evident with 0.01 and 0.005>yuCi/ml. With control EB^ cells, a drop
in. growth rate (as illustrated by a plot of log cummulative total
cell number) was observed with 0.1, 0.0£ and 0.01 ^iCi/ml ^H-TdR,
this being evident after 1; days incubation with 0.1 and 0.0f>yuCi/ml
and after 6 days with 0.01 yaCi/ml; there was no observed decrease in
growth rate with 0.005>yuCi/ml. With 10 MPS-treated cells, only
0.1 ^iCi/ml showed any marked decrease in growth rate.
This preliminary experiment was undertaken so that a continuous-
LI experiment could be performed on EB^ cells with a concentration of
"^H-TdR which showed no deleterious effects on either the growth rate
or the viability of the cells. The concentration of 0.00J?yiCi/ml
would seem ideal - however such a low concentration would require an
extremely long exposure time for detection of labelled cells on
autoradiographs. As this was not feasible, 0.01 jiCi/wl was there¬
fore used in further experiments as this concentration showed no
decrease in viability and the growth rate was not affected until 6
days after incubation with the "^H-TdR.
Effect of 10 MPS on the ^H-TcLR pulse-LI of EB^ cells
Typical autoradiographs of EB^ cells pulse-labelled for 30 min. with
1.0yiCi/ml ^H-TdR are shown in fig. 14.8(a); fig. l|8(b) illustrates a
'cold® standard. The frequency distribution of nuclear grain counts
(fig. I49) revealed that all cells with > 5 grains overlying the
nucleus could be scored as labelled. The majority of the population




Autoradiographs of control EB^ cells
(a) EB^ cells pulse-labelled with 1.0 ^iCi/ml %-thymidine
(^H-TdR) for 30 min. at 37°C. Cells containing radio-
actively labelled DNA in their nucleus (i.e., S-phase cells)
have black grains overlying them, (b) a 'cold' standard






Frequency distribution histogram of nuclear grain counts
from autoradiographs of control EB^ cells pulse-labelled
~ with 1.0 uCi/ml ^H-thymidine for 30 min. at 37°C
After pulse-labelling, smears of cells were prepared for
autoradiography. 500 cells were counted/autoradiograph
and the number of grains over each nucleus grouped together
as shown. Grain count distribution is clearly bimodal and
the background level was chosen to include the majority of
cells in the lightly labelled sub-population, with a mode
of 2 - 3 grains (as indicated).
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Results of the effect of 10 ^M MPS on the pulse-LI of EB^
cells are shown in fig. !%)• The pulse-LI of control EB^ cells
remained at 62% for the duration of the experiment. With 10 ^M MPS-
treated cells, the pulse-LI fell immediately after treatment to
reach a new stable level of 39% i.e., a fall of 23%. The mean
length of time for the level to decrease to 39% be calculated
from the inflection point between the falling arm of the curve and
the new plateau level where the mean = 33hr (range 23hr - 58hr)
(see fig. 50)•
Effect of 10 MPS on the mitotic index (Ml) of EB^ cells
Results are shown in fig. £1• The difference in MI values between
control and 10 MPS-treated cells increases from about 12hr after
addition of MPS and this reaches a new plateau level after about
l+2hr where the treated cells show a MI approximately 0.8% lower
than that of the control cells.
Effect of 10~^M MPS on the duration of the cell cycle time and the
individual phases of the cell cycle of EB^ cells - PIM technique
using ^H-TdR pulse-label
The well-known conventional technique of PIM (Quastler and Sherman,
1959j Baserga and Viebel, 19&9; Mitchison, 1971; Aherne, Camplejohn
and Wright, 1977; Steel, 1977) was used to determine the duration of
the cell cycle and its component phases (see Appendix Ill(a), p. 181+
for theoretical details) - this involves drawing a curve of best fit
by eye through the individual data points. In addition, data was
also fed through a Monte Carlo computer programme devised by Barrett




Effect of 10 methylprednisolone (MPS) on the ^H-thymidine
(•^H-TcLR) pulse-labelling index (Li) of EB^ cells
At the time intervals shown during treatment, samples of
control (water) and 10 MPS-treated EB^ cells were
pulse-labelled with 1.0 jiCi/wl ^H-TdR for 30 min. at 37°C
- smears of cells were then prepared for autoradiography.
Cell nuclei with > £ grains were scored as labelled. The
number of labelled cells for each point is expressed as a
percentage of a total of 2,000 cells counted. • •,
control EB^ cells; O O, 10 ^M MPS-treated EB^ cells.
- - -
-, indicates the point of inflection of the 2 arms
of the curve.
Each point represents the mean - 1S.E. of 2 experiments




Effect of 10 methylprednisolone (MPS) on the mitotic
index (Ml) of EB^ cells
At the time intervals shown during treatment, smears of both
control (water) and EPS-treated EB^ cells were prepared and
stained with Giemsa. The number of mitotic cells for both
control and treated cells is expressed as a percentage of a
total of 5j000 cells counted.
Each point represents the mean (control minus treated) -
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■by Dr. G.G. Steel; this fits a PEM curve from which cell cycle
parameters are derived, and also computes the distribution of cell
cycle times. These parameters are subsequently denoted in the text
as follows:
t = cell cycle time
t^ = duration of G^ phase
t = duration of S phase
D
t = duration of G_ phase
\JTC. C.
t^ = duration of mitotic phase
The PEM data was assessed on autoradiographs in serial samples
taken over a period of jGhr. Typical examples of such labelled or
unlabelled mitoses are shown in fig. £2. The frequency distribution
of nuclear grain counts (fig. 53) revealed that all mitotic cells
with > I). grains overlying the chromosomes could be scored as labelled
in both 10 MPS-treated and control EB^ cells. The majority of
the labelled cells showed >25 grains/nucleus.
The PEM curves for control and 10 MPS-treated EB, cells as
4
drawn by eye are shown in figs. 5U and 55 respectively. With control
curves, at least 1; waves of labelled mitoses are seen, but with
treated curves there is damping after the third wave to a level of
about 56% which suggests more variation from the control cells in
t^ and/or its phases.
The duration of t and its component phases as derived from
L/
these curves (see Appendix Ill(a), p. I8I4) are presented in table 9




Autoradiography of control EB^ cells
Cells were pulse-labelled for 30 min. at 37°C with 0.1
^iCi/ml "^H-thymidine (^H-TcLR), washed three times and
resuspended in fresh growth medium containing no ^H-TdR.
Cultures were sampled and smears of cells prepared for
autoradiography at (a) 8hr and (b), (c) 3^hr after






Frequency distribution histograms of nuclear grain counts
from autoradiographs of control and 10 me thylprednisolone
(MPS)-treated EB^ cells pulse-labelled with 0.1 pCi/ml
^H-thymidine (^H-TdR)
Control (water) and 10 MPS-treated EB^ cells were pulse-
labelled for 30 min. at 37°C, washed three times and
resuspended in fresh growth medium containing no ^H-TdR;
treatment with water and 10 MPS was maintained. Cultures
were sampled at 8hr after pulsing and smears of cells
prepared for autoradiography: (a) control EB^ cells,
(b) 10 ^M MPS-treated EB^ cells. 5>00 cells were counted/
autoradiograph and the number of grains over each nucleus
grouped together as shown. Grain count distribution is
clearly bimodal and the background level was chosen to
include the majority of cells in the lightly labelled
sub-population (as indicated).
Each bar represents the mean - range of counts from 2
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Percentage of labelled mitoses (PEM) curve for control
EB, cells
_ ^
After 6 days in culture, control (water) EB^ cells were
pulse-labelled for 30 min. at 37°C with 0.1^uCi/ml
thymidine (^H-TcLR), washed three times and resuspended in
fresh growth medium containing no ^H-TdR; treatment with
water was maintained. Samples were removed at the time
intervals shown after pulsing and smears prepared for
autoradiography. Mitotic cells with > 1; grains overlying
the chromosomes were scored as labelled. The number of
labelled mitoses for each point is expressed as a percentage
of a total of 200 mitoses counted.
Each point represents the mean - 1S.E. of I4. separate
observations from one experiment.
The curve is drawn by eye as a best fit to the data points.
The durations of the cell cycle (t^) and its phases (t ,
t , t^ and t^) are calculated from this curve as described
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Time (hr) after H-TdR pulse
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Fiff- $$
Percentage of labelled mitoses (PLM) curve for 10 '%[ methy1-
prednisolone (MPS)-treated EB, cells
^
After treatment with 10 "ii MPS for 6 days, EB^ cells were
pulse-labelled for 30 min. at 37°C with 0.1 ^iCi/ml "^H-
thymidine (^H-TdR), washed three times and resuspended in
fresh growth medium containing 10 MPS, but no ^H-TdR.
Samples were removed at the time intervals shown after
pulsing and smears prepared for autoradiography. Mitotic
cells with > grains overlying the chromosomes were scored
as labelled. The number of labelled mitoses for each point
is expressed as a percentage of a total of 200 mitoses
counted.
Each point represents the mean - 1S.E. of I4. separate
observations from one experiment.
• The curve is drawn by eye as a best fit to the data points.
The duration of the cell cycle (t ) and its phases (t ,0 G1
tg, t^ and t^) are calculated from this curve as described
in Appendix III (a), p. 18I4. or in the text p. 132.
8.4 hr
Time (hr) after 3H-TdR pulse
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-both control and treated cells. Unfortunately the first trough in
the PEM curves does not fall to below the 50% level - this could be
due to the selected background grain count ( 5 U grains) being too low,
or again a very marked variation in t^ and its phases. As a conse¬
quence, t can only be roughly estimated by visual methods: a notional
O ^ w
descending portion of the first wave was constructed as shown in
figs. 5U and. 55 "by extrapolating the leading edge of the second wave
back to the mid-point of the first wave and then subtracting this
from the trailing edge of the first wave. For measurement of t^
MI
= — x t - see Appendix Ill(a), p. 185) "the MI and LI wereIII O
measured from the 2+hr sampling point: MI = 1.81+% and 0.97% for control
and 10 ^M MPS-treated cells respectively; LI = 59*7% and 35*1% for
control and 10 MPS-treated cells respectively.
TABLE 9 ESTIMATION OF THE DURATION OF THE CELL CYCLE AND ITS
COMPONENT PHASES FOR CONTROL (WATER) AND 10~^M METHYIFREDNISOLONE
(MPS)-TREATED EB^ CELLS FROM THE PERCENTAGE OF LABELLED MITOSES


















the negative values for t^ are accounted for in the sub-section on
continuous/...
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.continuous-labelling with "^H-TcLR - see table 11, p. 1l|0.
The computed PLM curves are shown in figs. £6 and 57 for control
and 10 "*M EPS-treated cells respectively. There appears to be a
marked discrepancy from the hand-drawn curves, as in both control and
10~^M MPS-treated cells the computer does not simulate the second and
subsequent peaks of the curve - this arises, however, as the programme
incorporates sufficient spread in and sufficiently long values of
t and t from the first peak data to render it impossible to fit a
i o
curve that can rise again to simulate the early second peak of the
data (G.G. Steel, personal communication). This possibly indicates
that the first peak may be prolonged or delayed due to a disturbance
by the presence of ^H-TdR or perhaps to the technique of removing
^H-Tcffi from the cultures (vide infra). Figs. 56 and 57 also show
the computed distribution of t for both control and 10 ^M MPS-
treated cells respectively.
The duration of the cell cycle parameters as obtained from the
computer analysis are shown in table 10, p. 136 (cf. table 3, p. 132 )»
and again the duration of individual parameters are similar for
control and 10 MPS-treated cells. However, as the curves do not
fit the data points, then these measurements are. not considered to
be of any further value.
TABEE 10/.
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Monte Carlo computer analysis of percentage of labelled
mitoses (PIM) data for control EB^ cells
(a) PIM curve. - - - computed; > drawn by eye
through data points as previously shown in fig. Sh (this
is included for comparison), (b) computed distribution
of cell cycle times. (See legend to fig. 5>l+ for experimental
details.)
Time (hr) after 3H-TdR pulse
(b)
Cell cycle time (hr)
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Fig- 57
Monte Carlo computer analysis of percentage of labelled
mitoses (PEM) data for 10 methylprednisolone-treated
EB, cells
- l±
(a) PLM curve. - - - computed; , drawn "by eye
through data points as previously shown in fig. 55 (this
is included for comparison), (b) computed distribution
of Cell cycle times. (See legend to fig. 55 for
experimental details.)
Time (hr) after ^H-TdR pulse
(b)
Cell cycle time (hr)
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TABLE 10 ESTIMATION OF THE DURATION OF THE CELL CYCLE AM) ITS
COMPONENT PHASES FOR CONTROL (WATER) AM) 10~^M METHYLPREDNISOLONE
(MPS)-TREATED EB^ CELLS AS OBTAINED PROM THE COMPUTED PERCENTAGE
OF LABELLED MITOSES DATA (FIGS. 36 AND 67)
Cell cycle
parameter











Effect of 10 _M MPS on the growth fraction (f^) of EB^ cells as
measured from the PLM pulse-labelling curves
There are 2 well-recognised methods of measuring fn from the PIEIt
pulse-labelling curves:
(a) fp = LI (Mendelsohn, 1962)
< PLM>
(b) In (1 + fG) = *0 x In 2 (Steel, 1968)
^C(pot)
(see Appendix IIl(c), p. 190 for further details).
Unfortunately, as the PLM data could not be fitted accurately
by computer model analysis (figs. 56 and 57) and as Steel's equations
for calculating f^ and (see Appendix IIl(c), p. 190) assume
a conventional cell cycle model, then it was not considered worthwhile
making/...
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making a detailed computer analysis of these parameters (G.G. Steel,
personal communication).
Thus, Mendelsohn's method alone was used to calculate f .
(x
<" PEM > was estimated from averaging the values of PIM obtained
every hour over one cell cycle duration, between the first and second
peaks on the PIM curves in figs. 5U and 55*
< PIM> , control cells = 79-1%
<PLM>, 10~^M MPS-treated cells = 73-2%
Thus, fn values for control and 10 ^M MPS-treated cells arelx
found to be 75% and 1+8% respectively i.e., treated cells show a 27%
decrease in fn value compared to the control cells.(x
Effect of 10~^M MPS on t^2» t^ and f^ as measured by ^H-TcLR
continuous-labelling techniques
Continuous-labelling with ^EI-TcLR is another conventional technique
which may be used to determine t , t and f„ values by analysing\jfd CxT Cx
the PIM and continuous-LI curves (see Appendix Ill(b), p. 185 for
theoretical details.
For continuous-labelling experiments, the frequency distribution
of nuclear grain counts on autoradiographs revealed that cells with
y 1+ grains overlying the nucleus could be scored as labelled in both
control and 10 MPS-treated cultures (fig. 58).
The PIM curves for both control and 10 ^M MPS-treated cultures




Frequency distribution histograms of nuclear grain counts
from autoradiography of EB^ cells continuously-labelled for
1hr vith 0.01 ^iCi/ml ^E-thymidine (a) control (water) EB^
cells and ("b) 10 ~^M methylprednisolone (MPS)-treated EB^ cells
After labelling, smears of cells were prepared for autoradio-
> graphy. ^00 cells were counted/autoradiograph and the
number of grains over each nucleus grouped together as shown.
Grain count distribution is clearly bimodal and the back¬
ground level was chosen to include the majority of cells in
the lightly labelled sub-population (as indicated).
Each bar represents the mean - range of counts from 2
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Percentage of labelled mitoses fPLM) as a function of time for
(a) control and (b) 10 methylprednisolone (MPS)-treated EB^
cells, exposed continuously to 0.01 pCi/ml ^H-thymidine (^H-TdR)
After treatment for 6 days, control'(wate^ and 10 MPS-treated
EB^ cells were continuously labelled with 0.01 ^.Ci/ml "^H-TdR.
At the time intervals shown after addition of "^H-TdR, samples
were removed and smears of cells prepared for autoradiography.
Mitotic cells with > grains overlying the chromosomes were
scored as labelled. The number of labelled mitoses for each
point is expressed as a percentage of a total of 200 mitoses
counted.
Each point represents the mean - 1S.E. of 2 experiments each with
duplicate observations. The duration of t^, + -J-t^ is calculated
as shown.
3
Incubation time (hr) with H-TdR
- 11+0 -
.level showed a mean t + value of 5*2hr and 5>.6hr for control and
treated cultures respectively. These t values are lower than those
\JCC-
found by the pulse-labelling PIM technique (see table 9j P« 132 ); this
possibly arises as the pulse-labelling PIM method involves excessive
disturbance of the cells due to the washing and centrifuging procedure
required to remove the excess ^H-TdR. It is thought that this might
cause a transient delay or blockage of cells in or at the QrJ'S
interphase such that t is overestimated (see 'Comments', p. 11+7)-CJC.
Thus the lower t values obtained from the continuous-labelling PIM
curve (where no disturbance of cells occurs) have been used together
with the values for tn and t already obtained from the pulse-labellingU D
PIM data to devise the cell cycle phase data shown in table 11.
TABLE 11 ESTIMATION OF THE DURATION OF THE CELL CYCLE AND ITS
COMPONENT PHASES FOR CONTROL (WATER) AND 10~^M METHYLPREDNISOLONE (MPS)-
TREATED EB, CELLS PROM THE PERCENTAGE OF LABELLED MITOSES CURVES USING
u















t^j and by substitution t^ values obtained from continuous-
labelling PIM curve - compare table 95 P- 132 .
The/.
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The continuous-LI curves obtained for control and 10 MPS-
treated EB^ cells are shown in fig. 60. As expected both curves show
an initial lag phase over a period of time equivalent to t^ (as
measured from PIM continuous-labelling curves - fig. 59)* It appears
from the upward slopes of the curves that entry of cells into S is
slightly faster for control than 10 M MPS-treated cells - however
such a result is highly subjective as curves are only drawn by eye
through data points.
The LI values for control and 10 ^M MPS-treated cultures
increase from 59% and 39% respectively, values similar to those
obtained from "^H-Tcffi pulse-LI experiments (cf. fig. 50); both curves
asymptotically approach 100% labelling. Prom these curves fU-
values can be calculated by extrapolating the 'slowly rising' portion
back to the end of by eye (see Appendix Ill(b), p. 185) - this
method, however, only gives a rough estimate as it depends on which
part of the 'slowly rising' curve is chosen for extrapolation.
Accepting such limitations, f values for control and 10 MPS-Cx
treated cells are calculated as 92% and 78% respectively (see fig. 60),
i.e., treated cells show a 1lj% decrease in f_. Qualitatively this is(j
in agreement with PLM pulse-labelling data where the f value forCx
treated cells was lower than that of control cells: however a quanti¬
tative discrepancy might be expected considering the inherent errors
present in both techniques for calculating f . A rough estimate ofCx
the mean t^ + t^. + t values can also be calculated from these
curves (see fig. 60): the mean t^ + t^ + t^ value for control cells
= 1%.$hx (range 12 - 32hr) and for 10 ^M MPS-treated cells = 23-5hr




Effect of 10 methylprednisolone (MPS) on the thymidine
C^H-TdB) continuous-labelling index (Li) of EB^ cells
After treatment for 6 days, control (water) and MPS-
treated EB^ cells were continuously labelled with 0.01juCi/ml
"^H-TdR. At the time intervals shows after addition of "^H-TdR
samples were removed and smears of cells prepared for autoradio¬
graphy. Cell nuclei with )> 1; grains were scored as labelled.
The number of labelled cells for each point is expressed as a
percentage of a total of 2,000 cells counted. • •, control
EB^ cells; O O, 10 MPS-treated EB^ cells;
represent the mean - 1S.E. of 2 experiments each with duplicate
observations; M , represent the mean - range of duplicate
observations from one experiment.
For calculation of growth fraction (fn) see Appendix Ill(b),
p..185. The mean value for t^ + t^ + i, is calculated from





Incubation time (hr) with H-TdR
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a
in t^ "by 7.6hr (substituting t^ and values from table 11, p. II4O);
again such an extrapolation is subjective as it depends on the
drawing of curves by eye through data points. This increase in t .
G1
is both qualitatively and quantitatively incompatible with t valuesG1
obtained from PEM pulse-labelling curves (see tables 9 and 11, pp.
132 and II4.0) but this could be due to the different experimental
designs, where the PEM pulse-labelling favours measurement of the
fastest cycling population as opposed to the continuous-labelling
technique which measures the entire proliferating population.
Effect of 10 ^M MPS on population doubling times ("tqyp) °f cells
for ^H-TdR pulse-labelling and continuous-labelling experiments
Results 'for "t-^'s are present in table 12 (see p. II4I1). For both
control and 10 ~^M MPS-treated EB, cells t_^'s show values within the
4 JJT
range previously recorded for the growth inhibitory response in
Part II, Section 1.
Measurement of potential doubling time (and cell loss factor
(0) from PEM pulse-labelling curves
t , obtained from PEM pulse-labelling (table 9> P- 132) is much shorterL»
than tj^, obtained from the increase in total cell concentration in
the same experiments (table 12, p. 11+1+), for both control and treated
EB^ cells. This discrepancy is expected and is due either to a
decrease in growth fraction (Mendelsohn, 1962) or an increase in cell
loss (Steel, 1968). The f values obtained from PEM curves can be
used to calculate ^Q^pQ^) (the doubling time of the population
assuming no cell loss) and 0 (the cell loss factor):
where (Mendelsohn, 1962)
and/. . .
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and 0=1- tc^pt^ (Steel, 1968)
tDT
(these equations are also presented in context in Appendix IIl(c),
p. 190).
The results for control and 10 MPS-treated cells are presented
in table 13.
TABLE 13 ESTIMATION OF POTENTIAL DOUBLING TIME AUD CELL
LOSS FACTOR (0) FROM PERCENTAGE OE LABELLED MITOSES (PIM) CURVES
AFTER PULSE-LABELLING WITH ^-THYMIDINE FOR BOTH CONTROL AND 10~"^M









^C(pot) 31.Ohr . 8hr
0 0.11 0.13
The calculation of t./ gives values similar to t,®s andC(pot) 0 DT
0 values show a more or less equal cell loss factor of >10% for both
control cells and treated cells. The 0 value for control cells is
surprisingly high bearing in mind the low background level of cell
death observed in morphological studies.
- 11+6 -
COMMENT
These cell cycle kinetic studies on the growth inhibitoiy
-<
response of EB^ cells to MPS have revealed that 10 M MPS causes the
following major effects:
(a} a stable reduction in the ^H-TdR pulse-LI
(b) a reduction in the MI
(c) conservation of t and its components phases but with a
decrease in fn when using the technique of PIM after pulse-labellingCx
with ^H-TdR on a population of cells showing stable growth inhibition
(i.e., after 6 days incubation with MPS)
. (a) an apparent increase in t and a decrease in f when using
Vx I (x
"^H-TdR continuous-labelling techniques on a population of cells
showing stable growth inhibition.
These different results are discussed below, and from their
interpretation a mechanism of action of MPS on the EB^ cell cycle is
proposed.
Stable reduction in pulse-LI (see fig. 50); reduction in MI (see fig. $1)
The reduction in pulse-LI (by 2J%o) in treated cells suggests that
10 ^M MPS causes:
(a) either a decrease in t - however this is not supported by
D
PLM pulse-labelling data which suggests that t values are conserved
in treated cells (table 9> P» 132)
00 or a decrease in f - this is supported by calculations
vx
from both pulse-labelling and continuous-labelling PIM data where f„Cx
values of treated cells are lower than control cells by 27% and 11$
respectively/...
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respectively; this is also suggested "by the observed reduction in MI
for treated cells.
The stability of the reduction in LI implies that all cycling
cells within the population remain potentially sensitive to the growth
inhibitory effect of 10 ~^M MPS i.e., there cannot be a significant
depletion by death of a sub-population of sensitive cells.
Conservation of t^, and its phases as measured by PEM pulse-labelling
0
technique (see figs. 3U and 5>$ and table 9» P» 132)
t values for control and treated cells as measured from PLM pulse-
labelling curves were surprisingly long, indeed, about 3br longer than
when measured by the PEM continuous-labelling technique (cf. table 9>
p. 132 with table 11, p. 1 i+0). This anomaly was also shown by
Drewinko at al (1978) when comparing continuous- and pulse-labelling
PIM techniques for measurement of cell cycle parameters on T^ cells
(a human lymphoma cell line derived from a patient with lymphocytic
lymphoma). The effect could be caused by handling trauma inherent
in the pulse-labelling technique which requires washing cells free
of label, with ice-cold medium to prevent further incorporation,
before assessing successive samples for PIM; therefore, for example,
the cells experience a fall in temperature, a pH change during
removal from the CO^ atmosphere in the incubator, and the force of
3 consecutive centrifugations. Thus the metabolism of cells may be
initially altered such that G^ cells are temporarily 'blocked® or
'slowed down®. In addition, t elongation could be due to a ^H-TdR-
\JCtL
induced radiation effect on EB, cells - this has been shown to result
4
in a transient G^ + M blockage in Chinese hamster fibroblasts with
3H-T£R/...
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'^H-TcLR concentrations similar to that used for pulse-labelling
(Ehmann et al, 1975)*
Despite this anomaly, the results clearly show that t^ and its
component phases are similar for control and treated cells. This
implies that in treated cultures, the passage of EB^ cells around
the cycle is unaffected once the decision to cycle is taken.
Reduction in f„ as measured by PLM pulse-labelling and continuous-
Vj
labelling techniques (see p. 136 and fig. 60 respectively)
The decrease in f., after treatment with 10 MPS as measured by
Vj
PEM pulse-labelling (27%) and continuous-labelling (ll+%) techniques
and the implication of a decrease in f from pulse-LI and MI data,Cx
show the presence of an increased 'non-cycling' fraction in the
treated cell population; moreover the pulse-LI data show that this
is a stable increase.
The rapidity of the decrease in pulse-LI of treated cells
(see fig. suggests that this 'non-cycling' fraction of cells is
pre-S, and the delay before the decrease in MI (fig. 5>1) excludes
the possibility that these 'non-cycling' cells are pre-M; this there¬
fore implies that the 'non-cycling' fraction is somewhere in G^ and
this is in general agreement with other studies both in vitro and
in vivo which suggest that the growth inhibitory effect of glucocor¬
ticoid occurs due to an accumulation of cells in G^ or a blockage of
the transition of G^ cells into S (Ernst and Kallmann, 1970; Lampkin,
McWilliams and Mauer, 1972; Mendelsohn, Multer and Berriheim, 1977;
Norman and Thompson, 1977; Braunschweiger, Stragand and Schiffer, 1978).
The/...
- 1U9 -
? The question now arises as to the fate of these 'non-cycling'
or growth-inhibited, cells and to this end I have proposed a cell
cycle model for the mechanism of action of 10 MPS on EB^ cells
which is presented in fig. 61; it is based on the previously
discussed model (fig. 1); 'non-cycling' cells may be considered as
cells 'shunted' into Gq or cells blocked in G^. My results indicate
that there are two possible pathways for the 'non-cycling' fraction
induced by 10 MPS - these are illustrated in fig. 61(b):
(a) 'non-cycling' cells may be committed to death - this is
supported by morphological studies in the previous section where a
small stable increase in cell death was observed in treated cultures
(see fig. 1+3)
00 'non-cycling' cells may return to cycle after a delay in
G^ - this is supported by: (i) morphological studies in the previous
section which suggest that some affected cells only show sub-lethal
damage; (ii) continuous-LI curves (fig. 60) which suggest an apparent
increase in t^ for treated cells; (iii) PIM pulse-labelling data
which although suggesting that t and its component phases areo
conserved for treated cells, do not preclude the possibility that a
proportion of cells may return to cycle - PIM curves for treated
cultures show damping out after 3 waves as compared to control
cultures which show at least 1+ waves (see figs. 5U and 55)' this
suggests a greater variation in t or its phases in treated cultures
o
which could be accounted for by an increased t ; moreover, as PIMCxi
curves tend to follow the fastest cycling population, a sub-population
with an increased t may not necessarily be detected.(j I




Cell cycle model of the proposed mechanism of action involved










determine more precisely the proportion of these 'non-cycling' cells
committed to each pathway. However previous studies on glucocorticoid-
induced growth inhibition in different cell types have suggested
that both death of blocked cells (Norman, Harmon and Thompson, 1978)
or return to cycle of blocked cells (Kollmorgen, 19&9; Braunschweiger,
Stragand and Schiffer, 1978) can be involved in the response.
The question of whether blocked cells are committed to death or
return to cycle could have important implications in the treatment
of lymphoid tumours, which usually involves administration of
glucocorticoids with other drugs which act on specific stages of the
cell cycle. If blocked cells can return to cycle, then these cells
will be protected against the effects of drugs which act on other
phases (S, or M); if blocked cells die, then an additive effect
should be achieved with other cell cycle active drugs - we have not
as yet tested such possibilities.
Finally, the proposed cell cycle model for the action of
10 MPS on EB^ cells has permitted further speculation on the
observed morphological changes involved in growth inhibition and
this is summarised schematically in fig. 62. Evidence remains
insufficient to determine whether sub-lethally damaged cells can then
return to cycle or whether they are irreversibly committed to death.
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Fig. 62
Diagrammatic summary of the sequence of morphological changes
occurring in EB^ cells in vitro, with or without 10
methylprednisolone (MPS)
Interpretation is from transmission electron microscope
(TEM) or light microscope (IM) studies.
Normal cycling
10 M MPS-TREATED EB4 CELL
? GQ 'shunt'
? blockage in
? lengthening of tG4
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PART II SUMMARY
SECTION 1 Exponentially growing cultures of EB^ and BLA^ cells
showed a dose-dependent growth inhibitory response to MPS within the
concentration range 10 ^M - 10 St MPS: there was an increase in the
population t^ over 16 days incubation with MPS; there was also a
small (5~10%) concomitant increase in cell death as assessed by
nigrosine dye uptake which was dose-dependent and was not found
until several days after treatment with MPS.
The 10 St MPS growth inhibitory response in EB^ cells was
almost immediately reversible on removal of the glucocorticoid even
after the cells had been incubated with MPS for 1l| days.
SECTION 2 A study of the morphological changes involved in the growth
inhibitory response of EB^ cells to 10 "St MPS revealed that:
(a) with EM, there was a small increase in the number of
apoptotic and autolytic cells in smears after l\. days treatment, and
this was accompanied by a small increase in the percentage of cells
taking up nigrosine. No other changes were evident in smears even
after 16 days incubation with MPS.
(b) with TEM, in addition to apoptotic and autolytic changes,
gross mitochondrial alterations were seen after I). days treatment
which included disorganisation of cristae and formation of myelin




SECTION 3 Cell cycle kinetic analysis of the growth inhihitoxy
response of EB^ cells to 10 ~^M MPS revealed that inhibition is caused
by-a 'blockage1 of a proportion of cells in (or Gq)* The blocked
cells may either be committed to death or may return to cycle with
an apparently lengthened t ... This was proposed after studies had
showed that 10 ~^M MPS causes:
(a) a stable reduction in the H-TdR pulse-LI
(b) a reduction in MI
(c) conservation of t and its component phases, and a decrease
in f using the PEM ^H-TdR pulse-labelling techniqueCx
(a) an apparent increase in t . and a decrease in f whenCxi Cx
using -^H-TcLR continuous-labelling techniques.
The implications of these results was briefly discussed.
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GENERAL DISCUSSION
In this thesis I have described the cytolethal and growth
inhibitory responses of human lymphoid cell lines to methylprednisolone
- these were analysed on a kinetic and morphological basis. It now
remains to comment on the biochemical mechanisms which may be involved
in these responses and the relationship between these responses and
glucocorticoid-induced tumour regression in vivo.
Biochemical mechanisms involved in glucocorticoid-induced responses
Cytolethal response. There is much evidence to suggest that cyto¬
plasmic receptors are involved in mediating the glucocorticoid-induced
lethal effects via the classic gene-activation pathway (see fig. 3) in
rodent lymphoid cells (Claman, 1972; Thompson and Lippman, 197U;
Rosen and Milholland, 1975)* However no proof exists as to whether
this mechanism of action is involved in glucocorticoid-induced death
in human lymphoid cells. The role played by receptors has therefore
been investigated in our human lymphoid cell lines for the cytolethal
response.
From receptor studies (Bird jrfc al, 1975» 1977; Waddell, Bird
and Currie, 1977a) it would appear that the 10 MPS-induced cyto¬
lethal response is not mediated by receptors as receptors become
-7
saturated around 10 M MPS, a concentration 10,000 times lower than
that which causes cell death. What mechanism of action may therefore
be involved in the cytolethal response?
Evidence has been brought forward from other cell systems
supporting/...
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supporting the idea that the cell membrane may be the target for direct
glucocorticoid interactions: e.g.,in cultured Novikoff rat hepatoma
cells, inhibition of glucose transport takes place on immediate contact
with glucocorticoid (Plagemann and Renner, 1972); surface alterations
are evident in HeLa cells after addition of prednisolone (Fiskin and
Melnykovych, 1971)•
Two cell surface functions have therefore been investigated on
our human lymphoid cell lines with 10 MPS:
(a) uptake of thymidine and uridine substrates - normal uptake
of nucleosides consists of a 2-component system of both facilitated
and simple diffusion pathways. 10 MPS appears to act at the cell
surface by inhibiting facilitated diffusion uptake (Waddell, Bird and
Currie, 1976, 1977b). In addition, this inhibition is instantaneous,
which again supports non-involvement of specific cytoplasmic receptors
in the mediation of the cytolethal response, as there is no time for
altered gene activity to mediate this effect - this effect is minimal
at concentrations <10 MPS.
(b) concanavalin-A (con-A) agglutination - binding sites for con-
A (a plant lectin) are present within the cell surface. Con-A agglu¬
tination of cells depends on the amount of con-A which binds to the
sites and the distribution and mobility of the con-A binding sites.
10 % MPS inhibits the rate of agglutination of cells probably by
affecting the distribution of binding sites (Waddell eit al, 1979) and
this would indicate cell surface changes induced by the lethal concen¬
tration of MPS.
Thus the lethal 10 ^M MPS response in our in vitro system would
appear/...
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appear to be associated with changes at the cell surface, and not
with the cytoplasmic receptor gene-activation pathway.
A study of the sequence of morphological changes occurring
after treatment with 10 MPS has also been of value in determining
other mechanisms that may be involved in the glucocorticoid-induced
cytolethal response in human lymphoid cells and one such possibility
is the role played by intracellular ATP. Changes typical of apoptosis
are observed within 1 - 2hr after treatment and this is followed by
autolysis. It has been suggested that ATP plays an early primary
role in cell death by coagulative necrosis (Trump and Arstila, 1971)-
However in human lymphoid cells it was found that intracellular ATP
concentrations decrease after treatment with 10 ^M MPS at the same
rate as the number of cells excluding nigrosine (Waddell _et al, 1979)
i.e., the levels do not decrease until after apoptotic cells are
morphologically detected in smears (see figs. 31 32). Thus, as
apoptosis precedes ATP changes it can be concluded that ATP does not
play a role in initiating the early morphological changes - this
does not exclude the possibility that a decrease in the intracellular
level of ATP is involved in the later appearance of autolysis.
Growth inhibitory response. Little is known about the biochemical
mechanism of action of glucocorticoids involved in the growth inhibitory
response of human lymphoid cells in vitro, but recent evidence would
suggest that cytoplasmic receptor activity is involved (Chen, Aronow
and Feldman, 1977; Norman and Thompson, 1977)- Our studies on EB^
cells (Waddell et al, 1979) would also suggest that the growth
inhibitory response could be mediated via the receptors:
(a)/...
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(a) the growth inhibitory response is apparent at about
10 - 10 M MPS, the concentration range over which cytoplasmic
glucocorticoid receptors become saturated (Bird at al, 1975)
(b) the relative growth inhibitory potencies of 3 glucocorticoids
- triamcinolone acetonide (TA), MPS and Cortisol (OHC) - could be
correlated with their relative affinities for the receptors where
TA > MPS = OHC
(c) recently we have isolated a sub-line of EB^ cells resistant
to the growth inhibitory effect of MPS with concentrations as high
as 10 V MPS - the resistant line consistently has less glucocorticoid
receptors than the 'sensitive* line.
The reason for this loss of steroid binding capacity in resistant
cells is not as yet known, but could be due to a decrease in the
number or affinity of the specific glucocorticoid receptors,the
presence of an inhibitor of glucocorticoid binding, or the destruction
of receptors. This would agree with other isolated resistant cell
line systems, namely cultured rodent lymphoid or fibroblastic cells,
in which the resistant cells nearly always have quantitatively or
qualitatively altered receptors or perhaps some deficiency in a
later stage in the process of glucocorticoid hormone action (Pratt and
Ishii, 1972; Rosenau at al, 1972; Kaiser, Milholland and Eosen, 197U;
Sibley and Tomkins, 197U; Yamamoto, Stampfer and Tomkins, 197^4-) •
The involvement of receptors in the growth inhibitory response
implies a different mechanism of action of glucocorticoids from that
involved in the cytolethal response - this is confirmed by studies
which show that the cell line resistant to growth inhibition maintains
its/...
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its sensitivity to the 10 ^M cytolethal response (Waddell _et al, 1979)-
It remains to be determined whether the growth inhibitory response is
also attributable to altered gene products i.e., whether the mechanism
involved conforms to the classic receptor gene-mediated model for
steroid hormone action.
Morphological studies on the growth inhibitory response can also
be related to studies on intracellular ATP levels. Other than the
small increase in cell death, the major morphological changes seen
after treatment with 10 ^M MPS are in the mitochondria which show
autophagic activity, the result of sub-lethal damage. Autophagy,
itself, is thought to be an energy requiring process which utilises ATP
or other high energy intermediates (Trump and Arstila, 1971)• In ATP
studies, the ratio of ATP/10^ nigrosine-excluding cells is found not
to alter on exposure of cells to growth inhibitoiy concentrations of
MPS; this suggests that ATP is in fact conserved and is consistent with
ongoing autophagy.
Relationship between in vitro (cell line) and jn vivo responses to
glucocorticoid
Cytolethal response. The initial sequence of morphological changes in
the 10"^M MPS-induced cytolethal response jui vitro is consistent with
apoptosis, the mode of cell death known to occur in the regression of
certain tumours; hence this has provided a suitable model for studying
the mechanisms involved in its initiation. However, two lines of
evidence together would suggest that this high concentration effect
has little relevance to human disease therapy:
(a) the highest therapeutic dose of steroid attainable in vivo
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(b) the effect is not mediated by the classical receptor gene-
activation pathway.
Growth inhibitory response. Growth inhibition in human lymphoid cell
lines, which involves the blockage of cells in G^ (Gq)» appears to
show more relevance to human disease therapy than the cytolethal
effect:
(a) it occurs at concentrations of glucocorticoid attained in
the therapy of patients with lymphoid neoplasia
00 cytoplasmic glucocorticoid receptors are possibly involved
in its initiation and much work has been done to suggest a role for
receptors in the response in vivo.
With freshly obtained human leukaemic lymphoblasts Lippman _et al
(1973) found that the presence of specific cytoplasmic receptor mole¬
cules could be related to the responsiveness of the leukaemic patient
in vivo, whereas normal lymphocyte controls which are insensitive to
glucocorticoids showed no cytoplasmic receptor activity. In patients
who originally responded to drug therapy which included glucocorticoids,
glucocorticoid receptor activity was present; however when these patients
developed resistance to glucocorticoid therapy no glucocorticoid
receptor activity was evident. It was also shown that "^H-thymidine
uptake was not inhibited by glucocorticoids in leukaemic blast cells
which lacked receptor activity.
This result was confirmed in a later study by Lippman, Perry and
Thompson (1975) on cells from patients with acute myeloblastic
leukaemia (AMl) where 13 out of 16 patients lacked glucocorticoid
receptor/...
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.receptor activity. This correlates with the known response of AML
patients to treatment with glucocorticoids, where remission is only
occasionally achieved.
Gailani et ad (1973) also studied glucocorticoid receptor
activity in cells obtained from patients with ALL, AML and chronic
lymphocytic leukaemia (CLL). Again, the presence of glucocorticoid
receptors could be related to the frequent clinical response of these
leukaemias to glucocorticoid treatment.
Yarbro _et al (1977) have also shown that lymphoblasts from ALL
patients can be divided into prognostic groups based on glucocorticoid
receptor content and cell surface immunological markers. Ly^phoblasts
in the patients studied were characterised as either T cells or null
cells (no B cells were recorded in this study) and it was found that
null cells contained three times as many receptors per cell as T cells.
This correlates with clinical evidence which suggests that null-cell
leukaemias respond more favourably to therapy than T cell leukaemias.
However, whilst these four studies seem to suggest that it is
necessary for leukaemic cells to have steroid receptors for the patient
to show a therapeutic response, more recent studies have questioned
the prognostic value of receptors (Duval and Homo, 1978; Iacobelli £t al,
1978). Iacobelli et al (1978) in fact showed that freshly isolated
leukocytes from a patient with ALL contained receptors and responded
to the inhibitory effects of glucocorticoids in vitro, yet the patient
responded to glucocorticoid therapy with an increase in the white
blood cell count.
This lack of a general role for receptor assays emerging from
recent/...
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recent studies could be explained from my cell cycle kinetic results
where the stability of the growth inhibitory response implies that
all cycling cells within the population remain potentially sensitive
to the growth inhibitory effect of 10 MPS - thus although cells
possess receptors they may not necessarily respond.
Whilst cell death, and possibly a lengthening of t^ play a
small role in the growth inhibitory response, it is difficult to see
how these low level effects could account for the marked decrease in
blood blast cell count (Henderson, 1969; Lampkin, Nagao and Mauer,
1969; Ernst and Kallmann, 1970) and hyperuricaemia (Sandberg,
Cartwright and Wintrobe, 1996; Wolff et al, 1967) seen in some
leukaemic patients after glucocorticoid therapy.
How, therefore, can the observed in vitro responses be related
to the in vivo clinical remission response?
There are three possible explanations:
(a) the cell lines have been maintained in culture for many
years and they may have changed in their sensitivity to glucocorticoids.
In this respect, freshly isolated human neoplastic lymphoid cells
treated with glucocorticoids might have provided an in vitro system
more directly comparable to in vivo therapy - however, we did not use
this system for reasons already detailed in the General Introduction
(b) glucocorticoids in in vivo therapy may alter lymphoid
tumour cells such that they are 'recognised' and destroyed by phago¬
cytic cells (i.e., host defence mechanisms)
(c) the glucocorticoid response may be enhanced in vivo by
interaction of glucocorticoid with other circulating factors.




have also been shown to exert other effects which may be responsible
for life-support in patients undergoing chemotherapy:
(a) immunosuppressive and anti-inflammatoiy effects (see review
by Fauci, Dale and Balow, 1976) - such effects include: changes in
the function of lymphocytes, leukocytes and monocytes; a marked
transient lymphocytopoenia and monocytopoenia which is caused by an
apparent redistribution of the intravascular recirculating lymphocyte
pool into extravascular lymphoid compartments (the spleen, lymph nodes,
thoracic duct and bone marrow)
(b) a potentiation effect with other drugs used in combination
therapy. Long-term treatment of ALL is only successful with drug
combination therapy and not with glucocorticoid therapy alone.
Glucocorticoids are usually combined with drugs effective in other
parts of the cell cycle e.g., vincristine, which arrests cells in
mitosis and blocks entry of resting cells into the mitotic cycle
(Lampkin, McWilliams and Mauer, 1972) or methotrexate which inhibits
DNA synthesis (Ernst and Killmann, 1970; Lampkin, McWilliams and
Mauer, 1972). It is possible that these drugs in combination may
either exert their effects independently, or perhaps more importantly,
may act synergistically with glucocorticoids to cause cell kill -
indeed in vitro studies on human lymphoid cell lines have shown that
glucocorticoids in combination with vincristine (Bosner _et al, 1975;
Norman, Harmon and Thompson, 1978) and methotrexate (Norman, Harmon
and Thompson, 1978) show synergistic activity. However in the same
context, Norman, Harmon and Thompson (1978) have also shown that
prednisolone combined with 6-mercaptopurine, which arrests cells in
S-phase, gives an effect which is less than additive - thus not all
drug combinations may show potentiation in in vivo therapy
(c) induction of cell differentiation (Weintraub, 1972). In vivo,
lymphoid cells are a heirarchy of stem cells, differentiating cells
and/...
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and mature cells, whose proliferation and differentiation are under
homeostatic control - this involves positive or negative feedback
control mediated by cellular or humoral events (Cline and Golde,
1979)- In lymphoid tumours, normal homeostasis is altered due to an
accummulation of malignant cells which fail to differentiate fully
and which may produce humoral factors which suppress the growth of
normal haematopoietic cells (Cline and Golde, 1979) - thus a
stimulation of cell differentiation might have an important signif¬
icance in therapy.
Thus the mechanism of action of glucocorticoids in vivo may be
far more complex than can be analysed from studies on human lymphoid
cell lines.
Future developments
From these studies, two interesting areas have emerged for further
investigation.
Firstly, it is necessaiy to develop a more sophisticated in vitro
technique such that we can predict the in vivo response of patients
with lymphoid neoplasia to glucocorticoid therapy. Recently, for
example, measurement of the ability of bone marrow cells from patients
with myeloma and carcinoma to form colonies in in vitro agar culture
after exposure to certain chemotherapeutic agents, has shown promise
as a predictive assay for the in vivo response (Salmon jst al, 1978).
Secondly, it is necessaxy to determine more precisely the role
played by receptors and the gene activation pathway in glucocorticoid-
induced growth inhibition in human lymphoid cells. The isolation of
sub-lines/...
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sub-lines resistant to the growth inhibitory effect has provided a
tool for such a study, where analysis of glucocorticoid-induced
effects by such means as fusion of sensitive and resistant cells may
give some indication of the mechanisms involved.
Hopefully such future studies may enlarge our understanding of
the mechanisms involved in glucocorticoid-induced tumour regression
in vivo such that chemotherapeutic regimes which include glucocorticoids
may be employed on a more rational basis.
- 166 -
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APPENDIX I
CALCULATION OF GROWTH KINETIC PAPAMETERS fa) DOUBLING TIME AND
(b) CUMULATIVE TOTAL CELL'NUMBER, FOR MEASUREMENT OF GROWTH
INHIBITORY RESPONSE OF HUMAN LYMPHOID CELLS TO METHYLPREDNISOLONE
(a) Doubling time ("tjyj)
^typ = log 2 where K = growth constant
K
K = . log N where t = time interval
t Nq
N = total number of cells
at end of t
Nq= total number of cells
at beginning of t





(b) Cumulative total cell number
[n]j_ = g x where N = total cell number
n
at end of l+8hr interval
M= cumulative total cell
number at end of I|.8hr
interval
n = total cell concentration
at beginning of i|8hr
interval




EFFECT OF A 30 MINUTE PULSE-LABEL WITH VABIOUS CONCENTRATIONS OF
"^H-TdR ON GROWTH RATE OF EB, CELLS
^
This experiment was carried out under my supervision by Karen M.
Mayne as part of her Honours Thesis (1977) entitled ®A study of the
glucocorticoid-induced cytostatic response of a human lymphoblastoid
cell line (EB^)'. Most of the 'Materials and Methods' and 'Results'
are already detailed in the text (Part II, Section 3)> however more
information is presented here.
Materials and Methods (see Part II, Section 3, p. 113)
The method of feeding cultures differed from that used for my own
growth inhibitory experiments (Part II, Section 1, p. 82); cells were
fed every l;8hr by replacing 2/5 of 'old' medium with fresh growth
medium but without diluting the cell concentration such that cells
tended to approach plateau growth phase after only $-6 days in culture.
However, this period was long enough to assess an effect on the growth
rate.
Results (see Part II, Section 3> P- 117)
Fig. U5 (p* 118) illustrates the effect of various concentrations of
^H-TdR on the growth rate of EB^ cells over a period of 6 days. The
smallest difference in growth rate between control and ^H-TdH-treated
cells which is statistically significant was calculated by K. Mayne to




TIME INTERVAL DURING WHICH PULSE OF VARIOUS DOSES OF ^H-TdR











The data represent the mean of duplicate experiments.
0.1 ynCi/ml "11-TdR is the only concentration which shows no significant




CONVENTIONAL AUTORADIOGRAPHIC TECHNIQUES FOR MEASUREMENT OF THE
PUPATION OF THE CELL CYCLE AND ITS COMPONENT PHASES, AND THE GROWTH
FRACTION
List of abbreviations:
*c = cell cycle time
= duration of phase
*s = duration of S phase
*<52 = duration of G^ phase
*m = duration of mitosis (m)
*C(pot) = potential doubling time of population
fG = growth fraction
*DT = the overall population doubling time
mi = mitotic index
li = labelling index
^H-TdR = "^H-thymidine
0 - cell loss factor
(a) The percentage of labelled mitoses (PLM) technique - pulse-
labelling with ^H-TdR (Quastler and Sherman, 195>9; Baserga and Wiebel,
19^9; Mitchison, 1971; Aherne, Cample,john and Wright, 1977; Steel, 1977)
Cells are pulse-labelled with ^H-TdR thereby labelling all cells
which are in the S-phase at the time. The progress of the cohort of
labelled cells is then followed round the cell cycle by assessing the
PLM on autoradiographs taken in serial samples.
Theoretical/.
- 18£ -
r Theoretical curves obtained from the scoring of labelled mitoses,
and hence the method by which the t and its various phases areL»
calculated, are shown in fig. 63. The labelled cohort of S-phase cells
initially passes through during which time no labelled mitoses are
present. It then passes through M where the proportion of labelled
mitoses increases to 100% over a period equal to t^. It remains at
this level over a period equal to tg and then drops again to zero level
over tj^ as all the labelled cells move out of M into G^. As cells
move through G^ > S and into the next cycle, the same pattern is
repeated and t is calculated as the time between the mid-points of
the two peaks. The values of t and t are calculated from the median
50% level, and t . is then calculated from the equation:Cxi
Vl + 4tM = *C - (*S + *02 + *
In practice, there is variation in the slopes of the curves
(measuring the rate of entry into the phases) and damping of the
curves due to variation in the t and its phases (see fig. 63).
The value of t^ can be calculated from:
t^ = iff x tg (Denekamp, 1970)••• -where a measurement of
LI
MI and LI is taken from the first sampling point.
(b) ^H-TdR continuous-labelling technique (Baserga and Wiebel, 1969;
Aherne, Cample.john and Wright, 1977? Steel, 1977)
Theoretical curves obtained for the continuous-LI of proliferating
cell populations are shown in fig. 61;. At the time of addition of
-TdR, the initial LI represents the initial cohort of cells in




Theoretical curves for percentage of labelled mitosis technique
after pulse-labelling a population of proliferating cells with
^H-thymidine (^H-TcLR)
The percentage of labelled mitoses (PEM) is counted in
successive samples, ms&sssh idealised curve where no varia¬
tion exists among the cells between the cell cycle time and
its individual phases; , more realistic curve, where
variation in the cell cycle time and its phases causes
variation in the slope of the curve and damping of the
curve due to desynchronisation of the labelled cohort.
For further explanation see text p. 181|.
Time after 3H-TdR pulse
- 187 -
FiS- 6k
Theoretical curves for the ^H-thymidine (^H-TcLR) continuous-
labelling index (Li) of proliferating populations of cells
Adapted from Steel (1977» fig- 2.8, p. 77) where growth
fraction and t_. vary "between curves.Car i
For further explanation see text, p. 185.
n





then proceeds through G^ into mitosis where they divide and so cause
the sudden observed increase in rate of appearance of labelled cells.
As the population of G^, M and G^ cells proceed through to S then
these too become labelled due to the continuous presence of ^H-TdR.
If the entire population is proliferating or if cell loss only
occurs from the oldest non-proliferating cells then 10096 labelling
will be achieved after time t^ + t^ + t^ as shown in fig. 61;.
However if f„ < 100%, then the curve will asymptotically approachU-
100% labelling: when G^ and G^ cells enter S and become labelled, the
only cells remaining unlabelled are non-proliferating cells which
were present when labelled cells began to come through mitosis and
which will progressively be diluted by growth of the dividing
population. f„ can therefore be found by extrapolating the more
VT
slowly rising component of the curve back to the end of G^ (Steel,
1977) (fig. 6U).
The technique of continuous-labelling can also be used to measure
^G2 + wkich ^-s needed to label all mitotic cells. This is
estimated by assessing the PIM in successive samples and fig. 65 shows
theoretical curves obtained from such data (this follows the same
logic as for the initial part of the PIM curve after pulse-labelling
with ^H-TdR (fig. 63).
t can then be calculated from these two sets of continuous-
vJ 1
labelling data where:




Theoretical curves for the estimation of t
^ + g-t^ by continuous-
labelling of a population of proliferating cells with
^H-thymidine (^H-TdR)
The percentage of labelled mitoses (PLM) is counted in
successive samples. regw idealised curve with no varia¬
tion in t ; > more realistic curve where variation
\JrtL
exists in the t values.
\jrel.




,(c) Calculation of f^, and 0 from PLM - pulse-labelling curve
Two methods can be used to calculated these parameters:
(i) Mendelsohn, 19&2
f_ = II -....where LI can be calculated from the first
< PLM>
autoradiograph sample
< PIM > = mean or equilibrium value
of PEM after flash-labelling with
"^H-TcLR
< PLM > can be measured from the level on the curve at which the
wave of PIM damps out to give a steady value. Alternatively, if the
experiment is not continued long enough for sufficient damping to
occur, then < PLM > can be measured by averaging the values of PIM
obtained over 1 cell cycle duration.
The equation above is derived from:
f„ = N ....where N = number of cells cyclingG c c
N
or rewritten,
N = total number of cells
L£ = /N A //N \ ....where Ng = number of cells in S
^s = LI
N
Ns = < PIM > , since when the
N
Q
labelled cohort of cells is
desynchronised, the propor¬
tion of cells labelled in
each of the cell cycle phases
and in the cell cycle as a
whole will be the same.
This/.
- 191 -
This method involves certain difficulties as:
(a) < PLM > could be underestimated - in order to achieve complete
desynchronisation, cells must go through several cell cycles during
which time the number of grains/nucleus is halved such that a 'true'
labelled cell has fewer grains than the estimated background grain
count.
(b) < PLM > could be overestimated - if cells die, the label is
released and taken up by other S-phase cells not in the original
pulse-labelled cohort.
The f_ can then be used to calculate
G C(pot)
where f^, = 1, then ^0^^) - (obtained from PLM curve)
where fG = <1, then tc(pQt) =
fG
(ii) Steel, 1968
In (1 + f.,) = t x In 2 ....equation (i)Cx u
^C(pot)
where = A ....equation (ii)
Tr
\ = correction factor to allow for the non-uniform age




2 <*02 + V) - (ln 2 *G2^C(pot) J e \ ^C(pot)
....equation (iii)
A is obtained by a series of successive approximations between
equations (ii) and (iii).




Loss of cells by death can also occur in cultures. In populations
with no cell loss, then
^C(pot) ~ ^DT
However if cell loss occurs, then
tC (pot) < tDT
and the cell loss factor (0) is defined as
^ ~ 1 Vpot)
tDT
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Summary.—The cytolethal response to treatment with prednisolone was investi¬
gated in vitro in eight human lymphoblastoid cell lines containing varying concen¬
trations of specific cytoplasmic glucocorticoid receptors. A similar response was
observed in seven of the lines irrespective of their concentration of cytoplasmic
receptors, and pharmacological doses of steroid, well above those required to saturate
receptors in cell-free extracts, were required for a massive lethal response. One
cell line derived from Burkitt's lymphoma was refractory to lethal effects even with
pharmacological doses of steroid.
A similar unresponsiveness to the cytolethal effect of prednisolone in vitro was
observed in fresh lymphoblasts derived from patients with acute lymphoblastic
leukaemia despite evidence of a satisfactory clinical response to therapy which in¬
cluded steroid. The resistance of human lymphoblastoid cells to treatment with
glucocorticoids in vitro may result from a defect in activation subsequent to the
binding of steroid to cytoplasmic receptors.
The cytolethal effects of gluco¬
corticoid hormones on normal and neo¬
plastic lymphoid cells are well established
(Dougherty, 1952; Harris, 1970; Rosenau
et al., 1972). Moreover, in combination
with other drugs, glucocorticoid hormones
are highly effective in the treatment of
acute lymphoblastic leukaemia (ALL) of
man (Simone, 1974). At the molecular
level, however, the precise mode of
action of glucocorticoid hormones on
lvmphoid cells has still to be resolved.
It is generally held that binding of
steroid to specific protein receptor mole¬
cules in the cytoplasm is the first step
in the cytolytic process in sensitive cells.
Subsequently, steroid-receptor complexes
are believed to undergo a temperature-
dependent conformational change and
migrate to the nucleus, where they
influence transcriptional activity in such
a way that cell lysis results (Munck et
al., 1972; Higgins et al., 1973; Thompson
and Lippman, 1974).
However, much of the current state
of knowledge concerning the mechanism
of glucocorticoid hormone action is based
on experiments with rodent tissues, in¬
cluding thymocytes and various cultured
cell lines. Little is known of these
events in human lymphoid cells and, in
particular, the role of cytoplasmic re¬
ceptors in the initiation of hormone
effects appears uncertain. In one study
(Lippman et al., 1973) with freshly isolated
lymphoblasts from patients with ALL, a
close correlation was found between hor¬
mone responsiveness in vivo and the
concentration of cytoplasmic receptors.
However, other studies (Gailani et al.,
1973; Lippman, Perry and Thompson,
1974) with 3 lymphoblastoid cell lines in
vitro, failed to reveal such an association
and the role of cytoplasmic receptors in
the initiation of cytolethal effects by
glucocorticoids in human cells remains to
be established.
To investigate this problem, we have
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studied the relationship of cytoplasmic
receptor levels and glucocorticoid cyto-
lethal effects in a series of human lympho-
blastoid cell lines derived from patients
with leukaemia or lymphoma, or without
malignant disease.
MATERIALS AND METHODS
Cell lines.—The cell lines were derived
from freshly isolated human lymphoid cells
of lymph glands, lymphoid tumours or
peripheral blood. They were established as
permanent cell lines in suspension culture,
either spontaneously or by a process of
co-cultivation with lethally irradiated cells
containing Epstein-Barr virus (EBV) as
described previously (Pulvertaft, 1965; Jen¬
sen et al., 1967; Steel and Edmond, 1971;
Steel, 1972). Previous studies have shown
these cells to have the characteristics of B
lymphocytes by their ability to synthesize
immunoglobulins (Evans, Steel and Arthur,
1974), to have C13 receptors on their surface
membranes (Moore and Minowada, 1973),
to lack receptors for sheep red blood cells
(Evans, Smith and Steel, 1975) and to be
devoid of cvtotoxic activity (Steel et al.,
1974).
Cell culture.—Cells were grown in suspen¬
sion in conical glass flasks or roller culture
bottles in Eagle's minimum essential medium
(MEM, Gibco Biocult), or Ham's F10
medium with 10% tryptose phosphate broth
(Gibco Biocult), supplemented with 20%
heat-inactivated (56°C for 1 h) foetal calf
serum (PCS, Gibco Biocult), at 37°C in a
humidified atmosphere of 5% C02 in air.
They were maintained at densities between
3 and 10 x 103/ml by feeding with fresh
medium every 3-4 days.
Chromosome analysis.—Approximately
2 X 10® viable cells were resuspended in
5 ml of fresh growth medium. After 24 h,
a drop of 0-02% dimethylcolchicine was
added to the culture and the incubation
continued at 37°C for a further 60-90 min.
The cells were harvested by centrifugation,
exposed to 0-0075 mol/1 KC1 for 10 min
and fixed in 3 changes of methanol : glacial
acetic acid (3:1, v/v). Drops of the fixed
suspension were allowed to dry on clean
slides, stained for 8 min in 0-5% quinacrine
dihydrochloride, washed for 5 min in running
water, mounted in distilled water under a
sealed coverslip and examined with a Leitz
Ortholux microscope with Ploem's vertical
illumination using an HBO 200 u.v. source.
Most cell lines have been examined repeatedly
at intervals of a few months, and from
6 to 30 metaphase spreads photographed and
fully analysed on each occasion.
Steroid binding by cell extracts.—The
binding of glucocorticoid hormones to specific-
high affinity cytoplasmic receptors was
studied by the competitive binding assay
developed by Baxter and Tomkins (1971)
using radioactively labelled and unlabelled
dexainethasone. 3-5 x 108 cells were har¬
vested by centrifugation (800 g for 10 min),
washed twice in phosphate buffered saline
(PBS; 0-025 inol/l KH2P04, 0-1 mol 1
NaCl, pH 7-4) at 0-4°C, recentrifuged and
homogenized in ice-cold tricine buffer (0-02
mol/1 tricine, 0-002 mol/1 CaCl2, 0-001 mol 1
MgCl2, pH 7-4). Rat thymuses were excised
aseptieally, rinsed in ice-cold PBS, blotted
dry and chopped finely with scissors in
1 vol of ice-cold tricine buffer and homo¬
genized. The cell and thymic homogenates
were centrifuged at 105.000 g at 4CC for
1 h and duplicate aliquots of cytosol (0-4 ml)
incubated at 0°C with varying concentrations
of [1, 2(n)-3H]-dexamethasone (19-29 Ci/
mmol; Radiochemical Centre, Amersham) in
the presence or absence of a 1000-fold excess
of non-radioactive dexamethasone (Sigma).
Unbound steroid was removed after 2 h
by addition of 50-100 /d activated charcoal
(200 mg/ml; BDH Chemicals), which was
vigorously agitated for 5 sec and centrifuged
(600 g for 1 min). The supernatant was
recentrifuged (10,000 g for 5 min) and aliquots
(200 /xl) of supernatant assayed for radio¬
activity in a toluene-based scintillant con¬
taining Triton X-100 (33% v/v; Inter-
technique) and butyl-PBD (5 g/1; Interteeh-
nique) in a Beckman LS-250 liquid scintilla¬
tion spectrometer (efficiency ~30%). Speci¬
fically bound dexamethasone represents the
difference in amount of 3H-dexamethasone
bound to cytosol in the absence and presence
of 1000-fold excess of non-radioactive steroid.
Protein concentration was measured by the
technique of Lowry et al. (1951) using bovine
serum albumin as standard.
Cytolethal tests.—Duplicate cultures of
cells (3-5 x 105/ml) were grown in MEM
supplemented with 20% heat-inactivated
FCS at 37°C in a humidified atmosphere
of 5% C02 in air. After 48 h when cells
were in log phase of growth, methyl predni-
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solone sodium succinate (Solumedrone, Up¬
john) was added in aqueous solution at
concentrations between 10~7 and 10~3 mol/1
(final volume 1%). After incubation for a
further 48 h. the total number of cells was
enumerated with a haemacytometer and the
viability assessed by exclusion of nigrosine
(0-25%). Per cent lysis was calculated by
comparison with control cultures which
received no steroid.
RXA synthesis.—The effect of predni¬
solone on the incorporation of (5-3H)-uridine
(3HU: 27 C'i mmol; Radiochemical Centre,
Amersham) into the acid-insoluble fraction
of cells was estimated. Duplicate cultures
of cells (3-5 x 105/ml) were grown as
described above. Solumedrone was added
at concentrations between 10~6 and 10-3
mol 1 to duplicate 1-0 ml aliquots of cells
and after 1 h these were pulsed with 1-0
fxCi ml 3HU for 20 min. The cells were
collected in microfibre glass filters in a
sampling manifold (Millipore), precipitated
with ice-cold 5% trichloroacetic acid (3 x 10
ml) and washed with ice-cold 70% ethanol
(3 X 10 ml). Filters were dried at 37°C
and assayed for radioactivity in a toluene-
based sc-intillant containing butyl-PBD (5-0
g/l) in a Beckman LS-250 liquid scintillation
spectrometer (efficiency ~ 30%). Results
are expressed as incorporation of 3HU into
the acid insoluble fraction/106 viable cells.
RESLLTS
Origin and karyotype of lymphoblastoid
cell lines
The origin, karyotype and age in
vitro of the 8 cell lines used in our
studies are shown in Table I. Whereas
there was some variation in chromosome
constitution within each line, there was
always a clear modal karyotype. Four
lines—RUSj, RUS2, PEX2 and YAKj—
had only minor alterations to the normal
diploid human complement, but the
others had multiple breakages and recom¬
binations, including fragments and ab¬
normal chromosomes the precise origin
of which could not be established.
Glucocorticoid cytoplasmic receptors in
lymphoblastoid cell lines
In steroid binding studies specific
receptors in the cytoplasmic extracts
(cytosol) of lymphoblastoid cells became
saturated with dexamethasone at con¬
centrations above 5-8 x 10-8 mol/1 as
illustrated in Fig. 1. Scatchard (1949)
analysis of the data, shown in the insert
of Fig. 1, yields a straight line consistent
with a single class of receptor molecules
Table I.—Origin, Karyotype, Age in Culture and Cytoplasmic Receptor Concentration




Cell line Origin Modal karyotype (mth) protein)
RUS, Acute myeloblastic 46 XY 18p+ 27 0-82
leukaemia














48 XX Multiple breakages and
recombinat ions
73 0-71




PEX„ Adult blood* 48XXY 14— 24 0-09
YAK, Cord blood 47 XY Partial trisomy 4 17 0-37
Fresh thvmus RaU — 0-33
The results shown are the mean of 2 separate determinations.
* Klinefelter's syndrome. + Female pvg/c rats aged 88 days.
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Fig. 1.—Specific binding of dexamethasone to cell-free extracts of human lymphoblastoid cell lines
and rat thymus. Each point represents the mean of 3 separate experiments. The insert shows
Scatchard plots of the data. Q O, EUSjCells; Q Q,GS,cells; x X , rat thymus.
of uniform steroid affinity. The equi¬
librium (dissociation) constants for the
2 examples shown, calculated from the
intercepts of the reciprocal plots, were
1-0 X 10-8 mol/'l (RUS.,) and 2-3 X 10-8
mol/1 (GSj). For comparison, Fig. 1
shows also the binding of dexamethasone
to cytoplasmic receptors of fresh rat
thymus, a tissue of known high sensitivity
to the cytolytic effects of glucocorticoid
hormones in vivo (Dougherty and White,
1945); saturation occurred at similar con¬
centrations of steroid, and the dissocia¬
tion constant (3-7 x 10~8 mol/1) was of
similar magnitude.
Further characterization of lympho¬
blastoid cell receptors revealed that they
were thermolabile and completely in¬
activated by 30 min pre-incubation at
37 CC. Similarly, incubation for 10 min
at 20°C with trypsin (1 mg/ml) and
protease (1 mg/ml) destroyed the binding
capacity of cytosol. Incubation with
deoxyribonuclease (bovine pancreas, 100
ftgjml) and ribonuclease (bovine pancreas,
100 /(g/ml) had no significant effect on
the binding characteristics. Thus, the
cytoplasmic glucocorticoid receptors of
human lymphoblastoid cells appear to
be of a protein nature similar to those
described in other glucocorticoid sensitive
tissues (Hackney et al., 1970; Munck
and Wira, 1971; Baxter and Tomkins,
1971).
Using the competitive binding assay
at saturating concentrations of dexa¬
methasone (8 X 10~8 mol/1), the relative
concentration of receptors in the cytosols
of the various cell lines was determined.
As shown in Table I a gradation in
receptor concentration was found. The
highest levels (0-62-0-82 pmol/mg protein)
occurred in cell lines derived from patients
with acute leukaemia and from one case
of chronic lymphatic leukaemia, whilst
intermediate concentrations (0-37-0-43
pmol/mg protein) were found in lines
derived from a Burkitt's lymphoma and
a healthy placental corcl blood. The
lowest levels (0-09-0-16 pmol/mg protein)
08
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Fig. 2.—Cytolytic effect of prednisolone on human lymphoblastoicl cell lines. Per cent lysis was
calculated by comparison with control cultures which received no steroid. Each point represents
the mean of 2 separate experiments.
were found in the lines derived from a
patientwith subacute lymphatic leukaemia
and from the peripheral blood of a non-
leukaemic adult patient. The concentra¬
tion of receptors (0-33 pmol/mg protein)
in the fresh rat thymus corresponded
to the intermediate values obtained in the
cell lines.
Glucocorticoid cytolethal response
The lethal response was assessed mor¬
phologically by the ability of cells to
exclude the dye nigrosine, following in¬
cubation with aqueous preparations of
steroid for 48 h. As shown in Fig. 2, a
mild lethal response (10-15% of cells)
was observed with prednisolone at con¬
centrations of 10~7-10-4 mol/1 although
these effects were apparently not in
direct proportion to absolute concentra¬
tions of steroid. A marked increase in
the cytolethal effect was observed, how¬
ever, when the steroid concentration was
increased to 10~3 mol/1 and in some
instances more than 85% of cells were
killed. The magnitude of this enhanced
lethal response, however, did not corre¬
late with the measured levels of specific
cytoplasmic hormone receptors, and some
of the cell lines with low receptor con¬
centration appeared to be as sensitive as
those with high receptor levels (compare
Fig. 2 and Table I). The cell line derived
from Burkitt's lymphoma, however, was
notably resistant to lethal effects even
with high doses of steroid. Table I and
Fig. 2 show also that no correlation
could be established between steroid
receptor levels or sensitivity to cytolytic
effects and criteria which may be related
to the malignant potential " of lympho-
blastoid cells in vivo, namely the origin
of the cells (from malignant or non-malig¬
nant conditions), the degree of abnor¬
mality of modal karyotype or the age
of cells in vitro.
The concentration of prednisolone
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(103 mol 1) required to achieve severe
lethal effects exceeds physiological plasma
levels of steroid (10_6-10-7 mol/1) by
several orders of magnitude. Moreover,
as can be seen in Fig. 1, it is considerably
in excess of steroid concentrations re¬
quired to saturate receptors in cytoplasmic
extracts. However, when other gluco¬
corticoid hormones such as Cortisol and
dexamethasone were tested over the same
concentration range virtually the same,
or in some cases somewhat reduced,
lethal effects were obtained, and no
significant differences were observed when
steroids soluble in ethanol or dimethyl-
sulphoxide were substituted for aqueous
preparations. Furthermore, destruction
of transeortin binding activity of serum
with heat (56:C" for 1 h) did not reduce
the lethal response obtained with Cortisol
or prednisolone.
Ultrastruc-tural studies of cultures
treated with 10~3 mol/1 prednisolone
showed that less than 3% of steroid-
treated cells contained EBV particles and
the c-ytolethal effects could not be attri¬
buted to induction of virus lytic cycle.
C'ytolethal tests were also performed
with lymphoblasts isolated from the
peripheral blood of 6 patients with ALL
before commencement of therapy. De¬
spite an apparent satisfactory clinical
response to chemotherapy which included
prednisolone, these cells did not show
ant* greater sensitivity to the lethal
effects of glucocorticoids in vitro than the
cultured lymphoblasts. Insufficient ma¬
terial was available, however, to estimate
the receptor levels in these cells.
Glucocorticoid effect on BXA synthesis
The effect of prednisolone on the
incorporation of 3HU into the cold acid-
insoluble fraction of lymphoblastoid cells
was studied as an earlier and more
sensitive index of cell damage than
nigrosine. Preliminary investigations
showed that significant inhibition of 3HLT
incorporation could be detected within
1 h of addition of prednisolone: Similar
results were observed in all the cell lines
Table II.—Effect of Prednisolone on





Cell (ct/min 10*' concentration (mol/1)
line viable cells) 10-« 10-s 10—» 10-3
RUS, 2975 0-99 0-89 0-72 0-23
RUS2 7251 0-90 0-81 0-56 015
BLA^ 13152 0-87 0-79 0-47 0-09
F89 17743 102 0-86 0-58 013
GS, 5539 0-87 0-84 0-63 0-19
J1JOYE 45620 0-88 0-83 0-68 0-16
PEN. 12630 0-89 0-88 0-60 011
YAK/ 15571 0-91 0-86 0-64 015
The results shown are the mean of two separate
determinations and represent incorporation of
3H-uridine into the acid-insoluble fraction/106 viable
cells.
studied, including the Burkitt's lymphoma
cell line, as shown in Table II, irrespective
of their specific cytoplasmic receptor
concentration: thus, 1 h after addition
of 10~5 and 10~6 mol/1 steroid there was
a slight reduction (^720%) in 3HU incor¬
poration; with 10-4 mol/1 prednisolone
moderate reductions (30-50%) were ob¬
served whilst addition of 10-3 mol/1
steroid produced a marked inhibition
(>75%) of 3HLT incorporation in all
cell lines.
discussion
In contrast to the findings in vivo
with lymphoblastoid cells of ALL patients
(Lippman et al., 1973), our results clearly
show that the level of specific cytoplasmic
receptors in human lymphoblastoid cells
cannot be used to predict their responsive¬
ness to glucocorticoid treatment in vitro.
Similar responses to steroid treatment
were obtained with all but one of the
cell lines despite widely varying levels
of cytoplasmic receptors: the exception
was a cell line derived from Burkitt's
lymphoma, although it showed a similar
response to inhibition of RXA synthesis
as the other cell lines. It is noteworthy
that in our studies significant lethal
effects were observed only with doses
of steroid which produced a severe re¬
duction (>75%) in incorporation of RNA
/
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precursors. Other workers (Rosen et al.,
1972; Stevens, Stevens and Hollander,
1974) have claimed that smaller reductions
in RXA synthesis are associated with
impending lethal effects, although their
experiments did not include morpho¬
logical observations of cell death.
Although failure to exclude nigrosine
is a rather insensitive test of cvtolethal
damage since it occurs late in the process
of cell death, other techniques which
employ release of specific radiolabels
from damaged cells measure similar late
phenomena and are associated with in¬
herent interpretative difficulties due to
"
spontaneous " release of label (^chro¬
mium) or internal radiation effects
(123 iododeoxyuridine).
When compared with rodent lymph¬
oma cell lines, human lymphoblastoid
cells appear relatively insensitive to the
lethal effects of glucocorticoids in vitro.
Rodent lymphoma cell lines (Harris,
1970; Rosenau el al., 1972; Turnell,
Clarke and Burton, 1973; Kondo, Kikuta
and Noumura, 1975), nearly always show
marked lethal responses to concentrations
of glucocorticoids in the physiological
range (l(rt6-10_7 mol/1) and thus may
differ fundamentally in their biological
responsiveness to steroid hormones.
The failure to correlate cytoplasmic
receptor levels with glucocorticoid re¬
sponses, and the requirement of pharmaco¬
logical doses of steroid for substantial
cytolethal effects, suggest that cyto¬
plasmic receptors ma}* not be responsible
for initiation of the lethal glucocorticoid
effects we have observed in human
lymphoblastoid cells. Alternatively,
some form of steroid resistance may have
developed during the long period of
cultivation of cells in vitro. However,
in our hands freshly isolated lymphoblasts
from ALL patients showed a similar
resistance to lethal glucocorticoid effects in
vitro. It is possible, therefore, that, de¬
fects in activation of glucocorticoid cyto¬
lethal methanisms may occur in lympho¬
blastoid cells cultured in vitro for short
or long periods of time, rendering cells
insensitive to all but massive doses of
steroid.
Until recently, the emergence of re¬
sistance to steroid effects has been attri¬
buted to quantitative reductions in cyto¬
plasmic receptor levels (Rosenau et al.,
1972; Lippman et al., 1973). Clearly, in
our cell lines this cannot account for
steroid resistance if present. However,
Sibley and Tomkins (1974) have recently
sliown in studies with steroid-resistant
clones of mouse lymphoma cells that
whilst resistance to steroid effects results
predominantly from quantitative defi¬
ciencies in steroid receptors, other more
subtle defects in hormone activation may
occur. Thus, resistance may result from
qualitative defects in cytoplasmic re¬
ceptor molecules or reduction in the
capacity for transfer of formed steroid
receptor complexes to the nucleus. Rare¬
ly, defects in the specific localization
of complexes within the nucleus appear
to occur since nuclear binding of steroid
receptor complexes did not provoke a
lethal response in some clones.
It is evident, therefore, that the
binding of steroids to cytoplasmic re¬
ceptors represents only one stage of a
complex series of events leading to ex¬
pression of hormone effects. It remains
to be seen whether the activation of
steroids in human lymphoblastoid cells in
vitro differs fundamentally from that
occurring in vivo. It seems likely, how¬
ever, that analysis of each step in the
activation process will be required before
the potential responsiveness of cells to
glucocorticoid hormones can be predicted
accurately.
This work was supported by a grant
from the Cancer Research Campaign to
A.R.C. and by a grant from the Medical
Research Council.
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CYTOLETHAL EFFECTS OF GLUCOCORTICOIDS IN
HUMAN LYMPHOBLASTOID CELL LINES
C. C. Bird*, Alison M. G. Robertson, Judy Read and A. R. Currie
Department ofPathology, University ofEdinburgh, Teviot Place, Edinburgh EH8 9AG
Glucocorticoid hormones are employed extensively in the treatment of
lymphoid neoplasms ofman (DeVita, 1973; Simone, 1974; Schein et al., 1975).
It has been tacitly assumed that in human cells cytolethal hormone action is
achieved through the same mechanisms as those which produce cytolysis of
rodent lymphoid cells: after penetration of the plasma membrane steroid is
thought to bind rapidly to specific cytoplasmic protein receptors to form com¬
plexes which transfer to the nucleus and initiate a sequence of molecular events
culminating in a lethal response (Munck and Wira, 1971; Munck et al., 1972;
Higgins et al., 1973; Thompson and Lippman, 1974). Certain steroid-resistant
rodent lymphoma cells have quantitative deficiencies in cytoplasmic receptors
whereas others have defects either in the nuclear transfer of complexes or in
their activation within the nucleus (Kirkpatrick, Milholland and Rosen, 1971;
Rosenau etal., 1972; Sibley and Tomkins, 1974; Kondo, Kikuta and Noumura,
1975).
Specific cytoplasmic glucocorticoid receptors have been detected also in
freshly isolated lymphoblasts from patients with acute lymphoblastic leukaemia
and responsiveness in vivo to drug combinations, which included glucocorti¬
coids, appeared to correlate with the concentration of cytoplasmic steroid
receptors (Lippman et al., 1973). However, studies with human lympho-
blastoid cell lines (Gailani et al., 1973; Lippman, Perry and Thompson, 1974;
Bird et al., 1975) have failed to confirm any direct association between cyto¬
plasmic receptor levels and glucocorticoid responsiveness in vitro. Further¬
more, to obtain lethal effects we had to use doses of glucocorticoids which
greatly exceeded both physiological steroid levels and the binding capacity of
receptors in cytosol extracts of cells.
We have, therefore, studied the optimum conditions for obtaining gluco-
corticoid-induced lethal effects in human lymphoblastoid cells in vitro and have
also examined the kinetics of the response.
Materials and methods
Cell lines
Human lymphoblastoid cell lines were established in culture either spontaneously or by
a process of co-cultivation with lethally irradiated cells containing Epstein-Barr virus as
previously described (Pulvertaft, 1965; Jensen et al., 1967; Steel and Edmond, 1971; Steel,
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1972). The cells were grown in suspension cultures in glass flasks or roller culture bottles in
bicarbonate-buffered Eagle's minimum essential medium (MEM, GIBCO Bio-Cult, Scotland)
supplemented with 20 per cent, heat-inactivated (56° for 1 hr) foetal calf serum (FCS, GIBCO
Bio-Cult, Scotland) at 37° in a humidified atmosphere of 5 per cent. CO2 in air. Stock
cultures were maintained at densities between 3 and 10 x 105 cells/ml by feeding with fresh
medium every 3-4 days.
Glucocorticoids
The glucocorticoids used were: methylprednisolone sodium succinate (Solumedrone, Up¬
john, England); dexamethasone sodium phosphate (Decadron, Merck, Sharp and Dohme,
England); hydrocortisone sodium succinate (Solucortef, Upjohn, England); these were
dissolved in sterile distilled water at the required concentrations. Prednisolone was a gift
from Organon, Scotland, and was dissolved in dimethylsulfoxide (DMSO) or 95 per cent,
ethanol. The cells were able to tolerate concentrations of up to 1 per cent, ethanol or DMSO
without deleterious effects on their growth rate.
Steroid binding in cells
The specific binding of steroid to whole cells was determined after the method of Sibley
and Tomkins (1974). Cells in logarithmic growth phase were harvested by centrifugation at
800 x# for 3 min. and aliquots containing 1 x 106 viable cells (assessed by the ability to ex¬
clude nigrosine) resuspended in tubes with 0-5 ml of medium (37°) containing 20 per cent,
heat-inactivated FCS. (1, 2(n)-3H)-dexamethasone (27-29 Ci/mM; Radiochemical Centre,
Amersham, England) with or without a 1000-fold excess of non-radioactive dexamethasone
(Sigma, England) was added in 95 per cent, ethanol (final concentration 1 per cent.) to give
the desired steroid concentrations. The tubes were gassed with 5 per cent. CO2 in air,
stoppered and incubated at 37° in a shaking water bath at 60 revolutions/min. When the
incubation was complete for the time specified, the cells were centrifuged (800 xg for 3 min.),
washed immediately with 5 ml phosphate-buffered saline (PBS; 0-025m KH2PO4, 0-1m NaCl;
pH 7-4) at 25° and recentrifuged (800 xg for 3 min.); thereafter they were washed three times
with 5 ml of ice-cold PBS. The cell pellets were finally resuspended in ice-cold PBS and
duplicate aliquots (100^1) assayed for radioactivity in 10 ml of toluene based scintillant
containing Triton X-100 (33 per cent, v/v; Intertechnique, England) and butyl-PBD (5 g/1;
Intertechnique, England) in a Beckman LS-250 liquid scintillation spectrometer (efficiency~
30 per cent.). Specifically bound dexamethasone represents the difference in counts retained
by 1 xlO6 viable cells in the absence and presence of a 1000-fold excess of non-radioactive
steroid.
Cytolethal tests
In cytolethal tests duplicate cultures of cells in logarithmic growth phase were treated with
various concentrations of glucocorticoids. After incubation for 48 hr, the total number of
cells was enumerated with a haemocytometer or Coulter Counter and the viability was assessed
by the ability of the cells to exclude nigrosine (0-25 per cent.).
Kinetics of lethal response
Duplicate cultures of cells in logarithmic growth phase were treated with lethal concen¬
trations of glucocorticoid for 48 hr. Samples were removed at selected time intervals through¬
out the experiment, and the total cell number and viability assessed as above. In the experi¬
ments where the duration of exposure to glucocorticoid was varied, cultures were washed
three times (at 37°) with fresh medium after the desired period of exposure to steroid and the
cell pellet resuspended in the original volume of fresh medium which contained no steroid.
The cell viability was assessed before washing and at intervals afterwards up to 48 hr.
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Results
Steroid binding in whole cells
We have shown prevously (Bird et all) that the cytoplasm of human lympho-
blastoid cells contains protein receptors to which dexamethasone binds with
high affinity and in a saturable fashion (table). Specific binding of dexametha¬
sone in intact cells occurred in all cell lines with the same high affinity and at
comparable levels of saturation (1-2x10-7m) as with cytoplasmic extracts of
cells (fig. 1). Furthermore, uptake of steroid by cells at 37° was rapid, and
maximal incorporation was reached within 5-10 min. exposure to a saturating
concentration of steroid (fig. 2).
10 20 30
_8
Dexamethasone concentration (M x 10 )
Fig. 1.—Specific binding of 3H-dexamethasone in whole lymphoblastoid cells. Samples of cells were
incubated in growth medium at 37° in the presence of various concentrations of 3H-dexametba-
sone with or without a 1000-fold excess of non-radioactive dexamethasone. After 1 hr cells
were washed with buffer and assayed for radioactivity. BLAt cells (O O); RUS2 cells
(x——x); GSi cells (-1 1-); JIJOYE cells (□ □). Each point represents the mean of
either two or three separate experiments.
Glucocorticoid sensitivity of cell lines
To determine the relative sensitivity of cells to glucocorticoids, cultures were
exposed to increasing concentrations of methylprednisolone sodium succinate
for 48 hr. All cell lines showed a similar lethal response which was unrelated
to the concentration of receptors measured previously in cytoplasmic extracts.
Lethal effects were minimal (5-10 per cent, of cells) with steroid concentrations
within the physiological and usual pharmacological range (10_5-10~7m); and
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continued exposure of cells to steroid at these concentrations for up to 168 hr
did not augment the lethal response. However, when the steroid was increased
to 10~3m there was a massive lethal response (fig. 3) with LD50 levels for cell
lines ranging from 0-71 X 10" 3m to 0-99 X 10-3m (table).
Table
Origin, concentration of specific cytoplasmic steroid receptors and LD50 values for















JIJOYE Burkitt's lymphoma 0-43 0-99+0 12
* From Bird et ah, 1975.
t The concentration of methylprednisolone at which lysis occurs in 50 per cent, of the cells tested.



























Fig. 2.—Specific binding of dexamethasone at various times following incubation of whole lympho¬
blastoid cells with 1x10~7m 3H-dexamethasone with or without a 1000-fold excess of non¬
radioactive dexamethasone. Cells were washed with buffer at the times shown and assayed for
radioactivity. BLAi (O O); RUS2 (x x); GSi (-1 F); JIJOYE (□ □).
Each point represents the mean of three separate experiments.
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The results illustrated in fig. 3 were obtained at cell concentrations within
the optimal range for obtaining maximal lethal responses {vide infra).
Cell density and glucocorticoid sensitivity
Cytolethal tests were performed with 10" 3m methylprednisolone sodium
succinate in cultures where the cell concentration was adjusted to 2-20 x 105
-7 -6 -S -4 -?
10 10 10 3 10 10 J
Methylprednisolone sodium succinate concentration
(M)
Fig. 3.—Lethal effects of methylprednisolone sodium succinate on human lymphoblastoid cell lines.
Exponentially growing cells were treated with various concentrations of steroid for 48 hr when
cell viability was assessed. BLAi (O O); RUS2 (x x); GSi (4 b); JIJOYE
(□——□). Each point represents the mean of three separate experiments.
cells/ml before addition of steroid. The sensitivity of cells to steroid was
approximately in inverse proportion to the concentration of cells in cultures
although differences were slight where cultures contained 2-10 x 10s cells/ml
(fig- 4).
Steroid solvent and glucocorticoid sensitivity
Within the concentration range of 10~6-10_4m, preparations of prednisolone
in ethanol or DMSO were no more effective than aqueous solutions of methyl¬
prednisolone sodium succinate in producing a lethal response (fig. 5). With
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10~3m, all preparations showed a massive lethal response, the most severe
effects being achieved with methylprednisolone sodium succinate.
Cytolethal response to different glucocorticoids
Of the several glucocorticoid preparations tested, the most severe lethal
effects were obtained in cultures treated with methylprednisolone sodium
succinate; by comparison hydrocortisone sodium succinate was consistently
cr 20 "
2 4 6 8 10 20
5Initial viable cell concentration (xlO cells/ml)
Fig. 4.—Effect of initial cell density of RUS2 cells on lethal effect obtained with methylprednisolone
sodium succinate (10~3m); cells were incubated with steroid for 48 hr when cell viability and
total cell concentration were assessed. Solid bar, methylprednisolone sodium succinate treated;
open bar, control. Each bar represents the mean of three separate experiments.
much less potent than the other glucocorticoids (fig. 6). Inactivation of any
residual specific glucocorticoid binding by globulins in the serum by heating for
1 hr at 56° before adding it to the culture medium had no significant influence
on the cytolethal response obtained with either hydrocortisone sodium suc¬
cinate or methylprednisolone sodium succinate.
Kinetics of lethal glucocorticoid response
We studied the kinetics of the lethal response to methylprednisolone
sodium succinate at concentrations within the range 0-75X 10_3-2x 10~3m—
known to produce a lethal effect by 48 hr. With the higher concentrations
(1 x 10"3-2x 10-3m) a brief lag phase was observed before progressive lethal
effects ensued (fig. 7), whilst with the lower concentration (0-75 x 10~3m) there
was a more protracted latent interval.
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Fig. 6.—Lethal effects of various gluco¬
corticoids on BLAi (O O) and
RUS2 (x x) cells. Exponentially
growing cells were incubated with
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sodium succinate ( ) for 48 hr
when cell viability was assessed. Each
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Duration ofglucocorticoid pulse and lethal response
The duration of the glucocorticoid pulse to which cells were exposed was
varied by washing cultures free of a lethal dose of methylprednisolone sodium
succinate (10_3m) at intervals up to 48 hr. Continued exposure to steroid was
necessary for progression of lethal effects (fig. 8).
1.2 r-
12 24 36 48
Incubation time (hr)
fig. 7.—Kinetics of glucocorticoid lethal response in blai cells treated with 0-75 x10~3m (O O),
1 x 10-3m (x x) or 2x10"3m (h b) of methylprednisolone sodium succinate.
Samples were removed at the times shown and assessed for viability. Each point represents
duplicate observations from one typical experiment.
Discussion
Steroid binding
Under our culture conditions steroid penetrated readily into whole cells and
was retained with the same high affinity and at comparable levels of saturation
as previously demonstrated in cytoplasmic extracts of disrupted lympho-
blastoid cells. However, the role of cytoplasmic receptors in initiating lethal
steroid responses has still to be resolved. It seems clear that there is no direct
correlation between the absolute levels of cytoplasmic receptors in cells and
their sensitivity to lethal steroid effects. The complex nature of steroid acti¬
vation has been revealed in recent studies with mouse lymphoma cells (Sibley
and Tomkins, 1974) and it seems possible that resistance to lethal hormone
effects can occur at several points in the hormone activation pathway. Recent
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work has suggested that reductions in growth rate in vitro may be a more sensi¬
tive indicator of cell death in vivo than uptake of supravital dyes (Bhuyan et al.,
1976; Roper and Drewinko, 1976). We are currently investigating the relation¬
ship between nuclear binding of receptor-steroid complexes and cytostasis in
vitro; preliminary results suggest that this may have a more direct bearing on
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Fig. 8.—Duration of melhylprednisolone sodium succinate (10~3m) pulse and cytolethal effect on
RUS2 cells. Cells were washed free of steroid at the times shown (parenthesis). Cell viability
was assessed before washing (O O) and at intervals afterwards (x x) up to 48 hr.
Each point represents duplicate observations from one typical experiment.
We have also shown that inhibition of uridine and thymidine uptake into
BLAj cells is virtually instantaneous with a lethal concentration of methyl¬
prednisolone sodium succinate (1-4x 10"3m) (Waddell, Bird and Currie, 1976,
1977). Methylprednisolone sodium succinate appears to act by competitively
inhibiting facilitated diffusion uptake of uridine and thymidine. Since the
extent of inhibition is independent of the concentration of cytoplasmic recep¬
tors, and is too rapid to allow time for alterations in transcription and transla¬
tion, this also indicates that cytoplasmic receptors are not involved. The " cell
surface " is a possible alternative target for the action of methylprednisolone
sodium succinate in our system.
Glucocorticoid sensitivity of cell lines
These studies confirm our previous observation (Bird et al., 1975) that lethal
effects in human lymphoblastoid cell lines and in fresh peripheral blood lympho-
blasts from patients with acute lymphoblastic leukaemia can only be achieved
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in vitro with doses of glucocorticoids which greatly exceed normal physiological
and pharmacological levels. Assuming that equilibration of steroids within the
fluid compartments of the body is equal and non-concentrative, the highest
pharmacological doses of glucocorticoids employed in clinical practice (100-
500 mg/m2 body surface) would achieve peak intracellular concentrations
around 1-5x10~5m. Maximum physiological plasma steroid levels are
generally considered to be about 10~6-10~7m, much of which is probably
bound to plasma corticosteroid binding globulin (transcortin) (Burton and
Westphal, 1972). Thus human lymphoblastoid cells in vitro exhibit marked
resistance to concentrations of glucocorticoids which are normally considered
to have cytolethal activity in vivo. In this respect they differ fundamentally
from rat thymocytes and mouse lymphoma cells which are much more sensitive
to concentrations of steroid in the physiological and pharmacological range
(Harris, 1970; Munck and Wira, 1971; Rosenau et al., 1972; Turnell, Clarke
and Burton, 1973).
Our studies also show that the insensitivity of cultured human lympho¬
blastoid cells to glucocorticoids cannot be attributed to the steroid preparation,
steroid solvent or cell density at which routine cytolethal tests are performed.
All experiments were performed at optimal cell concentrations with methyl-
prednisolone sodium succinate in aqueous solution, the most potent of the
glucocorticoid preparations examined; and extension of the period of exposure
of cells to steroid for as long as 168 hr did not significantly augment the cyto¬
lethal response. This suggests that either lethal steroid mechanisms in vitro
differ fundamentally from those pertaining in vivo or the pharmacological
activity of glucocorticoids in vivo does not involve a direct cytolethal action.
Kinetics of lethal glucocorticoid response
Kinetic studies of the lethal steroid hormone response in vitro reveal patterns
suggestive of a dose-dependent relationship with maximal lethal effects occur¬
ring only where there is continuous exposure of cells to the steroid. Whilst the
possibility remains that the resistance of human lymphoblastoid cell lines to
lethal steroid effects results from a change in biological sensitivity induced by
the long peroid of cultivation of cells in vitro, our previous studies have shown
that fresh lymphoblasts from patients with acute lymphoblastic leukaemia
exhibit similar resistance in vitro despite an apparent clinical response to drug
combinations which included pharmacological doses of steroid (Bird et all).
It seems possible, therefore, that the pharmacological concentrations of steroid
routinely employed in clinical practice may be insufficient to produce significant
lethal effects per se but in combination with other chemotherapeutic agents act
in a synergistic fashion to achieve a massive cytolethal response.
Summary
Glucocorticoid hormones penetrate rapidly into intact lymphoblastoid cells
and are retained with the same high affinity and specificity as with cytoplasmic
extracts.
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Optimal conditions for lethal glucocorticoid responses in vitro were deter¬
mined for a series of human lymphoblastoid cell lines by using different gluco¬
corticoid preparations, and steroid solvents and by varying the cell density.
Kinetic studies revealed that lethal glucocorticoid effects are dose-dependent
and that continuous exposure of cells to steroid is necessary for progression of
lethal effects to occur.
Even under optimal conditions, human lymphoblastoid cells only exhibit a
marked cytolethal response to glucocorticoids at concentrations which greatly
exceed both physiological and therapeutically attainable steroid levels. They
are also greatly in excess of steroid levels required to saturate the cytoplasmic
receptors of intact or disrupted lymphoblastoid cells. It is suggested that either
lethal steroid mechanisms in vitro differ fundamentally from those in vivo or the
pharmacological activity of glucocorticoids in vivo does not involve a direct
cytolethal action.
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MORPHOLOGICAL ASPECTS OF GLUCOCORTICOID-
INDUCED CELL DEATH IN HUMAN LYMPHOBLAS-
TOID CELLS
Alison M. G. Robertson, C. C. Bird,* A. W. Waddell and A. R. Currie
Department ofPathology, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG
Plates LI-LV
In both normal and neoplastic tissues cell death is an important parameter in
growth kinetics (Steel, 1967; Laird, 1969) but little is known about the
mechanisms involved.
Coagulative necrosis (McLean, McLean and Judah, 1965; Saladino and
Trump, 1968; Hawkins et ah, 1972; McDowell, 1972) and in-vitro autolysis
(Trump and Ginn, 1969) result from the breakdown of normal homeostatic
control mechanisms, and usually occur with total disruption of structure of
affected areas. In vivo there is usually associated inflammation in surrounding
viable tissues (Majno, 1964).
Apoptosis, a morphologically distinctive type of cell death involved in cell
deletion in vivo (Kerr, Wyllie and Currie, 1972), affects scattered single cells
without surrounding structural damage or inflammation. In some situations it
appears to play a role complementary to mitosis in the controlled regulation of
normal (Wyllie et al., 1973) and tumour cell populations (Kerr et al.).
It is well established that glucocorticoid hormones exert cytolethal effects on
normal and neoplastic lymphoid cells (Dougherty and White, 1945; Burton,
Storr and Dunn, 1967; Whitfield, Perris and Youdale, 1968), and these steroids
are employed extensively in the treatment of lymphoid tumours in man (DeVita,
1973; Simone, 1974; Schein et al., 1975). The mechanisms by which they
induce tumour regression have yet to be resolved.
Since it is not possible to study sequential biochemical events in man in vivo,
we have been investigating the biochemical and associated morphological
changes in glucocorticoid-induced cell death of human lymphoblastoid cells in
vitro (Bird et al., 1975; Bird et al., 1977; Waddell, Bird and Currie, 1977).
This system involves cell death in a controlled environment and furthermore is
uncomplicated by the presence and action of phagocytic cells.
We here record the morphological aspects of cell death induced by a cyto¬
lethal concentration of methylprednisolone sodium succinate (500 /xg/'ml) on
a cell line (BLAi) derived from a patient with acute lymphoblastic leukaemia.
Materials and methods
Cell culture. The BLAi cell line was established from the peripheral blood of a patient
with acute lymphoblastic leukaemia; its characteristics have been described previously
Received 30 Apr. 1978; accepted 3 May 1978.
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(Bird et al., 1975). The cells were grown in suspension culture in conical glass flasks or roller
culture bottles in Eagle's minimum essential medium (MEM, GIBCO Bio-cult, Scotland)
supplemented with 20 per cent, heat-inactivated (56°C for 1 hr) foetal calf serum (FCS,
GIBCO Bio-cult, Scotland) at 37°C in a humidified atmosphere of 5 per cent. CO2 in air.
Stock cultures were maintained at densities between 2 and 10 x 105 cells/ml by feeding with
fresh medium every 3-4 days.
Glucocorticoid. Methylprednisolone sodium succinate (MPS) (Solumedrone, Upjohn,
England) was dissolved in sterile distilled water.
Morphological studies. Cultures of BLAi cells in logarithmic growth phase were treated
with MPS to give a final concentration of 500 /xg/ml steroid. Control cultures were treated
with the appropriate volume of sterile distilled water.
Cell preparation for light microscopy (LM). Samples were removed sequentially over a
48-hr treatment period (see table). Smears of 2-5 x 105 cells were prepared on glass slides,
air-dried, fixed in 95 per cent, methanol for 30 min., stained with 4 per cent, (v/v) Giemsa
(Gurr's Improved R66, Searle Diagnostic, England) for 10 min. and mounted in Harleco
synthetic resin (Harleco, Belgium).
Cell preparation for transmission electron microscopy ITEM). Samples were removed
sequentially over a 48-hr treatment period as for light microscopy (see table). 50-100 x 105
cells were centrifuged at 400 xg for 5 min. at room temperature, and the resulting pellet
resuspended in 1 ml of reconstituted sterile frozen-dried human plasma. All subsequent
procedures, unless otherwise mentioned, were carried out at 4°C. Three per cent, gluteralde-
hyde (TAAB, England) in 0-2m sodium cacodylate buffer (BDH, England) at pH 7 was added,
the suspension fixed for 1 hr and then centrifuged at 2000 xg for 5 min. to form a compact
pellet. After further fixation for 2 hr, the pellet was washed in 0-2m sodium cacodylate buffer
for 2 hr, post-fixed for 1 hr in 1 per cent, osmium tetroxide (Johnson Matthey, England) in
0-2m sodium cacodylate buffer, rewashed in buffer for 30 min. and dehydrated in increasing
concentrations of ethanol. The cells were resuspended in epoxy-propane (BDH, England) at
room temperature, and then impregnanted and set in epon resin (TAAB, England). Thin
sections were cut on an LKB Ultrotome I with glass knives and mounted on formvar (TAAB,
England) coated grids (Athene-type old 400). These were stained with saturated uranyl
acetate (BDH, England) in 50 per cent, ethanol for 15 min. followed with 004m lead citrate
(BDH, England) in 0 02m sodium hydroxide for 5 min. Sections were viewed on an AEI
Corinth 275 electron microscope.
Cell preparation for scanning electron microscopy (SEM). Samples were removed at
0-5, 1, 2, 3, 4, 6 and 12 hr after treatment. The cells were centrifuged gently (250xg for
5 min.) and resuspended at 50 x 105 cells/ml in the medium in which they were grown. One
drop of this suspension was placed at either end of a 6 x 35 mm coverslip and allowed to settle
for 30 min. The cells were fixed by addition of one drop of 1 per cent, osmium tetroxide in
0-2m cacodylate buffer, and after 30 min. were gradually dehydrated by passing through
increasing concentrations of acetone, and stored in 100 per cent, acetone. The samples were
dried by critical point drying, which involved the substitution of acetone with liquid CO2 and
raising the temperature until it was above the critical point at which there is instantaneous
evaporation of the CO2. After coating with gold, the samples were viewed in a Cambridge
Stereoscan 180 microscope.
Results
LM and TEM observations on lethal glucocorticoid response
Control cultures. BLAi cells were round, oval or elongated with occasional
cytoplasmic protrusions and long slender surface processes; cytoplasmic
vacuoles were common (fig. 1). Ultrastructurally (fig. 2), the cytoplasm was
rich in free polysomes and contained scanty profiles of rough endoplasmic
reticulum, mitochondria with plate-like cristae, Golgi apparatus and lipid
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droplets. Cells showed a high nuclear to cytoplasmic ratio and the nuclei,
usually one per cell, were of variable shape and size with chromatin dispersed
diffusely throughout the nucleoplasm and with one or more nucleoli (figs. 1 and
2). Scanty aggregates of heterochromatin were seen round the periphery of the
nucleus (fig. 2). Small numbers of necrotic cells were also observed (vide infra).
Treated cultures. No significant differences were observed from control
cultures until 1 hr after incubation with 500 /xg/ml MPS (table) when two
distinctive morphological changes were seen.
The first type of change, whose incidence was markedly increased from 1 to
6 hr after treatment with a peak at 2 hr (table), involved " blebbing " of the cells.
The cells showed loss of long slender surface processes with contortion and
blebbing of the cytoplasm and indentation of the nucleus, which sometimes
showed pyknosis and fragmentation (fig. 3). The " blebbing " cells then broke
Table
Percentage morphological types in smear preparations of BLAi cell cultures during treatment
with 500 pg/ml methylprednisolone over 48 hr
Percentage* morphological type
Time after Degenerate cells and
treatment degenerate fragments with
(hr) Normal " Blebbing " " Rounding-up " nuclear remnants
0 93-5 01 0-5 5-9
0-5 94-8 01 0-4 4-7
1 90-1 2-6 1-6 5-7
2 79-1 4-6 7-5 8-8
3 71-8 3-2 121 12 9
4 67-4 2-9 14-4 15-3
6 62-6 1-2 110 25-2
8 58-9 0-6 8-4 32-1
12 580 0-6 5-5 35-9
24 36-8 0-2 3-7 59-3
48 3-9 01 4-3 91-7
Control! 92-9 0-3 0-8 60
* 1000 cells scored per smear. Each value represents the mean of five separate experiments,
t Control percentages represent the means of counts at 0 hr and 48 hr.
into discrete membrane-bounded cellular fragments of variable size containing
some apparently normal organelles (fig. 4). In this example the nuclear
membrane still appears to be intact and there is no evidence of pyknosis.
By contrast, the second type of change, whose incidence was increased from
1 to 48 hr after treatment with a peak at 4 hr (table), involved " rounding up "
of the cells. These cells showed loss of protrusions and long slender surface
processes and this was accompanied by marked nuclear pyknosis and frag¬
mentation (figs. 5 and 6). In smears, the cytoplasm became intensely staining
and vacuoles appeared to congregate together within the cytoplasm (fig. 5).
This was confirmed by TEM (fig. 6) which demonstrated aggregation of cyto¬
plasmic organelles: several mitochondria with cristae were visible. The
pyknotic nuclei showed nuclear membrane breakdown (fig. 6).
Whilst these were the earliest morphological changes, from 3 hr onwards
after treatment an increasing percentage of cells and fragments began to show
184 ALISON M. G. ROBERTSON, C. C. BIRD, A. W. WADDELL, A. R. CURRIE
more marked degenerative changes (table), and at 48 hr over 90 per cent,
showed features of autolysis (Trump and Ginn). In smears, these cells were
recognised by their diminished intensity of nuclear and cytoplasmic staining.
Ultrastructural features typical of this late-stage process of cell death included
focal dissolution of the plasma membrane and breakdown of cytoplasmic
organelles, distended mitochondria with flocculent matrix densities and loss of
cristae, and further dissolution of the fragmented nucleus, the nucleoplasm
becoming increasingly electron lucent (fig. 7).
About 4 per cent, of the cells appeared to have survived steroid treatment
and retained normal morphology 48 hr after treatment (table).
Small numbers of necrotic cells were also seen in control cultures (table).
In smears these cells contained pyknotic nuclear fragments, and " blebbing "
cells and cellular fragments, with or without nuclear remnants, were also seen.
Ultrastructurally, some cells showed dilatation of the endoplasmic reticulum
and Golgi apparatus, with indentation of the nucleus and distension of the
nuclear envelope. Other ultrastructural changes typical of autolysis were also
occasionally observed. These observations suggest that death by both
" rounding up " and " blebbing ", followed by further degenerative changes,
were also naturally occurring in normal cultures.
SEM observations on lethal glucocorticoid response
Control BLAx cells were basically round with a " ruffled " surface, and
occasionally processes were seen adhering to the substrate (fig. 8). After
addition of 500 ^g/ml MPS there was an increase in the number of cells showing
" blebbing " on an otherwise smooth cell surface (fig. 9), and this reached a
peak 2-3 hr after treatment. Cells were examined up to 12 hr after treatment,
over which period there was a gradual increase in the number of small,
subcellular particles in the samples, and of cells with an irregular surface
morphology (fig. 10), which presumably were " rounding up " cells. A gradual
accumulation of enlarged cells and cell fragments were also seen and these were
undoubtedly autolytic.
Discussion
The BLAi cell line studied had morphological features typical of human
lymphoblastoid cells (Nilsson, 1971; Nilsson and Ponten, 1975).
In treated cultures, many of the morphological manifestations of the lethal
response to 500 /xg/ml MPS were consistent with apoptosis (Kerr et al., 1972).
The features are also similar to " popcorn " and " ballooning " processes of
cell death described in Hela cells after treatment with lymphotoxin (Russell,
Rosenau and Lee, 1972).
In our system, from 1 hr onwards after treatment with MPS, cells died by
•either " blebbing " or " rounding up ". " Blebbing " cells showed contortion
of the cytoplasm and nucleus resulting in the formation of discrete membrane-
bounded fragments of variable size containing some apparently normal
organelles; in some cases nuclear pyknosis preceded cellular and nuclear
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Fig. 1.—Control BLA] cells. The cell surface shows cytoplasmic protrusions (P) with numerous long
slender surface processes (SP), and the cytoplasm contains many clear vacuoles (V). The cells
have a high nuclear to cytoplasmic ratio, with the nuclei (N) showing diffusely dispersed
chromatin. Giemsa (G). X1500.
Fig. 2.—Transmission electron micrograph (TEM) of control BLAj cell. The cytoplasm is rich in
polysomes (P) with scanty profiles of rough endoplasmic reticulum (RER), mitochondria with
plate-iike cristae (M), Golgi apparatus (G) and lipid droplets (L). The nucleus (N) shows
diffusely dispersed chromatin with a prominent nucleolus (NU). Some scanty aggregates of
heterochromatin are seen along the nuclear membrane. Uranyl acetate and lead citrate
(UALC). X 8000.
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Fig. 3.—BLAi cells 2 hr after treatment with 500 ng/ml MPS. The cell (arrowed) shows marked
cytoplasmic and nuclear blebbing. The nucleus shows pyknosis and fragmentation. G. X4000.
Fig. 4.—TEM of BLAi cell I hr after treatment with 500 /xg/ml MPS. The cell is represented by a
cluster of membrane-bounded fragments, most of which contain structurally recognisable
organelles and one of which contains nuclear material (arrowed). (JALC. X8800.
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Fig. 5.—BLAi cells 4 hr after treatment with 500 jug/ml MPS. The cells show rounding up with loss
of surface protrusions and slender surface processes. The cytoplasm contains aggregated
vacuoles. The nuclei show pyknosis and fragmentation. G. X4000.
Fig. 6.—TEM of BLAi cell 6 hr after treatment with 500 /xg/ml MPS. The cell shows rounding up
with loss of surface protrusions and slender surface processes and cytoplasmic organelles are
aggregated together. The nucleus shows pyknosis with nuclear membrane breakdown. UALC.
x 9300.
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Fig. 7.—TEM of BLAi cell 4 hr after treatment with 500 /ig/ml MPS. The cell shows marked
degenerative changes with focal dissolution of the plasma membrane and loss of structure of
cytoplasmic organelles. The pyknotic and fragmented nucleus is becoming electron lucent.
UALC. x 13,800.
Fig. 8.—Scanning electron micrograph (SEM) of control BLAi cell. The cell shows a "ruffled"
surface with processes adhering to the substrate, x 10,400.
Robertson, Bird, Waddell and Currie
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Plate LV
Fig. 10.—SEM of BLA| cell 4 hr after treatment with 500 fig/ml MPS. The cell shows an irregular
surface, x 10,400.
GLUCOCORTICOID-INDUCED CELL DEATH 185
fragmentation. All these changes occur in apoptosis in vivo (Kerr et al.). The
" rounding up " cells also showed morphological changes typical of apoptosis:
loss of cytoplasmic protrusions and long slender surface processes, condensation
and preservation of structure of cytoplasmic organelles, and nuclear pyknosis
and fragmentation.
Both the " blebbing " and " rounding up " forms of cell death appear to
have certain features in common, but from these studies it is not possible to say
whether they are two distinct early changes or whether one form precedes the
other (see table). We cannot claim that " rounding up " precedes " blebbing "
which is the established sequence of events in apoptosis in vivo (Kerr et al.).
However, it seems likely that the response of cells in suspension culture in vitro
will differ in some respects from that of cells " organised " in vivo.
From 3 hr onwards after treatment, increasing numbers of dying cells and
fragments showed further degradative changes typical of coagulative necrosis
in vivo (Trump and Ericsson, 1965; Trump and Arstila, 1971) and of autolysis
in vitro (Trump and Ginn, 1969) or post-mortem autolysis. Such degenerative
changes are found in apoptosis in vivo after apoptotic bodies are phagocytosed
by surrounding viable cells. However, it seems reasonable to suggest that in an
in-vitro system, in the absence of phagocytes, " autolysis " would be expected
to occur in apoptotic bodies. We suggest that the morphological changes
demonstrated in our system are consistent with apoptosis followed by autolysis.
Certain in-vivo studies also support such a possibility: in mouse ascites
tumour cells treated with various non-steroidal cancer chemotherapeutic agents
(Searle et al., 1975), many tumour cells which initially undergo apoptosis,
ultimately exhibit the features of coagulative necrosis while lying free in ascitic
fluid, where apparently there are few active phagocytes. The same sequence
of changes has also been noted in apoptotic cells shed into the glandular lumina
of the involuting rat prostate in castration-induced atrophy (Kerr and Searle,
1973).
The morphology of spontaneous cell death in control cultures in vitro has
received scant attention and it is of interest that we found precisely the same
sequence of changes—albeit affecting only a small proportion of cells (see table)
—as described after treatment with methylprednisolone.
Since human lymphoblastoid cells treated in vitro with glucocorticoids show
a sequence of morphological changes closely similar to apoptosis in vivo we
believe this provides a suitable system for studying the early biochemical events
and intracellular control mechanisms involved in apoptosis.
Summary
Morphological aspects of cell death associated with a cytolethal concentra¬
tion ofmethylprednisolone sodium succinate (500 /xg/ml) on the BLAi lympho¬
blastoid cell line were studied over a 48-hr incubation period by light, transmis¬
sion and scanning electron microscopy.
Studies revealed two distinctive morphological changes induced by the
steroid from 1 hr onwards after treatment. One showed contortion and
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" blebbing " of the cytoplasm and nucleus accompanied or followed by nuclear
pyknosis, resulting in the formation of membrane-bounded bodies containing
apparently normal cytoplasmic organelles with or without nuclear fragments.
The other showed " rounding up " of the cell with loss of cytoplasmic pro¬
trusions and long slender surface processes, aggregation of well-preserved
cytoplasmic organelles, accompanied by nuclear pyknosis and fragmentation.
In both cases many of the features are typical of apoptosis. The subsequent
degeneration of cells and fragments not unexpectedly resembled in-vitro
autolysis.
This in-vitro system is suitable for studying the early biochemical events and
intracellular control mechanisms of apoptosis.
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